Transfert d'énergie par résonance de type Förster résolu en temps pour la bio-détection multiplexée des acides nucléiques by Guo, Jiajia
HAL Id: tel-02165949
https://tel.archives-ouvertes.fr/tel-02165949
Submitted on 26 Jun 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Time-resolved Multiplexed Förster Resonance Energy
Transfer for Nucleic Acid Biosensing
Jiajia Guo
To cite this version:
Jiajia Guo. Time-resolved Multiplexed Förster Resonance Energy Transfer for Nucleic Acid Biosens-
ing. Optics / Photonic. Université Paris Saclay (COmUE), 2019. English. ￿NNT : 2019SACLS162￿.
￿tel-02165949￿
 
  
 
 
Time-resolved Multiplexed Förster 
Resonance Energy Transfer for 
Nucleic Acid Biosensing 
 
 
 
 
Thèse de doctorat de l'Université Paris-Saclay 
préparée à l'Université Paris-Sud 
 
 
 
École doctorale n°575: 
 Electrical, Optical, Bio: PHYSICS_AND_ENGINEERING 
(EOBE) 
Spécialité de doctorat: Physique  
(Electronique et Optoélectronique, Nano et Microtechnologies) 
 
 
 
 
Thèse présentée et soutenue à Orsay, le 18 Juin 2019 
 
 Mme Jiajia GUO  
 
 
 
 
 
Composition du Jury : 
 
Mme Rachel Méallet-Renault 
Professeure, Université Paris-Sud                                                  Présidente 
 
Mme Julia Pérez-Prieto 
Professeure, University of Valencia                                                Rapporteur 
 
M. Marcus Wilhelmsson 
Professeur, Chalmers University Gothenburgh                               Rapporteur 
 
M. Andreas Reisch 
Maître de conférences, Université de Strasbourg                           Examinateur 
 
M. Niko Hildebrandt 
Professeur, Université Paris-Sud                                                    Directeur de thèse
N
N
T
 :
 2
0
1
9
S
A
C
L
S
1
6
2
 
 
Université Paris-Saclay           
Espace Technologique / Immeuble Discovery  
Route de l’Orme aux Merisiers RD 128 / 91190 Saint-Aubin, France  
 
Titre: Transfert d'énergie par résonance de type Förster résolu en temps pour la bio-détection 
multiplexée des acides nucléiques 
Mots clés: FRET, complexe de lanthanide, multiplexage, résolue dans le temps, acides nucléiques 
Résumé: Les biomarqueurs à base d’acides 
nucléiques, qui sont impliqués dans le contrôle 
de l'expression génétique, sont spécifiques de 
nombreux types de cancers. Les applications 
basées sur le transfert d'énergie par résonance de 
Förster (FRET) sont parmi les plus prometteuses 
pour la biodétection d’acides nucléiques. 
Comme la détection simultanée de plusieurs 
acides nucléiques est très demandée et que le 
multiplexage spectral est limité par des 
interférences (optical crosstalk), le multiplexage 
temporel est utilisé ici pour ajouter de nouvelles 
possibilités de multiples détections simultanées. 
La thèse porte sur le développement de systèmes 
comprenant différentes distances entre 
molécules donneuses et acceptrices de FRET 
(Terbium vers fluorophores) pour créer des  
 
signaux d'intensité spécifiques correspondant à 
différentes séquences d'acides nucléiques. Les 
distances Tb-to-dye peuvent être arrangées en 
positionnant spécifiquement le donneur Tb sur 
des molécules d’ADN de différentes longueurs. 
Les technologies d'amplification d’acides 
nucléiques, telles que la réaction d'hybridation en 
chaîne (HCR) et l’amplification circulaire de 
l’ADN (RCA), ont été utilisées pour obtenir 
simplicité, rapidité, sélectivité et sensibilité dans 
la détection d’acides nucléiques. Le 
multiplexage temporel du signal de FRET a 
également été combiné avec le multiplexage 
spectral (couleur) pour le démultiplier. De plus, 
la possibilité d'un multiplexage temporel à base 
de nanoparticules a été démontrée. 
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Abstract: Nucleic acid biomarkers, which 
involve in gene expression control, are found 
specific for many kinds of cancers. Förster 
Resonance Energy Transfer (FRET) based 
applications are one of the most promising for 
nucleic acid biosensing. As parallel detection of 
multiple nucleic acids is highly demanded and 
spectral multiplexing is limited by optical 
crosstalk, temporal multiplexing is used for 
opening another dimension of the multiplexing. 
The thesis focuses on developing different Tb-
to-dye FRET distances to create specific 
intensity signals corresponding to different 
nucleic acid sequences. The Tb-dye distances 
can be tuned by specific location of the Tb donor 
using different lengths of DNA. Amplification 
technologies, such as hybridization chain 
reaction (HCR) and rolling circle amplification 
(RCA), are used to achieve simplicity, rapidity, 
selectivity, and sensitivity of nucleic acid 
detection. Temporal multiplexing FRET was 
also combined with spectral (color) 
multiplexing for higher order multiplexed 
detection. Moreover, a single Tb-QD FRET 
modeling demonstrated the possibility of 
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1. Introduction 
Cancer kills millions of people every year and it is one of the greatest health challenges of 
human beings. The 2018 Nobel Prize in Physiology or Medicine was awarded to James P. 
Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative 
immune regulation. If cancer can be diagnosed at an early stage, it will greatly increase the 
chance for successful treatment. Recognizing possible warning signs of cancer and taking 
prompt action leads to early diagnosis.  
One of the best ways to diagnose cancer early is to use serum or tissue biomarkers. Cancer 
biomarkers can be DNA, RNA, proteins, metabolites, or processes such as apoptosis, 
angiogenesis or proliferation[1]. Such biomarkers are produced either by the tumor itself or by 
other tissues and can be found in a variety of fluids, tissues and cell lines, in response to the 
presence of cancer or other associated conditions. MicroRNAs (miRNAs) which are small 
(~22bp) highly conserved non-coding RNAs endogenously expressed in every cell type, have 
emerged as a new type of cancer-specific biomarker[2]. They function as key regulators of gene 
expression by silencing target transcripts through base-pair complementation. MicroRNAs can 
be secreted from cells and are found in a variety of body fluids including blood, saliva, and 
urine, where they are quantifiable and extremely stable[1]. For these reasons, miRNAs are 
becoming ideal candidates as non-invasive biomarkers for cancer. 
Förster resonance energy transfer (FRET)-based nucleic acid detection is one of the most 
promising techniques that can meet almost all the demands for a fast, simple, and multiplexed 
diagnostic[3]. FRET is a non-radiative energy transfer from an excited donor (FRET-donor) 
molecule to a ground state acceptor molecule (FRET-acceptor) through dipole-dipole 
interactions[4]. The principal conditions for FRET are the donor and acceptor should be in close 
proximity to each other and have a spectral overlap between the donor emission and the acceptor 
absorption. Due to their strong distance-dependence, FRET biosensors are very sensitive for 
analyzing biological interactions and structural changes in a nanoscale range of ca.1-20 nm. For 
most FRET-based nucleic acid detection assays, both donor and acceptor are conjugated with 
DNA, the target miRNA can complement them to change the distance between donor and 
acceptor, thereby changing the FRET efficiency and lifetime. MicroRNAs can be qualitatively 
and quantitatively detected by the change of FRET efficiency and photoluminescence (PL) 
intensity of donor or acceptor[5]–[9]. 
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As the increasing application of FRET, many kinds of fluorophores have been used as FRET 
donor. Compared to other traditional fluorophores, luminescent terbium complex (LTC) as 
FRET donor has unique advantages for multiplexing detection in combination to different 
FRET acceptors, such as organic dyes and quantum dots (QDs)[10], [11]. Due to the forbidden 
intra-configurational f-f transitions in the terbium ions, LTC provides distinguished 
photophysical properties, like large Stokes shift, multiple narrow emission bands and extremely 
long excited-state lifetimes (up to the milliseconds’ range) which allow for time-gated (TG) 
measurements[12]. The distinction between the FRET signal and short-lived auto-fluorescence 
background and high detection sensitivity for biological applications all benefit from time-gated 
measurements. The emission bands of Tb are well separated and therefore superior for spectral 
multiplexing; the long and distinguished decay time of the sensitized acceptors due to different 
FRET efficiencies provide a great potential for temporal multiplexing. 
Fluorescent dyes, also known as reactive dyes or fluorophores, are non-protein molecules that 
absorb light and re-emit it at a longer wavelength. They have been used in biological studies 
for decades because they are easy to handle and less toxic. Fluorescent dyes offer higher 
photostability and brightness and do not require a maturation time. Fluorescent dyes are popular 
because of their high quantum yields, solubility, and ease of bioconjugation. The large variety 
and wide commercial availability of fluorescent dyes have made them the most frequently 
applied class of fluorophores for FRET[13], [14]. The combination of LTC donors with 
fluorescent dye acceptors has been used for multiplexing FRET biosensing[15], [16]. Although 
multiplexed LTC-to-dye FRET is possible and can provide high sensitivity, the poor separation 
of the absorption and emission spectrum affect spectral crosstalk between different dye 
acceptors in spectral multiplexing, and appropriate correction is demanded. 
Regarding much narrower emission bands and size-tunable emission peaks, QDs are excellent 
FRET acceptor candidates for multiplexing. QDs have several unique intrinsic photophysical 
properties: relatively high quantum yields; the size- and material-tunable QDs can be used to 
give better spectral overlap with their FRET partner; 10 to 100 times higher extinction 
coefficient than fluorescent dyes which are extremely important for spectral overlap with the 
LTC emission[17], [18]. Förster distances R0 of more than 10 nm can be achieved by LTC-to-
QD FRET pairs which are significantly larger than the R0-values for conventional D-A 
pairs[19], [20]. The combination of LTC and QDs for FRET has a very high potential for the 
use in biosensing analysis with the possibility of high sensitivity and large Förster radii.  
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This thesis is divided into six chapters and completed by the appendix and the bibliography. 
Following the background of this work, three individual studies are presented. Each chapter is 
corroborated with introduction, materials and methods, results and discussion, and conclusion.  
The first study (Figure 1.1) presents a temporal duplexing assay for miRNA detection using a 
single Tb-dye FRET pair and hybridization chain reaction (HCR). I demonstrated the 
implementation of time-gated FRET between terbium donors and dye acceptors into HCR for 
multiplexed quantification of miRNAs (miR-20a and miR-21) and their DNA analogs. HCR-
TG-FRET provided washing-free nucleic acid quantification with very low limits of detection 
(LOD) down to 240 attomoles (1.7 pM) of miRNA and 123 attomoles (0.88 pM) of DNA. 
Efficient distinction from very homologous miRNAs demonstrated high target specificity. 
Multiplexing with a single measurement, a single excitation wavelength, and a single FRET 
pair allowed for simultaneous quantification of miR-20a and miR-21 at concentrations between 
30 pM and 300 pM from the same sample. HCR-TG-FRET showed similar performance for 
serum-free and serum-containing samples without the use of RNase inhibitors. Our results 
present a significant improvement in current HCR approaches regarding simplicity, sensitivity, 
and multiplexing. The versatile diagnostic performance of HCR-TG-FRET even in challenging 
biological environments presents an important advantage for advanced nucleic acid biosensing. 
 
Figure 1.1. Schematic representation for duplexed (miR-20a and miR-21) detection of miRNAs 
using HCR-TG-FRET.  
 
In the second study (Figure 1.2), I combined temporal multiplexing with spectral multiplexing, 
developed a quadrupling Tb-Dye FRET and rolling circle amplification (RCA) assay for single-
stranded DNA (ssDNA) detection. We demonstrated time-gated FRET from a long-lifetime Tb-
complex to Cy3.5 and Cy5.5 dyes for spectrotemporal multiplexing of four different DNA 
targets in the same sample by two time-gated windows for two different colors. We used rolling 
circle amplification (RCA) for high sensitivity and for placing Tb donors and dye acceptors at 
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controlled distances within the amplified DNA concatemers. We selected four different short 
ssDNAs (DNA-20a, DNA-20b, DNA-21, and DNA-191), which are the DNA-equivalents of 
the miRNAs hsa-mir-20a/20b/21/191, all of which have been found to be related to breast 
cancer. The principle of RCA-FRET is each DNA target is recognized by the terminal 
sequences of a specific padlock probe. After this hybridization step, a ligase closes the padlock 
nick over the target splint, which transfers the target into a primer for subsequent DNA synthesis. 
DNA amplification by RCA is performed at 37 °C for 2 h, and the resulting rolling circle 
product is labeled (specific hybridization) by Tb-donor and dye-acceptor DNA probes. The 
precise distance tuning led to target-specific PL decays of the FRET pairs and simple, 
separation-free, and higher-order multiplexed quantification of DNA. The RCA-FRET DNA 
assay could distinguish very homologous target sequences and provided limits of detection 
between 40 and 570 zeptomoles (0.3 to 4.1 fM) for four different DNA targets. We 
demonstrated the combination of the spectral and temporal dimensions of PL for higher-order 
multiplexing with the intensity dimension of PL for quantification of the four different DNAs 
at low femtomolar concentrations from the same sample, using a single excitation source and 
only two distinct fluorescence colors.  
    
Figure 1.2. The principle of spectrotemporal quadruplexing RCA-FRET assay and PL 
multiplexing in three dimensions. x-axis: lifetime; y-axis: color; z-axis: intensity 
 
In the third study (Figure 1.3), I investigated the Tb-to-QD temporal-multiplexing FRET by 
tuning the length of DNA. I analyzed 11 configurations of a 31 nt long DNA, which attached 
to QD by peptide-His6 sequence (peptide-DNA), with different Tb-conjugated complementary 
DNA probes hybridized at distances between 0 and 26 nt by time-resolved FRET and 
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biomolecular modeling. Our results show that the increasing Tb-to-QD distances led to 
increasing FRET-sensitized lifetimes of the decay curves, all 11 configurations can be 
distinguished without lifetime fitting of the curves.  The temporally distinct PL decays of the 
different DNA-FRET-configurations can be used for prototypical DNA hybridization assays. 
Such fine-tuning of PL decay curves via displacement of the Tb donor by only changing a few 
nucleotides demonstrates the high distance sensitivity of FRET and the possibility to extend 
nanoparticle-based temporal multiplexing. 
 
Figure 1.3. Top: Schematic representation for Tb-to-QD temporal-multiplexing FRET. 
Bottom: Biomolecular modeling was used to calculate Tb-to-QD distance ranges in parallel 
and vertical DNA-surface attachment configurations.  
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2. Background 
2.1 Nucleic acid biomarkers 
The term “biomarker”, short for “biological marker”, refers to an accurate and reproducible 
measurable indicator of some biological state or condition. In 1998, the National Institutes of 
Health Biomarkers Definitions Working Group defined a biomarker as “a characteristic that is 
objectively measured and evaluated as an indicator of normal biological processes, pathogenic 
processes, or pharmacologic responses to a therapeutic intervention”[21]. WHO International 
Programme on Chemical Safety gave an even broader definition of a biomarker as “any 
substance, structure, or process that can be measured in the body or its products and influence 
or predict the incidence of outcome or disease”[22]. Biomarkers have a range of potential 
clinical utilities, including identifying the presence of disease and characterizing disease 
subtype (diagnosis), determining disease prognosis, aiding in the selection of appropriate 
therapeutic doses, predicting clinical benefit or adverse response to therapy, and monitoring 
treatment outcomes[23]. In recent decades, promising candidate biomarkers such as proteins, 
metabolites, carbohydrates, steroids, lipids, peptides, nucleic acid and cells involved in different 
diseases such as cancer, metabolic disorders, inflammatory disorders, and diseases of nervous 
system and cardiovascular system have been reported[24], [25]. The focus of this work is on 
cancer-related nucleic acids biomarkers. The cancer diagnosis is the starting point of patient 
treatment, and a fast and accurate diagnosis is highly demanded.  
Nucleic acids include deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), which are 
essential for all forms of life. DNA stores genetic information and encodes the amino acid 
sequences of proteins responsible for cellular function. RNA plays various important roles in 
the coding, decoding, regulation, and expression of genes. Nucleic acids are used as important 
biomarkers for biological studies and medical diagnostics because sequence-specific 
hybridization and amplification technologies allow highly accurate and sensitive assessment of 
these biomarker levels over a broad dynamic range. In addition to their biological roles, nucleic 
acids can be used as high-affinity recognition molecules for ions, small molecules, proteins, 
and even whole cells[26], [27]. Nucleic acids can also be coupled with organic or inorganic 
materials for assembly and construction purposes[28].  
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2.1.1 MicroRNA biomarker 
MicroRNAs are one of the most important nucleic acids biomarker group. MicroRNAs are a 
class of ~22 nucleotide-long non-coding RNAs that play a central role in the regulation of gene 
expression by translational repression or degradation of messenger RNAs (mRNAs)[2]. 
Biogenesis of miRNA occurs through a multi-step process requiring both a nuclear and a 
cytoplasmic phase (Figure 2.1). Firstly, miRNA genes are transcribed into primary miRNAs 
(pri-miRNA) with a cap and a poly-A tail by pol II or pol III[29]. Pri-miRNA is characterized 
by a secondary hairpin structure. Then, pri-miRNAs are processed into short 70-110 nucleotides 
stem-loop structures known as precursor miRNAs (pre-miRNAs) by microprocessor complex, 
which consists of the RNase III enzyme Drosha, and a double stranded-RNA binding protein, 
Di George syndrome critical region 8 gene (DGCR8)[30]. Further processing of pre-miRNAs 
by the RNase III enzyme Dicer generate ~22 nucleotide miRNA duplexes (ds-miRNAs). This 
duplex binds to the active RNA-induced silencing complex (RISC) that performs gene silencing. 
Argonaute 2 (AGO2) unwinds the duplex, and removes the passenger strand retaining the 
mature miRNA molecule[31]. The mature miRNA functional strand is loaded into the RISC 
complex and AGO2. RISC-AGO2 complex guides the functional strand to target the 3’UTR of 
the target mRNA, causing translational inhibition or promoting their degradation. 
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Figure 2.1. Biogenesis of microRNA: miRNA is transcribed in the nucleus as a pri-miRNA 
and then is micro-processed by Drosha, a class 2 ribonuclease III enzyme, and transported to 
the cytoplasm by exportin 5 (XPO5) where the hairpin structure is removed by Dicer and a 
single-stranded mature miRNA is produced, which binds to RISC and induces gene silencing. 
(Reference [32], copyright 2018 SAGE Journals Publishers.)  
 
2.1.2 Cancer-associated miRNA 
Cancer is one of the leading causes of death worldwide. Subsequent investigations 
demonstrated that almost all cancers have an alternative miRNA expression profile compared 
to their adjunct normal tissues. Significant progress has been made on the relationship between 
miRNAs and cancers. For example, miR-181-5p, miR-361-5p, and miR-320b were 
significantly elevated in plasma exosomes of non-small cell lung cancers (NSCLC) patients[33]. 
The levels of miR-16-5p, miR-21-5p, and miR-199a-5p declined in plasma and tumor tissues 
of triple-negative breast cancer (TNBC) patients compared with both non-TNBC and healthy 
individuals, as well as miR-92a-3p and miR-342-3p elevated[34].  
Table 2.1 summarizes the blood-based circulating miRNA expression in the major cancer types. 
It clearly shows that some miRNAs are overexpressed in cancers, for example, miR-21 is highly 
expressed in breast cancer. In contrast, some miRNAs, for example, miR-128 is downregulated 
in brain cancer. More importantly, some miRNAs have different expression profile pattern in 
different cancer types. Like miR-103 is downregulation in breast cancer, but it is upregulation 
in prostate cancer. This alternative and unique expression pattern allows miRNAs to become 
good biomarker for early detection of cancers. 
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Table 2.1. Examples of the miRNA expression in the major cancer types. 
 
*(Reference [35], copyright 2018 Elsevier Publisher.) 
2.1.3 MicroRNA detection methods 
Detection of miRNA expression can help to identify miRNAs that regulate a range of vital 
processes and discover miRNA based biomarkers for diverse molecular diagnostic applications 
in cancer. Traditional strategies for detection of miRNA, including northern blotting, 
microarrays, and quantitative RT-PCR (qRT-PCR), have their relative strengths and 
weaknesses. Northern blotting is complex and requires radiolabeling, which can introduce 
significant contamination and has a low detection efficiency. Microarray is less expensive but 
does not have a lower sensitivity and dynamic range, therefore, it is often used as screening tool 
rather than as quantitative assay platform. qRT-PCR has the widest dynamic range and highest 
Cancer type miRNAs Expression statu Expression status
miR-7, miR-15b, miR-17-3p, miR-18a, miR-19a, miR-19b, miR-19a-3p, miR-20a, miR-21, miR-
25,miR-29a, miR-92, miR-92a, miR-92a-3p, miR-96, miR-106a, miR-106b, miR-133a, miR-139-3p, 
miR-143, miR-145, miR-155, miR-182, miR-183, miR-196a, miR-200c, miR-206, miR-210, miR-214, 
miR-221, miR-223-3p, miR-320a, miR-335, miR-372, miR-378, miR-409-3p, miR-423-5p, miR-431, 
miR-486, miR-720, miR-1180
Upregulated
miR-7, miR-24, miR-26a-5p, miR-29b, miR-30b, miR-93, miR-103, miR-106a, miR-107, miR-221, 
miR-124, miR-127-5p, miR-138, miR-142-3p, miR-143, miR-145, miR-146a, miR-151-5p, miR-191, 
miR-194, miR-199-3p, miR-218, miR-222, miR-320a, miR-375, miR-382, miR-409-3p, miR-422a, miR-
423-3p, miR-423-5p, miR-601, miR-652, miR-760, let-7d
Downregulated
miR-16, miR-19b, miR-21, miR-22a, miR-25, miR-29c, miR-92a, miR-96-5p, miR-127-3p, miR-133a, 
miR-145, miR-148a, miR-148b, miR-155, miR-199a, miR-222, miR-324-3p, miR-376a, miR-376c, 
miR-382, miR-409-3p, miR-424, miR-505-5p, miR-652, miR-801,
Upregulated
miR-103, miR-107, miR-195, miR-205, miR-200c, miR-451, let-7d, let-7i Downregulated
miR-16, miR-21, miR-34b, miR-92a, miR-92b, miR-103, miR-107, miR-130b, miR-141, miR-145, miR-
155, miR-197, miR-200a, miR-200c, miR-210, miR-221, miR-301a, miR-326, miR-328, miR-331-3p, 
miR-375, miR-432, miR-485-3p, miR-486-5p, miR-501-3p, miR-551b, miR-562, miR-574-3p, miR-
622, miRr-625*, miR-636, miR-640, miR-766, miR-885-5p, miR-1285, miR-2110
Upregulated
miR-30, miR-181a-2, let-7a, Let-7c, let-7e Downregulated
miR-15b-5p, miR-22, miR-26b, miR-28, miR-34b, miR-125a-5p, miR-125b, miR-145, miR-146a, miR-
191, miR-200b, miR-200c, miR-203, miR-205, miR-340, miR-425, miR-429, miR-590-3p, miR-766, 
miR-944, miR-3662
Upregulated
miR-15, miR-16, miR-16-5p, miR-17b-5p, miR-19-3p, miR-20, miR-20a-5p, miR-25, miR-28, miR-
34b, miR-92-3p, miR-148a, miR-148b, miR-152, miR-193a-5p, miR-203, miR-218, miR-323-3p, miR-
450b-5p, miR-485-3p, miR-566, miR-642, miR-661, miR-1290, let-7c
Downregulated
miR-210, miR-211 Upregulated
miR-29c, miR-324-3p, miR-509-3p, miR-509-5p, miR-4706, miR-4731 Downregulated
miR-26b-5p, miR-144-5p, miR-148b-3p, miR-152, miR-205, miR-374-5p, miR-663b Upregulated
miR-15b-5p, miR-27a-3p, miR-30a-5p, miR-92a, miR-100, miR-143, miR-497, miR-3187-3p Downregulated
miR-15b, miR-20a, miR-21, miR-106a, miR-128, miR-181b, miR-210, miR-220, miR-221 Upregulated
miR-29, miR-125b, miR-128, miR-342-3p, miR-497 Downregulated
miR-10b, miR-16, miR-17-5p, miR-18a, miR-20a, miR-21, miR-22-3p, miR-24, miR-25, miR-26b, miR-
27a-3p, miR-30c, miR-99a, miR-106b, miR-134, miR-146a, miR-150, miR-155, miR-181a, miR-181b, 
miR-182, miR-185, miR-191, miR-192, miR-194, miR-196a, miR-196b, miR-210, miR-212, miR-221, 
miR-375, miR-378, miR-484, miR-486-5p, miR-628-3p, miR-636, miR-642b, miR-885-5p, miR-938, 
miR-1290, miR-1825, miR-6075, miR-6836-3p
Upregulated
miR-26b-3p, miR-34a, miR-106b-3p, miR-122, miR-125a-3p, miR-126*, miR-145, miR-223, miR-
492, miR-505, miR-663a, miR-885-5p, miR-4294, miR-4476, miR-4530, miR-6799-5p, miR-6880-5p
Downregulated
Bladder 
Brain 
Pancreas
Colon 
Breast 
Prostate
NSCLC 
Melanoma
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accuracy and is the only method that can easily provide absolute miRNA quantification, 
however, it suffers from throughput issues. Except for these conventional detection methods, 
over the past decade, various methods have been implemented for sensitive, selective and high-
throughput detection of miRNAs, such as nanoparticle-derived probes, isothermal amplification, 
electrochemical methods, optical methods and other emerging technologies as summarized 
in Figure 2.2.  
 
Figure 2.2. Detection methods of miRNA. (Reference [36], copyright 2018 Elsevier Publisher.) 
 
2.2 Förster resonance energy transfer 
Förster resonance energy transfer is a well-established photophysical phenomenon of non-
radiative resonance energy transfer of excitation energy (not electron) from an excited donor 
fluorophore to a proximal ground-state acceptor. It was first established theoretically in 1948 
and was named after the German scientist Theodor Förster. FRET is analogous to near-field 
communication, in that the radius of interaction is much smaller than the wavelength of light 
emitted. In the near-field region, the excited chromophore emits a virtual photon that is instantly 
absorbed by a receiving chromophore. These virtual photons are undetectable since their 
existence violates the conservation of energy and momentum, and hence FRET is known as a 
radiationless mechanism[37]. The principal conditions for FRET are: (i) the energy of the 
electronically excited state of donor must be higher than the possible energy level of acceptor; 
(ii) there should be a spectral overlap between the donor emission and the acceptor absorption; 
(iii) the donor and acceptor should be in close proximity to each other (ca. 1-20 nm). The 
 
11 
 
applications of FRET have expanded tremendously in the last 30 years, and the technique has 
become a staple technique in many biological and biophysical fields. FRET is a highly distance-
dependent phenomenon and can be used as molecular ruler[38] to measure the distance between 
two positions of interest on a biological molecule by attaching appropriate donor-acceptor 
groups. If the molecule only involves one donor and one acceptor group, the distance between 
the donor and the acceptor can be measured when there is no conformational change. When the 
molecule has a big conformational change, FRET can also measure the dynamical activities 
between two sites on the molecule, such as protein interactions[39], [40]. FRET is widely 
applied in many other fields such as single-molecule experiments, biosensors and DNA 
mechanical movements[41]–[44]. This chapter provides the required theoretical background 
for successful use of FRET in biological applications.  
2.2.1 FRET theory 
FRET is understood as a non-radiative transfer through dipole-dipole interactions that allows 
electronic energy to be transferred from an excited donor D to a ground-state acceptor A[45], 
[46]. The donor and acceptor molecule can be seen as a group of coupled electrical oscillators. 
Donor oscillators will oscillate and generate their own electromagnetic field. Energy transfer 
only occurs when the acceptor oscillators are sensitive to the donor oscillators’ electromagnetic 
field and “share” electronic transitions, which enable the excitation of the molecule from its 
ground state to the excited state. These electronic transitions are presented in a simplified 
Jablonski diagram in Figure 2.3 (left) showing the basic principle of FRET. The donor is 
brought to an excited state (D*) from an electronic ground state (D) by light excitation (h𝜈), 
followed by inner relaxation (dotted arrows) to an excited electronic ground state and finally to 
the ground state by radiative decay (kD), non-radiative decay (kD-NR) or FRET (kFRET, dashed 
lines referring to possible resonant transitions). FRET (horizontal lines with dots on each end) 
occurs when the energy transitions of D* and A are in energetic resonance. After FRET, the 
acceptor is in an excited state (A*), followed by radiative decay (kA) and non-radiative decay 
(kA-NR) to its ground state. In spectroscopic terms, there should be a spectral overlap between 
the donor emission and the acceptor absorption spectra (Figure 2.3 right). So choosing a 
suitable FRET pair is the first step for successful FRET, as shown in Figure 2.4, there are many 
different fluorescent materials can be excellent FRET donor and acceptor. The selection of a 
correct FRET pair depends on the actual biological question to be investigated, the type of 
biological specimen, the available instrumentation and the technique applied to measure FRET. 
Various fluorescent proteins, organic dyes with improved photostability and excellent spectral 
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characteristics as well as quantum dots have been developed and used as FRET donor and 
acceptor.  
       
Figure 2.3. (Left) Simplified Jablonski diagram representing the energy levels of the donor (D) 
and acceptor (A) molecules. (Right) Spectral overlap between the donor emission and the 
acceptor absorption.  
 
 
Figure 2.4.  Examples of available FRET donor and acceptor candidates. (Reference [14], 
copyright 2006 Wiley-VCH Publisher.) 
 
FRET theory depends on the distance between the donor and the acceptor, the spectral overlap 
and their relative orientations, it can be summed up in below equations[47].  
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The rate of energy transfer is traditionally described as: 
                                                      𝑘𝐹𝑅𝐸𝑇 =
1
𝜏𝐷
(
𝑅0
𝑟
)
6
                                                             (2.1) 
where 𝜏𝐷 is the excited-state lifetime of the donor in absence of the acceptor; 𝑅0 is the Förster 
distance representing a transfer efficiency of 50 %; r is the donor-to-acceptor distance (Figure 
2.5). 
Then, the FRET efficiency is  
𝜂𝐹𝑅𝐸𝑇 =
𝑘𝐹𝑅𝐸𝑇
𝑘𝐹𝑅𝐸𝑇+𝜏𝐷−1
=
𝑅0
6
𝑅0
6+𝑟6
                                                  (2.2) 
The Förster distance R0 can be calculated by the spectral overlap integral between the emission 
spectrum of the donor and the absorption spectrum of the acceptor: 
𝑅0 = (
9(ln 10)𝜅2Φ𝐷
128𝜋5𝑁𝐴𝑛4
𝐽(𝜆))
1 6⁄
                                                   (2.3) 
where 𝑁𝐴 is Avogadro’s number (6.023 × 1023 mol-1); n is the refractive index of the medium; 
𝜅2 is the orientation factor of the coupled donor and acceptor transition dipole moments which 
is usually taken as 2/3; Φ𝐷  is the quantum yield of the donor; 𝐽(𝜆) is the spectral overlap 
between the donor emission and acceptor absorption. A FRET pair with a large R0 value is 
generally favored, because of increased likelihood of FRET occurrence. For a given FRET-pair, 
the larger spectral overlap results in larger Förster distance.  
     
Figure 2.5. FRET efficiency 𝜂𝐹𝑅𝐸𝑇 variation as a function of the donor-acceptor distance (r) 
shows the sixth power dependency and a measurable range of the FRET efficiency between 0.5 
R0 and 2.0 R0 with a steep curve around R0. (Reference [48], copyright 2012 MDPI Publisher) 
 
14 
 
To enhance the FRET efficiency, the donor group should have good abilities to absorb photons 
and emit photons. That means the donor group should have a high extinction coefficient and a 
high quantum yield. The overlap of the emission spectrum of the donor and absorption spectrum 
of the acceptor means that the energy lost from the excited donor to the ground state could 
excite the acceptor group. The energy matching is called the resonance phenomenon. Thus, the 
more overlap of spectra, the better a donor can transfer energy to the acceptor. The spectral 
overlap can be described as: 
𝐽 = ∫ 𝐼?̅? (𝜆)𝜀𝐴(𝜆)𝜆
4𝑑𝜆                                                      (2.4) 
Where 𝜀𝐴(𝜆) is the acceptor extinction coefficient, 𝐼?̅?(𝜆) is the donor emission spectrum 
normalized to unity and is given by: 
                                                 ∫ 𝐼?̅? (𝜆)𝑑𝜆=1                                                               (2.5) 
In addition, the Förster distance strongly depends on the orientation factor 𝜅2:  
𝜅2 = (cos 𝜃𝑅 − 3 cos 𝜃𝐷 cos 𝜃𝐴)
2                                            (2.6) 
where 𝜃R is the angle between the donor and acceptor transition dipole moments, 𝜃𝐷 and 𝜃𝐴 are 
the angles between the respective dipole moments and the line connecting the donor and the 
acceptor.  
Orientation factor 𝜅2 is in the range 0 to 4. 0 corresponds to a perpendicular orientation between 
the donor and acceptor transition dipoles, 1 is parallel and 4 a collinear orientation (Figure 2.6). 
In cases when the rotational reorientation of the chromophores is faster compared to the donor 
excited state lifetime, 𝜅2 averages to a value of 2/3. Since the sixth root is taken to calculate the 
distance, variation of 𝜅2 does usually not result in major errors in the calculated distances except 
when 𝜅2 is close to 0. In most biological FRET experiments, the orientation factor is assumed 
to be 2/3, which simplifies the application of FRET significantly.  
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Figure 2.6. The orientation of emission dipole moment of donor and absorption dipole moment 
of acceptor. (Reference [49], copyright 2015 MDPI Publisher) 
 
2.2.2 FRET applications  
The major constituents of all living beings are nano-sized molecular species like lipids, proteins, 
carbohydrates, and nucleic acids. These molecules are constantly in communication with each 
other through complex yet specific interactions in a crowded molecular environment, regulating 
the biological functions in an organism.[50], [51]. Due to the biological nanometer working 
distance and the high sensitivity for small distance changes, FRET has been widely applied in 
the study of structure elucidation, cellular processes, and diagnostics. The occurrences of the 
binding, diffusion, and mobility of molecular structures in situ are easily investigated under the 
spatial and temporal resolution of FRET[52]. Combined with microscopy and spectroscopy, 
FRET imaging allows scientists to study a variety of phenomena that produce changes in 
molecular proximity, thereby leading to many significant findings in the life sciences. FRET 
imaging is a powerful tool in life-science research[52]–[55]. Unlike the usual two molecule 
studies, FRET measurements have been made between single-molecules by labeling 
fluorophores to two different sites of the same molecule (i.e. single-molecule FRET; sm-FRET) 
to investigate the intra activities of the molecule[56]–[59]. FRET is increasingly being used in 
the area of “sensing/recognition” molecules as a simple, rapid, and sensitive transduction 
mechanism[60], [61]. Nearly every target of interest, like cancer markers, pathogen markers, 
microbes, cells, nucleic acids, toxins, drugs, can be sensed using FRET by exploiting the wide 
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field of recognition molecules, such as small organic molecules, polymers, carbohydrates, 
antibodies, proteins and peptides, nucleic acids and aptamers[60], [62]. Most sensing 
techniques are based on the binding or cleavage of donor and acceptor in the presence of the 
target, which can be measured mainly by changes of the donor/acceptor emission intensity. One 
of the main targets of interest which FRET has played a significant role in clinical analysis is 
nucleic acid testing.  
2.2.3 FRET for nucleic acid detection 
FRET has a significant impact on molecular diagnostic technologies for detecting specific, 
relatively short DNA or RNA sequences (typically identified during DNA sequencing) for 
infectious disease diagnosis, genotyping, and pharmacogenomics[63]–[65]. These technologies 
rely on the detection of target nucleic acid hybridization and/or amplification. Real-time, 
homogeneous, and high-throughput FRET-based technologies are desired. The hybridization 
reaction is one of the most important and sensitive tools in FRET-based nucleic acid assay 
(Figure 2.7A). It is real-time observation directly in solution, as a homogenous type without 
washing procedures. The high speed of hybridization in solution and the detection of only the 
hybridized probe signal makes it possible to perform in vivo hybridizations directly in live cells. 
Multiple formats of FRET hybridization probes have been developed[66]. Molecular beacon is 
one of the latest developments in the area of hybridizing DNA FRET (Figure 2.7B). Molecular 
beacons are designed as hairpin-shaped oligonucleotides. The double-stranded stem carries the 
donor and acceptor dyes. The loop fragment can hybridize to the target nucleic acid sequence. 
When the probe is not hybridized to the target, the donor and acceptor are brought in close 
proximity by the stem formation, resulting in the FRET-based quenching of the donor. However, 
in the presence of the target sequence, the FRET transfer is disrupted by the probe, which forms 
longer and stronger hybrids with the target. Additionally, FRET-based nucleic acid 
amplification technology has emerged from the marriage between polymerase chain reaction 
(PCR) and real-time monitoring of fluorescent chemistry. The TaqMan method was developed 
to allow the real-time monitoring of the reaction. The principle (Figure 2.7C) depends on a 
DNA-based probe with a fluorescent reporter at one end and a quencher of fluorescence at the 
opposite end of the probe. The close proximity of the reporter to the quencher prevents the 
emission of its fluorescence; hydroxylation of the probe by the 5' to 3' exonuclease activity of 
the Taq polymerase releases the reporter and thus allows emission of fluorescence. Therefore, 
an increase in the product targeted by the reporter probe at each PCR cycle causes a proportional 
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increase of fluorescence. Fluorescence is detected and measured in a real-time PCR 
machine[67].  
 
Figure 2.7. Designs of FRET probes for hybridization detection and TaqMan qPCR. (Reference 
[68], copyright 2015 Elsevier Publisher and Wikipedia) 
 
2.3 Lanthanides 
2.3.1. Introduction 
Lanthanides are one of the cornerstones of our modern technology. They play a major role in 
lighting industry[69], electroluminescent materials, telecommunication[70], biological 
assays[71] and medical imaging purposes[72], [73]. Their growing importance in biological 
and medical research has been highlighted in a number of recent reviews[74]–[78]. This 
versatile utilization of lanthanides is due to their unique electrical, optical and magnetic 
properties, which will be discussed in this chapter. 
According to the International Union of Pure and Applied Chemistry (IUPAC) 
recommendations (1968), lanthanides (Ln) include elements lanthanum (La) and 14 other 
elements (Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, and Lu) which are listed 
separately at the bottom of the periodic table. They are called lanthanides because the elements 
in the series are chemically similar to lanthanum. These fifteen lanthanides, along with similar 
chemical behavior scandium and yttrium, are often collectively known as rare-earth elements.  
Their similar chemical properties are due to the electronic configuration of the lanthanide atoms 
and their corresponding ions. The general electronic configuration of lanthanide atoms are 
usually denoted as [Xe]4fn5dm6s2, where [Xe] represents the electronic configuration of the 
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noble gas xenon, n represents the number of electrons from 0 to 14, and m represents the number 
of electrons 0 or 1. Xenon has an electronic configuration of 1s2 2s2 2p6 3s2 3p6 4s2 3d10 4p6 5s2 
4d10 5p6 and is abbreviated as [Xe]. The lowest energy orbitals are filled first with electrons and 
orbital energy follow the sequence: 
1s˂2s˂2p˂3s˂3p˂4s˂3d˂4p˂5s˂4d˂5p˂6s˂4f˂5d˂6p˂7s˂5f˂6d˂7p˂8s  
Depending on the relative energy levels, lanthanum, cerium, gadolinium, and lutetium belong 
to the electronic configuration type [Xe]4fn6s2, and the rest of the lanthanides to the type [Xe] 
4fn5d16s2 (for terbium both configurations are energetically close to each other, so either one 
may be adopted). The 4f orbitals have low radial expansion, and they are shielded from the 
surroundings by the filled energetically lower 5s and 5p sub-shells which results in very weak 
perturbations of the spectroscopic and magnetic properties of Ln ions by the surrounding 
microenvironment. Additionally, this shielding effect causes the interaction between Ln ions 
(the Ln ion being the central ion) with ligands to form complexes to be electrostatic in nature 
rather than covalent.  
2.3.2. Luminescence lanthanide complexes 
Most of the trivalent lanthanide ions are luminescent. The luminescence intensity of the 
lanthanide ion is dependent on the quantum yield, which is related to the ratio of radiative and 
nonradiative relaxation processes of the excited energy levels. The quantum yield is also related 
to the extent of the energy gap between the lowest excited energy level of the ion and the highest 
sublevel of its ground state multiplet [79]. The partial energy level diagram for aqueous 
lanthanide ions, illustrating also the energy gaps, is presented in Figure 2.8. Judged by the 
energy gap criterion, Eu3+, Tb3+, and Gd3+ ions have the strongest luminescence. The most 
commonly used lanthanide ions in bioanalytical applications are Eu3+ and Tb3+. In addition to 
their intense emission in the visible wavelengths, their particularly long lifetime is a very 
important reason[80].  
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Figure 2.8. Partial energy diagrams for the lanthanide aquo ions. The main luminescent levels 
are drawn in red, while the fundamental level is indicated in blue. (Reference [79], copyright 
2005 RSC Publisher.) 
 
The most common oxidation state of lanthanide ions in aqueous solvents is Ln 3+. The trivalent 
lanthanide ions may be implied in three types of electronic transitions: 
(1) Charge transfer transition: Both ligand-to-metal and metal-to-ligand transitions are allowed 
by Laporte's selection rule. Their energy is usually very large so that they appear in the UV[81]. 
(2) 4f-5d transitions: They correspond to the promotion of a 4f electron into the 5d sub-shell 
are also allowed by the parity rule, resulting in sizable oscillator strengths with absorption 
coefficients in the range 102-103 M-1cm-1, that is, comparable to those of the charge transfer 
transitions. Their energy depends largely upon the metal environment because 5d orbitals are 
external and they interact directly with ligand orbitals; however, these transitions are also quite 
energetic[82]. 
(3) f-f transitions: The very low level of direct excitation of the lanthanide ions as well as their 
extremely long excited state lifetimes come from the Laporte’s selection rule and spin-
multiplicity rule. Most of the transitions of the Ln3+ ions involve redistribution of electrons 
within the 4f sub-shell, but f-f transitions are parity-forbidden[83]. That explains their faint 
intensities and very low molar extinction coefficients (˂1 M-1cm-1)[84]. 
To get more excited, lanthanide ions usually require indirect excitation from a sensitizing 
structure, which can be an organic ligand containing a light absorbing chromophore structure 
and a moiety that coordinates the central ion, or an inorganic crystal structure containing a 
sensitizer. The absorption can be promoted by operators linked to the nature of light, the odd-
parity electric dipole (ED) operator, the even-parity magnetic dipole (MD) and electric 
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quadrupole (EQ) operators. Laporte’s parity selection rule states that levels with the same parity 
cannot be connected by electric dipole transitions, therefore, f-f transitions are forbidden by the 
ED mechanism. However, under the influence of a ligand-field, non-centrosymmetric 
interactions result in the mixing of electronic states of opposite parity, which somewhat relaxes 
the selection rule and the transitions become partially allowed. Together with the parity-allowed 
magnetic dipole transitions, the lanthanide ions are greatly sensitized in a three-step mechanism. 
Light is first absorbed by the immediate surrounding of the lanthanide, then energy is 
transferred to the Ln ion and then the Ln ion emits light. The overall process is quite complex 
and involves several mechanisms and energy levels. When sensitized by an inorganic matrix or 
an organic ligand, the molar absorption coefficients can be compared with that of organic 
fluorophores and they can emit multiple, characteristic narrow emission bands. The specific, 
narrow lanthanide emission bands are a result of the sharp transitions between the well-defined 
J-levels (be degenerated from the electronic configuration based on Coulomb interaction and 
spin-orbit coupling) of lanthanide ions due to the shielding of the 4f orbitals by the filled 5p66s2 
sub-shells. The J-levels can be further split into sublevels (which can be seen as the fine 
structure of the main emission bands of the lanthanide ion) if the lanthanide ions are in a 
coordinating environment[85]. Eu3+ ion is taken as an example in Figure 2.9. 
 
Figure 2.9. The interactions lead to the different electronic energy levels for the [Xe] 4f6 5d0 
configuration of Eu3+. (Reference [85], copyright 2005 Science Reviews 2000 Ltd.) 
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Luminescent lanthanide complexes offer several distinct advantages. First, their sensitized 
emission gives rise to a large Stokes shift between the absorption of the antenna and the 
emission of the lanthanide, thus avoiding concentration-dependent self-absorption problems 
(Figure 2.10a). Second, their emission spectra are characterized by very narrow bands (ca. 20 
nm wide), therefore, lanthanide probes can be concurrently employed to monitor several 
analytes simultaneously (Figure 2.10b). Lastly, lanthanide emissions are Laporte forbidden 
and therefore are characterized by extremely long luminescence lifetimes, in the millisecond 
range for europium and terbium and the microsecond range for samarium and dysprosium[12], 
[79]. In comparison, the lifetimes of most organic dyes are in the nanosecond range, whereas 
those of biological media are typically in the sub-microsecond range. The very long 
luminescence lifetime is ideal for the direct, time-gated detection of analytes in a complex 
biological medium. The time gate allows no auto-luminescence interference before measuring 
the luminescence of the complex (Figure 2.10c). For a high luminescent lanthanide complex, 
introducing a suitable light-harvesting chromophore or ‘‘antenna” is essential. The function of 
this antenna is to absorb energy from UV-Vis radiation and transfer it to the Ln3+ ion, then result 
in the high luminescence of lanthanide complex which can reach to 104-105 M−1cm−1, being 
essentially determined by the molar absorption coefficients of the surrounding ligands (Figure 
2.10d, e). This effective way to sensitize the Ln3+ ion is the so-called ‘‘antenna effect”. The 
commonly used antenna molecules are organic ligands bearing aromatic chromophores, such 
as bipyridine, terpyridine, triphenylene, quinoline, or substituted phenyl and naphthyl groups.  
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Figure 2.10. Principles of lanthanide luminescence. a) Stokes shift between the absorption of 
an antenna (orange) and the emission of terbium (green). b) Emission of terbium and europium. 
c) principle of time-gated spectroscopy. d) Indirect excitation of a lanthanide via an antenna. e) 
Simplified Jablonski diagram showing the main energy flow paths during sensitization of 
lanthanide luminescence via its antenna. (Reference [86], copyright 2009 Springer Publisher.) 
 
2.3.3. Lanthanide complex applications 
Luminescent lanthanide complexes play a crucial role in biological applications, such as probes 
for diagnostics, and bioconjugates for medical imaging and the photodynamic treatment of 
cancer[87], [88]. They are widely used in Magnetic Resonance Imaging for diagnostic purposes 
or for monitoring the effects of therapy, usually applied for patients with cancers, 
cardiovascular problems, central nervous system, and other conditions[89], [90]. Moreover, 
lanthanide complexes are good factors for luminescence imaging because of their emission in 
the near-infrared region (NIR)  which can be used to study the biological structures at different 
depths and resolutions with the accuracy of analysis[91]. Lanthanide complexes offer several 
advantages over conventional organic fluorophores in bioanalysis due to their unique 
 
23 
 
spectroscopic properties, such as large Stokes shifts, long luminescence lifetimes, and narrow 
emission bands. The large Stokes shifts contribute to the low background signal since there is 
minimal crosstalk between excitation and emission signals. The long-lived luminescence of 
lanthanide complex can be collected using time-resolved fluorescence measurement, while the 
interference of short-lived background fluorescence can be eliminated. Furthermore, narrow 
emission can improve the detection sensitivity of luminescent probes for analytes, hence, 
lanthanide-based luminescent probes have favorable signal-to-noise ratios and could serve as 
sensitive probes for various targets. Some of them have been successfully commercialized 
within detection systems for immunoassays and DNA assays based on luminescent Tb3+ or Eu3+ 
complexes to detect various clinical biomarkers in biomedical diagnostics and imaging[11], 
[92]. The conjugation of lanthanide complexes to biomolecules can be established by covalently 
bound functional groups on the ligand. The most popular conjugation strategies are using Ln-
complexes functionalized with NHS-esters or maleimide groups, which selectively bind to 
amino or thiol groups, respectively.  
Multiplexing 
Multiplexing has stimulated the renewed interest because it can save time and reagents, 
increasing demand for the simultaneous measurement of multiple biological parameters (e.g., 
concentrations or distances) in a single sample. The most frequently used technique to detect 
multiple parameters from the same sample is spectral (or color) multiplexing with different 
fluorophores, such as organic dyes[93], [94], fluorescent proteins[95] and quantum dots[96]. 
Luminescent lanthanide complex-based FRET is a valuable tool for sensitive and versatile 
multiplexing. In preference to other lanthanide complexes, luminescent Tb complexes have 
been the major players in this field because of their large quantum yields, extremely long 
lifetime and multiple emission bands. 
In recent years, different multiplexed LTC-based FRET biosensors have been developed, most 
of them use the principle of FRET from one LTC donor to different acceptor molecules or 
particles (spectral multiplexing)[8], [97]. As shown in Figure 2.11, the multiplexing capacity 
of LTC donor is due to the narrow and well-separated emission bands, where we can put several 
different acceptors in between or beyond the LTC emission bands.  
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Figure 2.11. LTC-donor-based multiplexed FRET. Top: Broad spectral overlap between LTC 
emission and the absorption of several different acceptors (Left: organic dyes; Right: QDs). 
Bottom: Separation of the single Tb emission bands allows the measurement of different 
acceptors in wavelength ranges with very low Tb intensity. Left: organic dyes, Oregon 
Green(blue), Alexa Fluor555 (green), Alexa Fluor568 (orange), Cy5 (red) and Alexa Fluor700 
(brown); right: QDs, Qdot525 (blue), Qdot565 (green), Qdot605 (orange), Qdot655 (red) and 
QDot705 (brown), LTC-PL-spectra in black. (Reference [10], copyright 2014 Elsevier 
Publisher.) 
 
The number of spectral multiplexing is still limited. Thus, the big challenge in multiplexing is 
to create additional distinguishable dimensions. The multiplexing based on lifetime (temporal 
multiplexing) is a very promising concept. LTC based FRET is well suited in temporal 
multiplexing. Using the extremely long PL lifetimes of LTC and different donor-acceptor 
distances for a single donor-acceptor pair would allow for designing different FRET-quenched 
and FRET-sensitized PL decay times. 
If different PL decay times can be distinguished, then temporal and spectral multiplexing could 
be reliably combined. When different acceptor PL intensities can also be distinguished and 
controlled, this parameter can be used as a third multiplexing dimension (Figure 2.12). 
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Figure 2.12. Photoluminescence multiplexing in three dimensions. The combination of PL 
wavelengths (e.g., from different QD sizes) with PL decay times (e.g., from different LTC-
donor to QD-acceptor distances) and PL intensities (e.g., from different concentrations of the 
LTC-QD hybrid nanoparticles) can offer different distinguishable signals for multiplexed 
sensing or optical barcoding. (Reference [10], copyright 2014 Elsevier Publisher.) 
 
Although the advantages of LTC for multiplexed FRET are numerous, and theoretical 
construction of a multiplexed LTC-based FRET is relatively easy, the practice is much more 
challenging. Pulsed excitation and time-gated or time-resolved detection must be combined 
with different wavelength separation technologies. Determination of conformational changes 
as well as distance distributions within a biological FRET system can most often only be 
determined by time-resolved measurements[3]. Time-resolved measurement provides more 
dynamic information that is available from the steady-state data. Time-dependent intensities are 
measured following short pulsed excitation of light. Data collection starts after the excitation 
pulse has decayed and fluorescent samples with long lifetimes even allow an almost 
background-free detection after the complete decay of detrimental effects such as sample auto-
fluorescence.  
Each fluorophore requires a distinct detection channel and excitation wavelength and spectral 
overlap, which needs to take into account the entire spectrum of each fluorophore (not only the 
full-width-at-half-maximum, FWHM), imposes fundamental limits to color multiplexing. Even 
the spectra of quantum dots (with FWHM of ~30 nm) extend over >100 nm, which limits the 
spectral range of 400 to 800 nm to approximately four completely distinct signals. 
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2.4 Fluorescent dyes 
In the last decades, the popularity of organic dyes as fluorescent probes has steeply risen in 
biophysical research. Fluorescent dyes are often used as fluorescent labels attached to specific 
locations within the biomolecule. The message of the labeled object is qualitatively or 
quantitatively transferred by detecting the fluorescence intensity. The majority of common 
fluorophores such as fluoresceins, rhodamines, 4,4´-difluoro-4-bora-3a,4a-diaza-s-indacenes 
(BODIPY dyes) and cyanines have been widely used in bioimaging, biosensing, medical 
diagnosis, and environmental detection. Fluorescent dyes have many good chemical and 
physical properties, such as, easy chemical structure tuning, good biocompatibility, low-
toxicity, easy metabolism in the biological system, and non-radiation which are based on their 
slight structure, high molar absorption coefficient, moderate-to-high fluorescence quantum 
yield, etc. However, their comparatively not narrow absorption and emission bands can favor 
crosstalk between different dye molecules and small Stokes shifts (typically less than 25 nm) 
can lead to serious self-quenching and fluorescence detection errors because of excitation 
backscattering effects. Fluorescence dye probes have been used to detect the structures of RNA 
and DNA, study the remedy of DNA damaged basic group, identify the status of the  amino 
group and the active area of the protein molecule, distinguish nucleic acids with different 
conformation and the chemical reactive activities of related drugs. 
 
Figure 2.13. Examples of available fluorescent dye. (Reference [14], copyright 2006 Wiley-
VCH Publisher) 
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2.4.1 Cyanine dyes 
Cyanine dyes are small organic molecules with two nitrogen-containing aromatic heterocyclic 
rings linked via a polymethine bridge, which are also named polymethine cyanine dyes. 
Cyanine dyes are broadly used in the life sciences and other biologically related disciplines as 
optical probes of membrane potential[98], organelle[99], [100], labels for neuron pathway 
tracing[101] and as probes for membrane structure and dynamics. Moreover, their applications 
as fluorescent labels for proteins, nucleic acids and other demanding fluorescence microscopy 
applications made cyanine dyes more popular in the last two decades because of their 
remarkable photostability, good fluorescence efficiency, and commercial availability as 
derivatives for covalent labeling of proteins and nucleic acids. The small organic dyes with 
spectral properties are covalently or non-covalently bound to biomolecules. The interaction of 
small organic dyes with proteins or nucleic acids giving a detectable signal is a very useful 
method for the investigation of biological processes on the molecular level.  
2.4.2 Cyanine dyes applications in FRET 
Cyanine dyes as energy acceptors have been widely used in a variety of FRET biophysical 
applications. Lee[102] reported dye cyanine 3-labeled human serum albumin can be applied to 
construct QDs-based FRET systems by their high affinity interaction with CdZn SeS/ZnS QDs 
capped with multifunctional polymer ligands containing dihydrolipoic acid (DHLA). This dye-
based FRET protein complex can serve as a sensitive sensor for probing the interaction of 
clofazimine with proteins using fluorescence spectroscopic techniques (Figure 2.14A). 
Löhmannsröben[103] developed an aptasensing system based on FRET from a lanthanide 
terbium complex to a cyanine 5 to detect L-selectin in PBS. FRET signal was measured by 
time-resolved luminescence spectroscopy. Using their system, L-selectin can effectively be 
recognized in the concentration range of 10-500 ng/ mL that covers the completely relevant 
pathological range for Alzheimer's disease (Figure 2.14B ). Bald[104] investigated the FRET 
between the donor fluorescein and the acceptor cyanine 3 to establish a DNA origami-based 
dye array for light harvesting, signal amplification, and sensing. For the last 15 years, the most 
popular FRET probes in nucleic acid studies is cyanine dyes (Figure 2.14C). 
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Figure 2.14. Cyanine dyes-based FRET biosensor, cyanine dyes as the acceptor with different 
donors. 
(A) QD to Cy3 FRET sensor. (Reference [102], copyright 2016 ACS Publisher.) 
(B) The L-selectin detection based on FRET from a Tb-complex to a cyanine dye. (Reference 
[103], copyright 2015 Elsevier Publisher.) 
(C) DNA origami-based fluorescein to Cy3 FRET array. (Reference [104], copyright 2018 ACS 
Publisher.) 
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The disadvantage of organic dyes for FRET applications is their crosstalk, which results from 
direct acceptor excitation due to the relatively broad absorption bands of organic dyes and needs 
to render tedious correction of measured signals in multiplexing detection. Lifetime 
multiplexing can overcome this problem. It can be performed by making use of fluorophore-
specific decay behavior, measured at a single excitation and a single emission wavelength to 
discriminate different decays. This approach has no crosstalk from different acceptors but 
requires sufficiently different lifetimes. Lifetime multiplexing, as well as combining spectral 
multiplexing can be used to realize multiplexing detection for nucleic acids detection in this 
thesis. 
2.5 Quantum dots 
Luminescent semiconductor nanocrystals, also known as quantum dots (QDs), are generally 
composed of atoms from groups II-VI (ZnO, ZnS, CdS, CdSe, CdTe) and III-V (GaN, GaP, 
GaAs, InP, InAs) elements in the periodic table and are defined as particles because of small 
physical dimensions between 1 and 12 nm [18]. QDs are nanometer-sized crystals with unique 
photochemical and photophysical properties, which are not available from either isolated 
molecules or bulk solids. For example, symmetrical emission spectra, high quantum yield, 
broad absorption spectra, good chemical, and photo-stability and size-dependent emission 
wavelength tunability. QDs can be covalently linked with biorecognition molecules such as 
peptides, antibodies, nucleic acids, or small-molecule ligands for use as biological labels. High-
quality QDs are also well suited for optical encoding and multiplexing applications due to their 
broad excitation profiles and narrow emission spectra. QDs have been successfully used as 
luminescent probes with a considerable advantage over conventional organic fluorophores in 
many biological fields.   
2.5.1 Photophysical properties 
QDs have unique photophysical properties, including tunable photoluminescent emission as a 
function of core size and quantum confinement effects for binary combinations of 
semiconductors[17], [18]; broad absorption spectra with high molar extinction coefficients (10-
100 times larger than those of conventional dyes) [105]; narrow symmetric PL spectra (full 
width at half maximum ~25-40 nm) spanning the UV to near-IR with relatively high quantum 
yields, large Stokes shifts and high resistance to both photobleaching and chemical degradation 
[106], [107]. Compared with conventional organic fluorophores (Table 2.2), QDs present 
considerable advantages, especially broadband excitation and narrow bandwidth emission are 
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the most important properties since they permit multiplexed analysis studies, in which more 
than one target are investigated simultaneously. 
Table 2.2 Comparison of the properties of conventional organic fluorophores and quantum dots.  
Property Conventional organic dyes QDs 
Broadband excitation × √ 
Narrow bandwidth emission × √ 
Emit light of high intensity Moderate √ 
Available in many colors √ √ 
Readily attachable to analytes √ Moderate 
Resistant to quenching × √ 
Photochemically stable × √ 
Cheap and readily available √ × 
*(Reference [108], copyright 2002 Elsevier Publisher) 
The optical properties of QDs arise from interactions between electrons, holes, and their local 
environments. Figure 2.15 shows the different-sized QDs and their fluorescence emission. The 
defining property of QD is that there is an energy gap (band-gap) between a filled continuum 
of electron energy states (valence band) and an empty continuum of states (conduction band). 
QDs absorb photons when the excitation energy exceeds the band gap. During this process, 
electrons are promoted from the valence band to the conduction band. The difference in energy 
between the discrete ground and excited states increases with increasing degree of confinement 
(i.e. decreasing particle size), the size of the band gap and the color of emitted light can be fine-
tuned by adjusting the QD size. The composition of the material is another important parameter, 
which alters the energy gap of QD. QD with a diameter of 5 nm can be engineered to radiate 
photon between 610-800 nm by changing the construction of the alloy CdSe and Te [109], [110].  
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Figure 2.15. Size and composition tuning of optical emission for quantum dots. (Reference 
[110], copyright 2017 Med DocsCrave) 
 
2.5.2 Bioconjugation 
The conjugations of QDs with specific biological molecules are essential to their biological 
applications. QDs can be modified by a variety of biomolecules, including nucleic acids, 
antibodies, proteins, and peptides [111], [112]. In recent years, QD bioconjugation techniques 
have been developed very quickly [113]–[115]. There are two main approaches to immobilize 
biomolecules on the QD surface: covalent linking and non-covalent binding, including coupling 
directly to the QD surface or surface ligand coating the QD. The covalent linkage is obtained 
via different bioconjugation chemistry using activated functional groups at the surface of QDs. 
Non-covalent binding is determined by hydrophobic, electrostatic, or affinity interactions 
between biomolecules and the QD surface. 
The most common covalent linking methods are using bifunctional groups EDC (1-ethyl-3(3-
dimethylaminopropyl) carbodiimide hydrochloride) [116], DCC (dicyclohexylcarbodiimide) 
[117], NHS (N-hydroxy-succinimide) [118], SMCC (succinimidyl 4-N-maleimidomethyl 
cyclohexane-1-carboxylate) [119] to catalyze a reaction between the carboxylic acid group and 
amino group, generating a stable amide linkage.  
Non-covalent attachment of biomolecules to the QD surface is mainly based on direct 
interaction, electrostatic interaction and high affinity secondary interactions. For example,  
metal-affinity driven coordination of polyhistidine to the metal atoms of QDs, then the 
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biomolecules could be coordinated to polyhistidine [120]. And the biotin-streptavidin 
interaction represents an extraordinary example of the molecular key lock system in life 
processes, and this system has become a powerful tool for bioconjugation due to their specific 
and high affinity interaction[121], [122].  
Table 2.3 Strategies to couple various biomolecules onto QDs. 
 
*(Reference [123], copyright 2015 ACS Publisher.) 
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2.5.3 QDs applications in FRET 
The unique photophysical properties of QDs make them appealing as in vivo and in vitro 
fluorophores in a variety of biological investigations. The application of QDs for developing 
FRET-based biosensors provides many advantages, including high sensitivity (due to the 
brightness of QDs), multiplexing capability (due to the color tunability of QDs), and 
homogeneous assay formats (due to the biorecognition-specific FRET signal). 
QDs can act as highly efficient FRET donors because of their continuously tunable emissions 
that can be matched to any desired acceptor, such as organic fluorophores or dyes, as well as 
metallic nanoparticles. Oh, et al [124] used the streptavidin-conjugated QDs as energy donors 
and the biotinylated AuNPs as acceptors to modulate the FRET efficiency between QDs and 
AuNPs. The avidin concentration can be obtained by monitoring the changes of the 
streptavidin-conjugated QDs fluorescence. This method exhibits a detection limit of 10 nM and 
it can be used for inhibition assays(Figure 2.16A). Zhang [6] developed a single QD-based 
FRET sensor combine with isothermal amplification for microRNA assays with a detection 
limit as low as 0.1 aM. The reaction of reporter oligonucleotides with the Cy5-labeled reporter 
probes and the biotinylated capture probes results in the formation of biotinylated Cy5-labeled 
hybrids. With the addition of streptavidin-functionalized QDs, the hybrids can be assembled on 
the surface of QDs to form Cy5-DNA-QD conjugates through biotin-streptavidin interactions, 
inducing FRET from the QD to Cy5. The counting of Cy5 fluorescence burst can be used for 
the measurement of target microRNAs (Figure 2.16B). Algar [125] developed a 
multifunctional QD-based concentric FRET sensor for simultaneous measurement of both 
protease concentration and protease activity. They labeled the thrombin-specific aptamer with 
a Cy3 dye for the measurement of thrombin concentration and labeled the peptide substrate 
with an Alexa Fluor 647 dye for thrombin activity. After the conjugation of Cy3-labeled 
aptamer and Alexa Fluor 647 dye-labeled peptide substrate with DHLA-PEG-coated QD524, a 
concentric FRET sensor is obtained with the involvement of three FRET pathways: (i) FRET 
with the QD as the energy donor and Cy3 as the energy acceptor, (ii) FRET with the QD as the 
energy donor and Alexa Fluor 647 dye as the energy acceptor, and (iii) FRET with Cy3 as the 
energy donor and Alexa Fluor 647 dye as the energy acceptor. The concentric FRET signals 
may be modulated by either thrombin-induced displacement of Cy3-labeled oligonucleotide or 
cleavage of the peptide substrate by thrombin. Additionally, this sensor can be used for the 
discrimination of active thrombin from inactive thrombin and other proteases (Figure 2.16C).  
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Figure 2.16. QD-based FRET biosensor QDs as the donor with different acceptors. 
(A) Schematic illustration of inhibition assay method based on the PL quenching of SA-QDs 
by Biotin-AuNPs. (Reference [124], copyright 2005 ACS Publisher.) 
(B) FRET between 605QD and Cy5 through streptavidin-biotin binding. (Reference [6], 
copyright 2011 ACS Publisher.) 
(C) Multiplexed FRET between QD, Cy3 and Alexa Fluor 647 dye. (Reference [125], copyright 
2014 ACS Publisher.) 
 
QDs are typically not used as FRET acceptors because of their broad excitation band, which 
causes direct absorption of excitation light in many situations. However, they can become very 
effective FRET acceptors when luminescent lanthanide complexes (e.g., terbium and europium 
complexes) are employed as FRET donors. Lanthanides complexes with milliseconds PL decay 
time can be prospective FRET donors in combination with QD acceptors, providing a 
potentially significant increase in FRET efficiency. Time-gated detection provides extremely 
low background noise and a quick and simple one-step assay format[126], [127]. QDs as energy 
acceptors potentially offers various perspectives such as the possibility of very large Förster 
radii, low detection limits, and multiplex analysis in the study of interactions within very large 
molecules, and in the biomedical analysis by high throughput screening. 
Since 2007, Hildebrandt [128] reported a highly sensitive FRET Immunoassay using LTC as 
donors and QDs as acceptors, our group developed a series of Tb-QD complex-based FRET 
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biosensors for time-resolved immunoassay clinical diagnostics, and the detection of various 
biomarkers (e.g., carcinoembryonic antigen, prostate-specific antigen, a fetoprotein, epidermal. 
growth factor receptor, and microRNAs). Moreover, the construction of a QD-based FRET 
biosensor with LTC as the donor and different-colored QDs as the acceptor enables the 
simultaneous spectral multiplex assay. Bhuckory [129] present a facile and functional QD-
antibody conjugation method using three commercially available QDs with different PL 
maxima (605 nm, 655 nm, and 705 nm) (Figure 2.17A). The QD-antibody conjugates were 
successfully applied for FRET immunoassays against prostate specific antigen (PSA) in 50 μL 
serum samples using Lumi4-Tb antibody conjugates as FRET donors and time-gated PL 
detection. The results show that FRET based on QD acceptors is suitable for multiplexed and 
sensitive biomarker detection in clinical diagnostics. Qiu [8] also demonstrated the use of three 
different color QDs (605, 655, and 705 nm) and LTC for multiplexed detection of multiple 
microRNAs based on the measurement of the FRET ratio (Figure 2.17B).  In addition, the QD 
can function as both the energy acceptor and the energy donor in the development of a 
sequential FRET sensor [130]. With the integration of the QD terbium complex-based FRET 
and the QD-dye-based FRET, the sequential FRET can be applied for multiplexed monitoring 
activities of protease and the construction of biophotonic logic devices. 
 
Figure 2.17. QD-based multiplexed FRET biosensor with LTC as the donor and different color 
QDs as the acceptors. 
(A) The principle of the Tb-to-QD FRET immunoassay against PSA. (Reference [129], 
copyright 2016 MDPI Publisher.) 
(B) The three FRET systems based on LTC to three different QDs for multiplexed microRNA 
detection. (Reference [8], copyright 2015 ACS Publisher.)  
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3. Temporal duplexing Tb-Dye HCR-
FRET microRNA detection assay 
3.1 Introduction 
Recently, more and more FRET-based biosensors are being developed for use in nucleic acids 
detection and diagnosis field as a simple, rapid, and sensitive transduction mechanism[131]–
[133]. In order to detect low concentration nucleic acids, many different exponential and linear 
nucleic acid amplification and signal amplification strategies (without the generation of new 
nucleic acid products) have been developed over the last few decades[134] including reverse 
transcription quantitative polymerase chain reaction (RT-qPCR)[135], [136], rolling circle 
amplification (RCA)[137], [138], and strand displacement amplification (SDA)[139][140]. 
Despite very high sensitivities and specificities of such techniques, they all require enzymes 
and in some cases RNase inhibitors[6], [141], can be quite time consuming, and may be not 
isothermal and exponentially amplified. One of the most simple isothermal signal amplification 
methods is hybridization chain reaction (HCR) because it is completely enzyme-free[142]. 
HCR has been widely used to construct various biosensing platforms, including the detection 
of DNA[143], [144], miRNA[145], [146], messenger-RNA[147], [148], proteins[149], [150], 
and cells[151]. HCR technologies have been significantly advanced for both multiplexed 
imaging and quantitation of endogenous nucleic acids.  
The HCR can be further improved by attaching FRET donor-acceptor pairs to the HCR 
probes[132], [143], [151], [152]. With this approach, HCR amplification leads to double-
stranded DNA concatemers with many donors and acceptors in close proximity. Only HCR 
amplification can lead to FRET because free HCR FRET probes are separated and cannot 
engage in energy transfer. Although HCR-FRET has been demonstrated for both imaging in 
cells and quantification in solution, multiplexing has not been realized and low pM limits of 
detection could only be accomplished by double-step amplification[153]. Merging the 
multiplexing capabilities of luminescent terbium complex, temporal duplexed detection of a 
single FRET pair, and separation-free assay format of time-gated (TG) FRET with the enzyme-
free amplification of HCR has the potential to significantly advance nucleic acid biosensing.  
To demonstrate the feasibility of simple and sensitive HCR nucleic acid multiplexing, we 
selected two different miRNAs, miR-21 and miR-20a, both of which were found to be related  
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to different cancers[154]. Here, we implement a Tb-dye TG-FRET pair into HCR probes to 
demonstrate temporally multiplexed enzyme-free quantification of two different miRNAs with 
a single measurement, a single excitation wavelength, and a single detection channel. Both very 
low LODs (down to a few hundred attomoles) and high selectivity against very homologous 
miRNAs (dual-nucleotide variants) demonstrated the unprecedented performance of our 
multiplexed HCR-TG-FRET assay. 
3.2 Materials and methods  
3.2.1 Materials 
Lumi4-Tb-NHS (Tb) was provided by Lumiphore Inc. Cyanine5.5 NHS ester was purchased 
from Lumiprobe. All oligonucleotides were purchased from Eurogentec. Non-modified 
oligonucleotides were purified by the supplier. Cy5.5-modified oligonucleotides were purified 
with HPLC. All sequences and modifications of nucleic acids used in this study are summarized 
in Table 3.1. Both Cyanine5.5 (Lumiprobe) and Cy5.5 (GE Healthcare Cy dye used by 
Eurogentec for functionalization) are referred to as Cy5.5 because of their very similar 
photophysical properties and chemical structures. Tris(hydroxymethyl)-aminomethane, bovine 
serum albumin, and HEPES were purchased from Sigma-Aldrich. NaCl was purchased from 
Duchefa. All chemicals were used as received. Water was purified by MAXIMA (USF Elga, 
UK). Zeba Spin Desalting Columns (7 kDa MWCO) were purchased from Thermo Fisher 
Scientific. 
Table 3.1. DNA and miRNA oligonucleotides used in the study (mismatches between miR-20a 
and miR-20b shown in red, Tb-functionalization shown in green, Cy5.5 functionalization 
shown in blue) 
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Tb-DNA conjugates (Hairpin probes 1 and 3) were obtained by mixing Lumi4-Tb-NHS 
(lyophilized product dissolved was in anhydrous DMF to a final concentration of 8 mM stock 
solution) in concentration excess to amino-functionalized oligonucleotides in 100 mM 
carbonate buffer at pH 9.0. The mixtures were incubated overnight at 4℃. The Tb-DNA 
conjugates were purified three times by Zeba Spin Desalting Columns (7 kDa MWCO). 
Complete bioconjugation of DNA with Tb (~100 %) was verified by absorbance measurements 
at 340 nm for Tb and 260 nm for DNA. 
Dye-DNA conjugates were purchased at Eurogentec with 3’-terminal Cy5.5 (Hairpin probe 4) 
or prepared by mixing Cyanine5.5 NHS ester (lyophilized product dissolved in anhydrous DMF 
to a final concentration of 16.6 mM stock solution) in concentration excess to amino-
functionalized oligonucleotides in 100 mM carbonate buffer at pH 9.0 (Hairpin probe 2). The 
prepared mixtures were incubated overnight at 4℃ and then purified three times by Zeba Spin 
Desalting Columns (7 kDa MWCO). Complete bioconjugation of DNA with Cy5.5 (~100 %) 
was provided by Eurogentec (Hairpin probe 4) or verified by absorbance measurements at 684 
nm for Cy5.5 and 260 nm for DNA (Hairpin probe 2). 
Spectroscopic characterization. Absorption spectra (Lambda 35 UV/Vis System, 
PerkinElmer) and emission spectra (Xenius, SAFAS) for Tb and dye functionalized DNA were 
recorded in HEPES (100 mM, pH 7.4). All spectra are shown in Figure 3.1. Both Cy5.5 dyes 
have very similar spectra, use the same PL detection bandpass filter, and lead to almost identical 
Förster distances. A Förster distance (the donor-acceptor distance for which FRET is 50 % 
efficient) for the Tb-Cy5.5 FRET pair of R0 = 5.8±0.2 nm was calculated using Equation 3.1: 
𝑅0 = 0.0211(κ
2Φ𝐷𝑛
−4𝐽)1/6   nm          (3.1) 
An orientation factor of κ2 = 2/3 was used because of the random orientation of donor and 
acceptor during the FRET time (dynamic averaging), which is well justified by the long PL 
lifetime of the Tb donors and their unpolarized emission (fast isotropic rotation). A refractive 
index of n = 1.35 (aqueous solution) was used. The Tb-centered quantum yield was Φ𝐷 = 
0.78±0.05. The spectral overlap integral J was calculated by Equation 3.2: 
𝐽 = ∫ 𝐼𝐷(𝜆)𝜀𝐴
700 𝑛𝑚
450 𝑛𝑚
(𝜆)𝜆4𝑑𝜆        (3.2) 
where ID(λ) is the emission intensity from the area-normalized (to unity) emission spectrum of 
the Tb donor and εA(λ) is the molar absorptivity of the acceptor 
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Figure 3.1. Photophysical properties of the Tb-Cy5.5 FRET pair. Absorbance spectra (dotted, 
right axis) and PL emission spectra (line, left axis) of Cy5.5 (red for Cy5.5 from Eurogentec 
and blue for Cy5.5 from Lumiprobe). PL emission spectrum of Tb (green, left axis). The 
absorption spectrum of Tb not shown (maximum molar absorptivity of 26,000 M-1 cm-1 at 340 
nm). Transmission spectra of optical bandpass filters were 494/20 (Semrock) for the Tb 
detection channel and 716/40 (Semrock) for the Cy5.5 detection channel (gray, left axis).  
3.2.2 HCR-FRET miRNA/ssDNA single target assays.  
Stock solutions (30 nM) of hairpin probes were prepared in DNA hybridization buffer (20 mM 
Tris-Cl, 500 mM NaCl, 0.1% BSA, pH 8.0). Hairpin probes were heated to 95 ℃ for 2 min and 
then cooled down to room temperature for 2 hours to form hairpin structures. The annealed 
hairpin probes were stored in the refrigerator (4 ℃). For the detection of the target, 10 μL 
H1/H3 and 10 μL target miRNA/ssDNA at different concentrations were added into 0.5 mL 
Eppendorf tubes. After incubation at room temperature for 30 min, 10 μL H2/H4 were added 
and the mixture was further incubated for 60 min. Then, 120 μL hybridization buffer was added 
into the solution for obtaining a sufficient assay volume. From the total volume of 150 μL, 140 
μL were transferred into black 96-well microtiter plates for miRNA/ssDNA TG-FRET assays 
and PL decay analysis. TG-FRET assays were performed on a clinical immunofluorescence 
plate reader “KRYPTOR compact plus” (Thermo Fisher Scientific) with time-gated (0.1 to 0.9 
ms) PL intensity detection using optical bandpass filters (Semrock) with 494±20 nm for the Tb 
detection channel and 716±40 nm for the Cy5.5 detection channel. For ratiometric analysis, 
FRET ratios were calculated by the ratio of Cy5.5 and Tb time-gated PL intensities. 
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3.2.3 HCR-FRET miRNA/ssDNA duplexed assays.  
30 nM hairpin probes mixtures (H1+H3 and H2+H4, respectively) in DNA hybridization buffer 
were heated to 95 ℃ for 2 min and then cooled down to room temperature for 2 hours to form 
hairpin structures. The annealed hairpin probes were stored in the refrigerator (4 ℃). The 
reaction process is performed  as same as single target assays, then the samples were transferred 
into black 96-well microtiter plates for miRNA/ssDNA TG-FRET assays and PL decay analysis 
by a fluorescence lifetime plate reader (Edinburgh Instruments) using 4000 detection bins of 2 
μs integration time and pulsed nitrogen laser (MNL 100, LTB Berlin) excitation (337.1 nm, 20 
Hz). TG-FRET assays used two TG PL detection windows (TG1: 0.1 to 1.0 ms and TG2: 2.0 to 
3.0 ms) for FRET-ratio calculation. TG PL intensities (ITG) of Cy5.5 and Tb were determined 
at constant concentrations of hairpin probes and increasing concentrations of targets. These TG 
PL intensities were then used to calculate a background-subtracted FRET-ratio (FR-BG, 
Equation 3.3) for each target concentration c = x. 
FR-BG = 
𝐼𝐶𝑦5.5
𝑇𝐺 (𝑐=𝑥)
𝐼𝑇𝑏
𝑇𝐺(𝑐=𝑥)
−
𝐼𝐶𝑦5.5
𝑇𝐺 (𝑐=0)
𝐼𝑇𝑏
𝑇𝐺(𝑐=0)
                                                (3.3) 
The concentration-dependent FR-BG values were used to determine the calibration curves for 
each miRNA (or ssDNA) target in each detection window. The slopes of the four linearly fitted 
calibration curves (𝑧20a
TG1, 𝑧21
TG1, 𝑧20a
TG2, 𝑧21
TG2) were used to determine the concentrations in the 
duplexed assays that led to the concentration recovery. Equation 3.4 was used for determining 
the target concentrations of miR-20a and miR-21 (or the ssDNA analogs) in the duplexed assays. 
[
𝐹R-BG
1
𝐹R-BG
2] = [
𝑐(miR-20a) 
𝑐(miR-21)
] × [
𝑧20a
TG1 𝑧21
TG1
𝑧20a
TG2 𝑧21
TG2]    (3.4) 
where FR-BG
1 and FR-BG
2 are the background-subtracted FRET-ratios in TG PL detection 
windows TG1 and TG2, respectively.    
3.2.4. Gel Electrophoresis 
Hairpin probes H1 (0.9 μM) and H2 (0.9 μM) were heated to 95 ℃ for 2 min and cooled down 
slowly at room temperature for at least 2 hours to form the hairpin structure before use. 10 μL 
H1 and 10 μL target miRNA-20a of different concentrations were added into 0.5 mL Eppendorf 
tubes. After incubation at room temperature for 30 min, 10 μL H2 was added and the mixture 
was further incubated for 60 min. SYBR green II (Thermo Fisher) was used as DNA stain and 
an 8% polyacrylamide gel was prepared with 1×TBE buffer (pH 8.0). 15 μL of each sample 
was loaded into the lane and electrophoresis was performed on a Mini-PROTEAN Tetra 
 
41 
 
electrophoresis system (Bio-Rad) at a constant potential of 200 V for 30 min with 0.5×TBE 
(pH 8.0) as running buffer. The gel was then visualized under UV light (Figure 3.3). 
3.3 Results and discussion  
3.3.1 The principle of duplexed HCR-FRET 
The principle of enzyme-free duplexed miRNA detection based on a single Tb-Cy5.5 FRET 
pair and HCR is shown in Figure 3.2. Hairpin probes H1 and H3 were labeled with FRET donor 
Tb, whereas hairpin probes H2 and H4 were labeled with FRET acceptor Cy5.5 (internally for 
H2 and terminally for H4). System H1/H2 was designed for miR-20a and system H3/H4 for 
miR-21 detection. All hairpin probes have 14 base-pair stems, 6 nucleotide loops, and 6 
nucleotide sticky ends. Complementary sequences between H1 and H2 (H3 and H4) are shown 
in the same colors. The 6 nucleotides sticky end of H1 (H3) is complementary to the loop of 
H2 (H4) and the 6 nucleotides sticky end of H2 (H4) is complementary to the loop of H1 (H3). 
In the absence of targets, all probes are stable in hairpin structures. Thus, Tb and Cy5.5 are 
separated in solution (no FRET). In the presence of targets, which are complementary to H1 
(H3), an unbiased strand-displacement reaction opens the hairpin H1 (H3). The newly exposed 
ssDNA sequence of H1 (H3) will then be able to open hairpin H2 (H4). The consequently 
exposed ssDNA sequence of H2 (H4) is identical to the target sequence, which triggers the 
HCR that forms a long double-stranded DNA (dsDNA) composed of H1 and H2 (H3 and H4). 
Because H1 and H2 (H3 and H4) are conjugated with Tb and Cy5.5, many of these FRET-pairs 
are brought into close proximity. Thus, HCR produces an amplified TG-FRET signal. Another 
important feature of our HCR-TG-FRET system are the different Tb-to-Cy5.5 distances in the 
H1/H2 and H3/H4 concatemers, respectively. Due to the internal labeling of H2 with Cy5.5, 
the Tb-Cy5.5 distance (d1) in the H1/H2 HCR product is significantly closer than the one in the 
H3/H4 HCR product (d2). 
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Figure 3.2. Top: The principle of the HCR process. Bottom: Schematic representation for 
duplexed (miR-20a and miR-21) detection of miRNAs using HCR-TG-FRET. Long dsDNA 
concatemers are shown on the right. Tb and Cy5.5 are in close proximity and can engage in 
FRET. The different distances in the two different HCR products (d1 and d2) will lead to 
different PL decays. 
 
 FRET efficiency (EFRET) is proportional to the inverse sixth power of the distance 
between the donor and the acceptor, and the higher EFRET, the stronger the quenching of the 
donor PL decay time (τD)[3], [46]. Thus, the longer distance d2 will cause a lower FRET 
efficiency and a longer FRET-quenched donor PL decay time (τDA) compared to the shorter 
distance d1. Owing to the ca. 10
6-fold difference between the PL lifetimes of Tb (~ms) and 
Cy5.5 (~ns), the FRET-sensitized lifetime of the Cy5.5 acceptor (τAD) is the same as the FRET-
quenched lifetime of the Tb donor (τAD = τDA)[10]. These relations between FRET efficiency, 
distance, and PL decay times are summarized in Equation 3.5 (3.5a for distance d1 and 3.5b 
for distance d2)[3], [10], [46]. 
𝐸FRET1 =
𝑅0
6
𝑅0
6+𝑑1
6 = 1 −
𝜏DA1
𝜏D
= 1 −
𝜏AD1
𝜏D
               (3.5a) 
𝐸FRET2 =
𝑅0
6
𝑅0
6+𝑑2
6 = 1 −
𝜏DA2
𝜏D
= 1 −
𝜏AD2
𝜏D
              (3.5b) 
3.3.2. MicroRNA-Specific HCR-TG-FRET 
To confirm both the target-specific formation of luminescent HCR products and the different 
Tb-Cy5.5 donor-acceptor distances inside the two different HCR products (for miR-20a and 
miR-21), we performed gel electrophoresis and time-resolved PL spectroscopy. The gels 
(performed for miR-20a only) showed two main bands, one for the hairpin probes and another 
for the HCR products (Figure 3.3). For single hairpin probes without target (first two lanes), 
no HCR product could be observed and for the mixed hairpin probes (third lane), only a very 
 
43 
 
weak HCR product band appears (non-specific opening of the hairpin probes). When increasing 
target concentrations were added to the mixed hairpin probes, the HCR bands became clearly 
visible whereas the intensity of the hairpin probe bands got weaker with increasing target 
concentration because more H1 and H2 was consumed to form dsDNA structures (HCR 
products) with higher molecular weight. The formation of dsDNA structures of different lengths 
(different molecular weights) resulted in relatively broad smearing of the HCR bands. At the 
highest concentration (0.16 μM), different bands became clearly visible, indicating the 
formation of shorter dsDNA HCR products. The availability of many targets at such high target 
concentrations led to the formation of many assembly sites and a lower probability for H1 and 
H2 to assemble into longer structure[143][155]. 
  
Figure 3.3.  Electrophoresis gels for single hairpins (H1 in lane 1 and H2 in lane 2), mixed 
hairpins (H1 and H2 in lane 3), and mixed hairpins with increasing target (miR-20a) 
concentrations (0.01 to 0.16 µM in lanes 4 to 8). Hairpin probe bands are split due to open and 
closed probes.  
Time-resolved PL curves of FRET-sensitized Cy5.5 at different target concentrations (between 
0.01 and 0.7 nM) clearly showed the different decay times caused by the different Tb-Cy5.5 
distances (Figure 3.4). Owing to the shorter distance, miR-20a-specific HCR products led to 
significantly faster decays (τDA = 360±10 µs) than the miR-21-specific HCR products (τDA 
= 930±50 µs). These average PL decay times resulted in FRET efficiencies of EFRET(miR-
20a) = 0.87±0.01 and EFRET(miR-21) = 0.66±0.02, and distances of d1 = 4.3±0.1 nm and 
d2 = 5.2±0.2 nm. On the basis of a distance of ∼0.33 nm between two bp within a dsDNA[156] 
and the 12 bp (miR-20a-specific HCR product) and 20 (miR-21-specific HCR product) Tb-
Cy5.5 separation, the expected distances would be 4.0 and 6.6 nm. Taking into account the 
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differences in Cy5.5-DNA conjugation (internal labeling for H2 and terminal labeling for H4), 
the flexible linkers between the DNA and the fluorophores, and the many nicks inside the long 
dsDNA HCR products, these values are in relatively good agreement with the measured average 
distances d1 and d2. The most important property for our multiplexing approach was the 
significant difference between the two decay times (caused by different distances), and the exact 
reason for the differences in expected and measured donor-acceptor distances is of minor 
relevance. The decay curves for both miRNA targets also show increasing intensities with 
increasing target concentrations, which confirms the concentration-dependent HCR production 
and the possibility to use TG-FRET for miRNA quantification. The PL curves of miRNAs 
equivalent ssDNAs are also shown in Figure 3.5. 
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Figure 3.4. PL decay curves of the Cy5.5 FRET acceptor (top) and Tb FRET donor (bottom) 
for miR-20a (left) and miR-21(right)  detection at increasing target concentrations (0, 0.01, 0.05, 
0.1, 0.2, 0.3, 0.4, 0.5, 0.6, and 0.7 nM from pink to blue) and constant hairpin concentrations (2 
nM).  
miRNA-20a 
miRNA-21 
miRNA-20a miRNA-21 
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Figure 3.5. PL decay curves of the Cy5.5 FRET acceptor (top) and Tb FRET donor (bottom) 
for ssDNA-20a (left) and ssDNA-21 (right) detection at increasing target concentrations (0, 
0.01, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, and 0.7 nM from pink to blue) and constant hairpin 
concentrations (2 nM). 
3.3.3 PL decay fit results and distance calculations. 
Due to the better distinction of FRET-sensitized Cy5.5 PL from Tb background PL (minor 
contribution of Tb in the Cy5.5 detection channel due to spectral crosstalk) compared to FRET-
quenched Tb PL from Tb background PL (strong initial Tb PL signal of pure Tb), only Cy5.5 
acceptor decays were considered for distance estimations. Tb donor decays were also fit (see 
below) but led to less precise results. 
ssDNA-20a 
ssDNA-20a 
ssDNA-21 
ssDNA-21 
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Figure 3.6 PL decay curves of Cy5.5 acceptor (left) and Tb donor (right) used for PL decay 
time fitting and distance calculation in the miR-20a HCR-TG-FRET sensor with the increasing 
target concentrations (0.2, 0.4, 0.6, 0.8 and 1.0 nM from light blue to blue). Black lines represent 
the fit results from below. Tb and Cy5.5 are situated at distances of 12 bps from each other in 
the HCR products of the miR-20a HCR-TG-FRET sensor.  
 
Cy5.5 acceptor channel (3-exponential fit with a contribution of Tb at a constant PL decay time 
of 2.7 ms, which was fixed, whereas all other fit parameters were variable)   
 
 
Tb donor channel (2-exponential fit with a contribution of Tb at a constant PL decay time of 
2.7 ms, which was fixed, whereas all other fit parameters were variable) 
# 
miR-20a 
(nM)  
τD AD τDA1 ADA1 <τDA> EFRET 
1 0.2 
 
2700 1387 210 188 210 0.92 
2 0.4 
 
2700 1263 270 283 270 0.90 
3 0.6 
 
2700 1158 310 346 310 0.89 
4 0.8 
 
2700 1078 330 429 330 0.88 
5 1.0 
 
2700 929 340 495 340 0.87 
     average 1-5 290 0.89 
R0 = 5.8 nm    distance r (nm) 4.1 4.2 
# 
miR-20a 
(nM)  
τD AD τAD1 AAD1 τAD2 AAD2 <τDA> EFRET 
1 0.2 
 
2700 50 140 1482 430 1295 358 0.87 
2 0.4 
 
2700 51 150 2204 440 1827 363 0.87 
3 0.6 
 
2700 53 150 2786 440 2401 365 0.86 
4 0.8 
 
2700 55 150 3306 430 3071 360 0.87 
5 1.0 
 
2700 54 170 3827 440 3199 361 0.87 
   
 
 
  average 1-5 361 0.87 
R0 = 5.8 nm    
  distance r (nm) 4.3 4.3 
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Figure 3.7. PL decay curves of Cy5.5 acceptor (left) and Tb donor (right) used for PL decay 
time fitting and distance calculation in the miR-21 HCR-TG-FRET sensor with the increasing 
target concentrations (0.2, 0.4, 0.6, 0.8 and 1.0 nM from light blue to blue). Black lines represent 
the fit results from below. Tb and Cy5.5 are situated at distances of 20 bps from each other in 
the HCR products of the miR-20a HCR-TG-FRET sensor.  
 
Cy5.5 acceptor channel (3-exponential fit with a contribution of Tb at a constant PL decay time 
of 2.7 ms, which was fixed, whereas all other fit parameters were variable)   
# 
miR-21 
(nM)  
τD AD τAD1 AAD1 τAD2 AAD2 <τDA> EFRET 
1 0.2 
 
2700 87 100 653 910 687 856 0.68 
2 0.4 
 
2700 98 130 641 960 1022 915 0.66 
3 0.6 
 
2700 109 170 609 990 1353 949 0.65 
4 0.8 
 
2700 113 150 727 1000 1517 961 0.64 
5 1.0 
 
2700 128 170 706 1000 1874 966 0.64 
   
 
 
  average 1-5 929 0.66 
R0 = 5.8 nm    
  distance r (nm) 5.2 5.2 
 
Tb donor channel (2-exponential fit with a contribution of Tb at a constant PL decay time of 
2.7 ms, which was fixed, whereas all other fit parameters were variable) 
# 
miR-21 
(nM)  
τD AD τDA1 ADA1 <τDA> EFRET 
1 0.2 
 
2700 1617 320 120 320 0.88 
2 0.4 
 
2700 1479 560 172 560 0.79 
3 0.6 
 
2700 1446 750 246 750 0.72 
4 0.8 
 
2700 1248 880 294 880 0.67 
5 1.0 
 
2700 1360 850 391 850 0.69 
     average 1-5 670 0.75 
R0 = 5.8 nm    distance r (nm) 4.8 4.8 
 
 
48 
 
3.3.4 Duplexing HCR-FRET assay Development and Sensitivity. 
Sensitivity and Specificity 
The diagnostics performance of the miR-20a and miR-21 HCR-TG-FRET assays was evaluated 
on a clinical fluorescence plate reader (KRYPTOR) concerning sensitivity and specificity. The 
assay calibration curves (Figure 3.8A and B) showed linearly increasing time-gated FRET 
ratios (intensity ratio of Cy5.5 and Tb PL in a time window from 0.1 to 0.9 ms after the 
excitation pulse) with increasing concentrations from 0.005 nM to 0.3 nM for miR-20a and 
from 0.005 nM to 0.25 nM for miR-21. This linear dynamic range can be further increased by 
increasing the hairpin concentrations (Figure 3.9). Even higher concentration may be 
quantified by using the automatic dilution mode of the KRYPTOR system. The calibration 
curves, which show the target concentrations in the 140 µL detection volumes in the 96-well 
microtiter plates, revealed LODs (standard deviation was calculated for 30 independent 
background measurements, which contained all assay components but no miRNA target) of 2.8 
pM (390 attomoles) of miR-20a and 1.7 pM (240 attomoles) of miRNA-21. The sensitivities 
were (1.64±0.02) x 10-4 FR/pM for miR-20a and (5.7±0.1) x 10
-5 FR/pM for miR-21. Taking into 
account the rather small standard deviations (e.g., background standard deviations of 1.3 x 10-4 
FR for miR-20a and 7.7 x 10
-5 FR for miR-21) and the excellent fit of the data points to the linear 
calibration curves, this sensitivity allows to distinguish concentration differences of a few pM 
over the entire dynamic concentration range. The LODs of miRNAs equivalent ssDNAs are 
also shown in Figure 3.10.  
 
Figure 3.8. Assay calibration curves (A for miR-20a and B for miR-21) showed a linearly 
increasing FRET ratio over target concentration with LODs of 2.8 pM (390 attomoles) of miR-
20a and 1.7 pM (240 attomoles) of miRNA-21. Error bars present standard deviations from 30 
measurements for background (no target, c = 0) and 9 measurements for all other data points. 
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Figure 3.9. HCR-TG-FRET assay calibration curves for miR-20a (left) and miR-21 (right) at 
5 nM concentrations of hairpins. 
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Figure 3.10. Diagnostic performance evaluation of the single ssDNA sensors. Assay calibration 
curves (A for ssDNA-20a and B for ssDNA-21) showed a linearly increasing FRET ratio over 
target concentration with LODs of 1.0 pM (140 attomoles) of DNA-20a and 0.88 pM (123 
attomoles) of DNA-21. Error bars present standard deviations from 30 measurements for 
background (no target, c = 0) and 9 measurements for all other data points. 
 
The target specificity of HCR-TG-FRET was evaluated for miR-20a and miR-21 
(Figure 3.11) against each other and against miR-20b, which possesses only two nucleotide 
mismatches (one at the 5’ terminus and the other in the center) compared to miR-20a (cf. Table 
3.1).  Both sensors (for miR-20a and miR-21) showed concentration-dependent increasing 
FRET ratios exclusively for their target, whereas the other two targets led to background signal 
over the entire concentration range. Only at the highest concentration of miR-20b (1 nM), the 
miR-20a sensor showed a minor increase in the FRET ratio compared to the background signal. 
Overall, HCR-TG-FRET quantification of miRNA provided excellent performance concerning 
sensitivity and specificity.  
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Figure 3.11. Target specificity for miR-20a (left) and miR-21(right) was demonstrated against 
two different miRNA targets. 
Single FRET-Pair Multiplexing 
TG multiplexing from a single measurement requires the efficient distinction of different TG 
detection windows. We selected two TG windows and recorded calibration curves for both 
miRNA targets (Figure 3.12A and B), whose slopes are required for quantification of both 
targets from the same sample (Equation 3.4). The background-corrected FRET ratios of both 
TG windows for both targets increased linearly until 0.15 nM for miR-20a and 0.30 nM for 
miR-21. Due to the faster PL decay of the Tb-Cy5.5 FRET pair in the miR-20a HCR-TG-FRET 
sensor, the PL intensity in the second TG window (TG2) is almost exclusively dependent on 
miR-21 concentration. On the other hand, the miR-21 sensitivity in TG2 (slope of the blue 
calibration curve in Figure 3.12B) is ca. four times lower than the miR-20a sensitivity in TG1 
(slope of the green calibration curve in Figure 3.12A). Taking into account the ca. two-fold 
lower sensitivity of miR-21 compared to miR-20a in TG1 (slopes of the green calibration curves 
in Figure 3.12A and B), it can be expected that miR-20a can be measured with higher precision 
in a duplexed assay. Such considerations are important for multiplexed assay design because 
different targets often require different sensitivities for diagnostic evaluation.  
A first experiment to demonstrate duplexed quantification of miR-20a and miR-21 from the 
same sample by a single measurement consisted in mixing both targets at the same increasing 
concentrations that were used for the single sensor assays (0 to 0.15 nM for miR-20a and 0 to 
0.3 nM for miR-21). As expected, the PL decay curves presented a multiexponential 
convolution of the single curves and the FRET ratios increased in both TG detection windows 
(Figure 3.12C). The almost perfect overlap of the detected FRET ratios and the sum of the 
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single assay FRET ratios (Figure 3.12C, right) showed that a combination of duplexed FRET 
ratios and the slopes of the single assay calibration curves (Equation 3.4) should be applicable 
to simultaneously quantify different concentrations of miR-20a and miR-21 from the same 
sample. To verify this finding, we prepared 13 samples that contained both targets at different 
concentrations ranging from high miR-20a and low miR-21 to low miR-20a and high miR-21. 
Decay and calibration curves for DNA targets are shown in Figure 3.14. 
 
Figure 3.12. PL decay curves of FRET-sensitized Cy5.5 and corresponding FRET-ratios (right) 
determined from the TG PL intensities in the two TG detection windows. A: miR-20a, B: miR-
21, C: miR-20a and miR-21. Stars in C present the mathematical sum of the FRET ratios from 
the single miRNA-target assays in A and B. The overlap with the measured duplexed FRET 
ratios shows the applicability of the calibration curves from A and B to duplexed miRNA 
quantification in C.  
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Figure 3.13. PL decay curves of Tb corresponding the Cy5.5 PL decay curves shown in Figure 
3.12. A: miR-20a, B: miR-21, C: miR-20a and miR-21. Same concentrations as in Figure 3.12. 
 
Figure 3.14. PL decay curves of FRET-sensitized Cy5.5 (top) and FRET-quenched Tb (middle), 
and corresponding FRET-ratios (bottom) determined from the TG PL intensities in the two TG 
detection windows. A: ssDNA-20a, B: ssDNA-21, C: ssDNA-20a and ssDNA-21. Stars in C 
present the mathematical sum of the FRET ratios from the single miRNA-target assays in A 
and B. The overlap with the measured duplexed FRET ratios shows the applicability of the 
calibration curves from A and B to duplexed miRNA quantification in C. 
 
As shown in Figure 3.15, both miRNA targets could be quantified at varying 
concentrations between 30 pM and 300 pM with relatively high precision. The performance of 
HCR-TG-FRET was not compromised by the addition of serum (10 %) inside the sample and 
RNase inhibitors were not required. As expected, due to the lower sensitivity of the miR-21 
sensor, the precision of miR-21 quantification was lower. However, all experimentally 
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determined data points are still very close to the known concentrations. Taking into account 
that all measured miR-21 concentrations have a slightly less steep linear correlation with the 
actual concentrations (as visualized by the blue dashed lines in Figure 3.15), this deviation may 
even be correctable in case a higher accuracy should be required. Duplexed detection of DNA 
targets in buffer is shown in Figure 3.16. 
 
 
Figure 3.15. Duplexed HCR-TG-FRET quantification of miR-20a (black) and miR-21 (red) at 
varying concentrations in buffer (A) and in buffer containing 10% serum (B). Dashed lines 
represent known concentrations. Data points were determined by HCR-TG-FRET using the 
calibration curves from Figure 3.12 and Equation 3.4. Light blue dashed shows the slope of 
the red data points, which may be used for further improving the precision for miR-21.  
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Figure 3.16. Duplexed HCR-TG-FRET quantification of ssDNA-20a (black) and ssDNA-21 
(red) at varying concentrations. Dashed lines represent known concentrations. Data points were 
determined by HCR-TG-FRET using the calibration curves from Figure 3.13 and Equation 
3.4. 
3.4. Conclusion 
HCR is a very simple signal amplification strategy because it does not require any enzymes. 
Therefore, it is a frequently applied technique for sensitive nucleic acid detection. Although 
HCR has been significantly optimized since its first application in 2004, we showed that 
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simplicity, sensitivity, and multiplexing can be further improved by implementation of TG-
FRET into HCR. Because FRET can only occur in the HCR product and not in the free hairpin 
probes, HCR-TG-FRET does not require any washing or separation steps (simplicity 
improvement). The TG detection of Tb donor and Cy5.5 acceptor with long PL decay times 
allowed for efficient suppression of sample autofluorescence and of directly excited acceptor 
fluorescence, which leads to high signal-to-background ratios (sensitivity improvement). Using 
different TG detection windows enabled multiplexed detection of different targets from the 
same sample by a single measurement, single excitation wavelength, and single detector 
(multiplexing and simplicity improvement). We applied HCR-TG-FRET to both miRNA (miR-
20a and miR-21) and the analogous ssDNA targets and demonstrated very low LODs (down to 
240 attomoles of miRNA and 123 attomoles of ssDNA) with high sensitivities. High specificity 
was verified against other targets including very homologous miRNAs (miR-20a vs. miR-20b). 
Single-measurement multiplexing was demonstrated by simultaneous quantification of miR-
20a and miR-21 at different concentrations (between 30 pM and 300 pM) from the same sample 
with similar results for serum-free buffer and buffer containing 10% of serum without the use 
of RNase inhibitors. Our detailed analytical evaluation revealed the versatile and powerful 
diagnostic performance of HCR-TG-FRET even in challenging biological environments. 
Taking into account that the temporal multiplexing approach is not limited to two TG detection 
windows and that it can be combined with spectral distinction for higher order multiplexing, 
we expect that HCR-TG-FRET will become a very useful alternative to currently applied HCR 
approaches for advanced multiplexed nucleic acid detection both in solution and in situ. 
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For this work, I designed the studies, performed the experiments, analyzed the data, and wrote 
the manuscript. 
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4. Spectral-temporal quadruplexing 
Tb-Dye RCA-FRET ssDNA detection 
assay 
4.1 Introduction 
In this chapter, I will present another nucleic acid detection method that combines the spectral-
temporal quadruplexing Tb-Dye time-gated FRET (TG-FRET) with sensitivity and specificity 
of target-primed RCA. Although a combination of spectral and temporal multiplexing within a 
single biosensing technique may seem evident, an actual experimental realization is very 
complicated and such a method is not available. One of the main reasons is the third dimension 
of the intensity, which is required for quantifying the analytes. For each biological target or 
interaction, a three-dimensional PL biosensor must provide a specific and stable spectral-
temporal signal combination that is independent of the other targets and the environment and 
changes its intensity as a function of target concentration. This objective becomes even more 
challenging when extremely low concentrations (fM-pM) of various similar targets need to be 
specifically quantified. 
Low abundance of nucleic acids often necessitates their amplification. A well-known 
and highly specific isothermal amplification method is target-primed rolling circle 
amplification (RCA), in which a padlock-DNA circularization by ligation over DNA[157] or 
RNA[158] targets enables the amplification process. In contrast to PCR, target-primed RCA 
can be applied both in situ, e.g., for genotyping individual DNA or mRNA molecules[159], and 
in solution, e.g., for DNA[160] or micro-RNA (miRNA)[161] diagnostics. As FRET and the 
involved PL lifetimes are strongly distance dependent, RCA amplification strategies could be 
ideally suited for controlled PL lifetime tuning by precise adjustment of donor-acceptor 
distances within the amplified DNA sequence at sub-nanometer resolution. The separation-free 
and background-free assay format accomplished limits of detection between 40 and 570 
zeptomoles (0.3 to 4.1 fM) for four different DNA targets from the same sample, using a single 
excitation source and only two distinct fluorescence colors. 
4.2 Materials and methods  
 
56 
 
4.2.1 Nucleic acid probes and exogenous targets.  
All sequences and modifications of nucleic acids are summarized in Table 4.1. All 
oligonucleotides (including Cy3.5 and Cy5.5 functionalized DNA) were purchased from 
Eurogentec. Non-modified DNAs were purified with cartridge gold-desalting method. 
Phosphate DNAs were purified with polyacrylamide gel electrophoresis. All other modified 
DNAs were purified with HPLC. Lumi4-Tb-NHS (Tb-NHS) was provided by Lumiphore, Inc. 
Tb-DNA conjugation was performed as described in 3.2.1.  
Table 4.1 Sequences and modifications of all DNA probes and targets. Sequence differences 
are shown in red, target-specific termini of padlock DNA shown in blue, Tb-probe-
complementary sequences shown in green, and Cy3.5 and Cy5.5-probe-complementary 
sequences shown in orange. 
 
4.2.2 Photophysical analysis  
Absorption spectra (Lambda 35 UV/Vis System, PerkinElmer) and emission spectra (FluoTime 
300, PicoQuant) were recorded in HEPES buffer (100 mM, pH 7.4) and deionized water 
(purified by Purelab Option-Q equipped with bio-filter, ELGA LabWater) for Tb, Cy3.5, and 
Cy5.5 samples, respectively.  
4.2.3 RCA-FRET single target assays 
 In a typical DNA assay, 0.75 nM padlock probe and an appropriate amount of target DNA 
were prepared in 20 µL Taq DNA ligase reaction buffer (BUFFER-1, 1× buffer components: 
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20 mM Tris-HCl, 25 mM potassium acetate, 10 mM magnesium acetate, 10 mM dithiothreitol, 
1 mM NAD, 0.1% Triton X-100, pH 7.6) and incubated in a thermal cycler with a temperature 
control program (80°C for 2 min → decreased from 80°C to 22°C with a 2°C/min speed). Then 
4 U of Taq DNA ligase (New England Biolabs) prepared in 10 µL BUFFER-1 was added to 
the mixture and incubated at 37°C for 1 h. Afterwards, 60 µL phi29 DNA polymerase reaction 
buffer (BUFFER-2, 1× buffer components: 50 mM Tris-Cl, 10 mM MgCl2, 10 mM (NH4)2SO4, 
4 mM DTT, pH 7.4), which contained 5 U of phi29 DNA polymerase (New England Biolabs) 
and 0.5 mM dNTP (New England Biolabs), was added and incubated at 37°C for 2 h. Before 
termination of the polymerization process, 5 nM Tb probe and 5 nM Cy3.5 or Cy5.5 probe 
prepared in 60 µL hybridization buffer (BUFFER-3, 20 mM Tris-Cl, 500 mM NaCl, 0.1 % 
BSA, pH 8.0) were added and incubated in a thermal cycler with a temperature control program 
(65°C for 10 min → decreased from 65°C to 22°C with a 2°C/min speed → 22°C for 10 min). 
From the total reaction volume of 150 µL, 140 µL were measured in black 96-well microtiter 
plates on the clinical immunofluorescence plate reader KRYPTOR compact plus (Thermo 
Fisher Scientific) with time-gated (0.1-0.9 ms) PL intensity detection using optical bandpass 
filters with 494±12 nm (Semrock) for the Tb detection channel, 716±20 nm (Semrock) for the 
Cy5.5 detection channel and 608±4 nm (Delta) for the Cy3.5 detection channel. For ratiometric 
analysis, FRET-ratios were calculated by the ratio of Cy5.5 or Cy3.5 and Tb time-gated PL 
intensities. Trizma base, hydrochloric acid (HCl) and bovine serum albumin (BSA) were 
purchased from Sigma-Aldrich. NaCl was purchased from Duchefa. All chemicals were used 
as received. 
4.2.4 Temporal duplexing of DNA-20a and DNA-21  
The duplexed assay contained two different padlock probes (same amounts as single sensors), 
Taq DNA ligase (double amounts of single sensors), phi29 DNA polymerase and dNTP (same 
amounts as single sensors), two different Tb probes (same amounts as single sensors) and Cy5.5 
probe (double amounts of single sensors). 140 µL were measured in black 96-well microtiter 
plates on a fluorescence plate reader (Edinburgh Instruments) using 4000 detection bins of 2 μs 
integration time and nitrogen laser (MNL 100, LTB Berlin) excitation (337.1 nm, 20 Hz) and 
using optical bandpass filters with 494±12 nm for the Tb detection channel and 716±20 nm for 
the Cy5.5 detection channel.  
4.2.5 Spectral-temporal multiplexing of DNA-20a, DNA-21, DNA-20b, and 
DNA-191  
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The quadruplexed assay contained four different padlock probes (same amounts as single 
sensors), Taq DNA ligase (quadruple amounts of single sensors), phi29 DNA polymerase and 
dNTP (double amounts of single sensors), four different Tb probes (same amounts as single 
sensors), Cy3.5 probe (double amounts of single sensors) and Cy5.5 probe (double amounts of 
single sensors). 140 µL were measured in black 96-well microtiter plates on a fluorescence 
plate reader (Edinburgh Instruments) using 4000 detection bins of 2 μs integration time and 
nitrogen laser (MNL 100, LTB Berlin) excitation (337.1 nm, 20 Hz) and using optical bandpass 
filters with 494±12 nm for the Tb detection channel, 608±4 nm for the Cy3.5 detection channel 
and 716±20 nm for the Cy5.5 detection channel. 
4.3 Results and discussion  
4.3.1 The principle of multiplexed RCA-FRET 
The principle of multiplexed RCA-FRET is shown in Figure 4.1. First, a DNA target is 
specifically hybridized by the two ends of a linear probe DNA (padlock DNA) that circularizes 
upon target recognition. Then, the padlock nick is ligated over the target splint, which makes 
the target a primer for a polymerase to synthesize complementary DNA around the circular 
probe DNA. After each round, the previously synthesized DNA strand is displaced, which leads 
to a long ssDNA concatemer. As the repetitive sequence of this long RCA product is known 
(by the design of the padlock), FRET-donor (Tb) and FRET-acceptor (Cy3.5 or Cy5.5) DNA 
probes can be designed to hybridize at desired positions within the concatemer and thereby at 
defined but distinct donor-acceptor distances (R). Due to the strong distance-dependence of the 
FRET efficiency (~R-6), different values of R lead to different PL decays of the FRET-quenched 
donors and FRET-sensitized acceptors (the closer the distance the faster the decay).[3], [46] 
These different PL decays can then be used for straightforward temporal multiplexing by time-
gated PL intensity detection. The use of two different acceptors (Cy3.5 and Cy5.5) for the same 
Tb donor allows for spectral multiplexing with a single excitation wavelength. In principle, x 
distinct spectral signals and y distinct temporal signals can be combined to x·y distinct signals 
in solution or xy distinct signals if the different RCA products are spatially separated (e.g., in-
situ imaging). Such higher-order multiplexing has the potential to significantly advance the 
detection of multiple targets from a single sample. Another advantage is the separation-free 
format of RCA-FRET because FRET is not possible for Tb and dye DNA probes that are free 
in solution (not hybridized to the RCA product). Finally, the ratiometric detection of time-gated 
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PL intensities of dye and Tb leads to very precise (low coefficients of variation) signal 
quantification.  
 
Figure 4.1. Each DNA target is recognized by the terminal sequences of a specific padlock 
probe. After this hybridization step, a ligase (Taq DNA ligase) closes the padlock nick over the 
target splint, which transfers the target into a primer for subsequent DNA synthesis (by phi29 
DNA polymerase and dNTP, a mixture of the four deoxyribonucleotides). DNA amplification 
by RCA is performed at 37 °C for 2 h, and the resulting rolling circle product is labeled (specific 
hybridization) by Tb-donor and dye-acceptor DNA probes. Combining the same Tb donor with 
two different dye acceptors (Cy3.5 and Cy5.5) and hybridizing the DNA probes at different 
distances (bps: base pairs) inside of the target specific RCA products provides four 
distinguishable signals (two distinct time-gated detection windows TG1-TG4 for two different 
colors) in the two Cy3.5 and Cy5.5 detection channels. Ratiometric TG-FRET measures the 
FRET-ratio of the FRET-sensitized dye PL intensity (left) and FRET quenched Tb PL intensity 
(right) within a specific time window after pulsed excitation (to suppress autofluorescence). 
Black/purple decay curves present signals without/with a target. The FRET-sensitized dye-
acceptor intensity strongly increases with increasing target concentration, whereas the overall 
Tb-donor signal is not significantly quenched (because also free Tb DNA probes in solution 
emit PL). 
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Figure 4.2. (a) Spectra of Tb absorption (black) and emission (green) that partly overlaps with 
the absorption of Cy3.5 (orange) and Cy5.5 (red). (b) Emission spectra of Tb (green), Cy3.5 
(orange), and Cy5.5 (red). Optical bandpass filter transmission spectra, which represent the 
detection channels for Tb, Cy3.5, and Cy5.5, are shown in gray. 
 
Absorption/emission spectra of donor LTC, acceptor Cy3.5 and Cy5.5 are shown in Figure 4.2. 
Förster distances (the donor-acceptor distance for which FRET is 50 % efficient) of 
R0(Cy3.5) = 6.5 ± 0.3 nm and R0(Cy5.5) = 5.8 ± 0.2 nm were calculated using Equation 4.1. 
The orientation factor κ2 was taken as 2/3 because of the random orientation of donor and 
acceptor during the FRET time (dynamic averaging), which is well justified by the long PL 
lifetime of the Tb donors and the unpolarized emission (fast isotropic rotation). The refractive 
index was n = 1.35 (aqueous buffer solution). The Tb-centered quantum yield was 
ΦD = 0.80 ± 0.05. The overlap integral J was calculated by Equation 4.2 where ID(𝜆) is the 
emission intensity from the area-normalized (to unity) emission spectrum of Tb donor and 𝜀A(𝜆) 
is the molar absorptivity of the acceptor.   
nm)(02108.0 6/1420 JnR D
                                     (4.1) 
 d)()( 4
nm700
nm475
AD IJ                    (4.2) 
4.3.2 Spectral-temporal multiplexing RCA-FRET assay development 
Sensitivity 
As a representative system for multiplexed nucleic acid detection, we selected four different 
short ssDNAs (DNA-20a, DNA-20b, DNA-21, and DNA-191), which are the DNA-equivalents 
of the micro-RNAs hsa-mir-20a/20b/21/191, all of which have been found to be related to breast 
cancer.[154], [162]–[164] Because target-primed RCA via padlock probes was already applied 
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for longer DNA as well as RNA targets,[157], [159] our short ssDNA-based detection is in 
principle transferable to other nucleic acids.  To evaluate the sensitivity and versatility of RCA-
FRET, we quantified the four DNAs at concentrations between 1 and 250 fM and with two 
different TG-FRET donor/acceptor pairs (Tb/Cy3.5 and Tb/Cy5.5). All eight RCA-FRET 
sensors showed a linear signal-over-concentration behavior within the tested concentration 
range (Figure 4.3 and Figure 4.4), which allowed for the distinction of even very similar 
concentrations, and LODs between 40 and 570 zeptomoles (0.3 to 4.1 fM) of DNA. For 
statistical analysis and the estimation of LODs, all samples were prepared 3 times and measured 
in triplicates (n = 9) apart from the zero-concentration samples (without DNA targets), which 
were prepared 10 times and measured in triplicates (n = 30). 
 
Figure 4.3. PL decay curves measured in the Tb and the dye detection channels for the different 
DNA targets with increasing concentrations (0, 0.01, 0.025, 0.05, 0.075, 0.1, 0.25 pM). FRET-
sensitized dye PL is more obvious than FRET-quenched Tb PL. This is caused by the fact that 
long-lived dye PL can only be generated by FRET (very low background), whereas the Tb PL 
is already long-lived (high background).  
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Figure 4.4. RCA-FRET assay calibration curves for four different DNA targets with Cy3.5 or 
Cy5.5 as FRET acceptor. LODs were 4.1±0.6 fM (Cy3.5) and 1.3±0.2 fM (Cy5.5) for DNA-
20a, 2.8±0.4 fM (Cy3.5) and 1.1±0.2 fM (Cy5.5) for DNA-20b, 2.5±0.4 fM (Cy3.5) and 1.2±0.2 
fM (Cy5.5) for DNA-21, and 0.8±0.1 fM (Cy3.5) and 0.3±0.1 fM (Cy5.5) for DNA-191. 
 
Specificity 
For specificity testing, DNA-20a and DNA-20b had only two nucleotide variations, from which 
one was at the 5’-terminus. All four sensors provided specificity solely to their respective 
targets without non-specific background signals from the other three DNAs and with increasing 
FRET signals over a concentration range of more than three orders of magnitude (Figure 4.5). 
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Figure 4.5. Broad dynamic concentration range (0 fM to 2 pM) and high specificity of RCA-
FRET demonstrated by the distinction of each DNA target against the other three DNAs. For 
DNA-20a and DNA-21 the FRET pair Tb/Cy3.5 and for DNA-20b and DNA-191 the FRET 
pair Tb/Cy5.5 were used.  
 
Temporal duplexing of DNA-20a and DNA-21 
To verify the sensitivity and selectivity, temporal duplexing (2-plex) of DNA-20a and DNA-21 
were performed. We prepared 13 samples with varying concentrations of DNA-20a and DNA-
21, and all samples were prepared 2 times and measured once (n=2). Figure 4.6 shows that the 
measured concentrations were in excellent agreement with the actual target concentrations.  
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Figure 4.6. PL decay curves (top), calibration curves (bottom left), and recovery tests (bottom 
right) of varying concentrations of DNA-21, and DNA-20a from 13 different samples using 
temporal TG-FRET multiplexing. Dotted lines represent known concentrations; data points 
represent RCA-FRET measurements.  
 
Spectrotemporal multiplexing of DNA-20a, DNA-21, DNA-20b, and DNA-191. 
Multiplexing from a single sample is highly important to simultaneously measure various 
targets, to reduce sample volume and reagents, and to increase the measurement throughput. 
We have previously shown that Tb-to-dye TG-FRET can be used for efficient and sensitive 
color multiplexing in immunoassays[16] and miRNA assays (three targets)[7][8] and for 
temporal multiplexing of two different miRNAs shown in Chapter 3. However, neither the 
combination of these two concepts into higher-order spectral-temporal TG-FRET multiplexing 
from a single sample, nor the detection of extremely low concentrations (fM-pM) of 
biomolecules has been realized. Following the RCA-FRET concept from Figure 4.1, we 
designed four different padlocks and six different FRET probes (four Tb probes and two dye 
probes), which allowed us to place the two different FRET-pairs at distinct distances within the 
target-specific RCPs. This, in turn, led to distinct PL decay curves (Figure 4.7) due to the 
different FRET efficiencies. The different decay curves show the contribution of each target 
into the Cy3.5 (left) or Cy5.5 (right) detection channels and were used to calculate the 
calibration curves in Figure 4.8a. All PL signals were generated by using a single excitation 
source because the same Tb donor was used in all cases.  
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Figure 4.7. PL decay curves of the dye detection channels for calibration of spectrotemporal 
TG-FRET multiplexing. The assays contained all four probe-systems presented in Table.  
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Figure 4.8. (a) Contributions of the different RCA-FRET signals (FRET-ratiozero) to the 
different time-gated detection windows. The calibration curves (lines) were used to calculate 
the concentrations for the 4-fold TG-FRET multiplexed assays (see Supporting Information for 
mathematical treatment). (b) Recovery of varying concentrations of DNA-20a, 20b, 21, and 
191 from 10 different samples using spectrotemporal TG-FRET multiplexing. Dotted lines 
represent known concentrations; data points represent RCA-FRET measurements. 
 
Mathematical treatment of multiplexed signal deconvolution.  
TG PL intensities (ITG) of the Cy3.5/Cy5.5 acceptors and the Tb donor were determined in their 
specific time windows (from the corresponding PL decay curves). These TG PL intensities were 
then used to calculate a background-subtracted FRET-ratio (FRET-ratiozero) for each target 
concentration c = x: 
FRET-ratiozero =
𝐼𝑑𝑦𝑒
𝑇𝐺 (𝑐=𝑥)
𝐼𝑇𝑏
𝑇𝐺(𝑐=𝑥)
−
𝐼𝑑𝑦𝑒
𝑇𝐺 (𝑐= 0)
𝐼𝑇𝑏
𝑇𝐺(𝑐=0)
                (4.3) 
The concentration-dependent FRET-ratiozero values were used to determine the calibration 
curves for each DNA target in each detection window (Figure 4.6 for temporal TG-FRET 2-
plex assays and Figure 4.8a for spectrotemporal TG-FRET 4-plex assays). 
- 2-plex (DNA-20a and DNA-21) temporal TG-FRET using a single Tb/Cy5.5 FRET pair: 
The slopes of the four linearly fitted calibration curves (𝑧20𝑎
𝑇𝐺𝐴, 𝑧21
𝑇𝐺𝐴, 𝑧20𝑎
𝑇𝐺𝐵, 𝑧21
𝑇𝐺𝐵) from Figure 
4.6 (bottom left) were used to determine the concentrations in the duplexed assay that led to the 
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concentration recovery in Figure 4.6 (bottom right) by solving the following equation for the 
concentrations c(DNA-20a) and c(DNA-21). FRET-ratioAzero and FRET-ratio
B
zero were the 
FRET-ratiozero values from the two TG detection windows (TGA and TGB) in the 2-plex assay. 
[
FRET-ratiozero
A
FRET-ratiozero
B
] = [
c(DNA-20a)
c(DNA-21)
] × [
𝑧20𝑎
𝑇𝐺𝐴 𝑧21
𝑇𝐺𝐴
𝑧20𝑎
𝑇𝐺𝐵 𝑧21
𝑇𝐺𝐵
]                         (4.4) 
Figure 4.6 (bottom right) shows the selective, sensitive, and accurate recovery of DNA-20a 
and DNA-21 at varying sub-picomolar concentrations from thirteen different samples. 
- 4-plex (DNA-20a, DNA-20b, DNA-21, DNA-191) spectrotemporal TG-FRET using a 
Tb/Cy3.5 and a Tb/Cy5.5 FRET pair 
Due to negligible spectral crosstalk of Cy5.5 into the Cy3.5 channel (Figure 4.2), the two TG 
channels for the Tb/Cy3.5 FRET pair (TG1 and TG2) contained PL signals only for DNA-20 
and DNA-21 (Figure 4.7). Therefore, a similar method to the one from duplexing (vide supra) 
could be used to determine the concentrations c(DNA-20a) and c(DNA-21). In this case, the 
slopes (𝑧20𝑎
𝑇𝐺1, 𝑧21
𝑇𝐺1, 𝑧20𝑎
𝑇𝐺2, 𝑧21
𝑇𝐺2) of the four linearly fitted calibration curves for DNA-20a and 
DNA-21 from Figure 4.8a were used to determine the concentrations: 
[
FRET-ratiozero
1
FRET-ratiozero
2
] = [
c(DNA-20a)
c(DNA-21)
] × [
𝑧20𝑎
𝑇𝐺1 𝑧21
𝑇𝐺1
𝑧20𝑎
𝑇𝐺2 𝑧21
𝑇𝐺2
]              (4.5) 
Due to significant spectral crosstalk of Cy3.5 into the Cy5.5 channel (Figure 4.2), the two TG 
channels for the Tb/Cy5.5 FRET pair (TG3 and TG4) contained PL signals for all targets (DNA-
20, DNA-21, DNA-20b, and DNA-191 – Figure 4.8a). This means that the slopes (𝑧20𝑎
𝑇𝐺3, 𝑧21
𝑇𝐺3, 
𝑧20𝑏
𝑇𝐺3, 𝑧191
𝑇𝐺3, 𝑧20𝑎
𝑇𝐺4, 𝑧21
𝑇𝐺4, 𝑧20𝑏
𝑇𝐺4, 𝑧191
𝑇𝐺4) of all eight linearly fitted calibration curves for DNA-20a, 
DNA-21, DNA-20b, and DNA-191 from Figure 4.8a needed to be taken into account to 
determine the concentrations of DNA-20b and DNA-191. Because the concentrations c(DNA-
20a) and c(DNA-21) were determined by the Tb/Cy3.5 FRET-pair (vide supra), they could be 
used in combination with 𝑧20𝑎
𝑇𝐺3 , 𝑧21
𝑇𝐺3 , 𝑧20𝑎
𝑇𝐺4 , and 𝑧21
𝑇𝐺4  (note that 𝑧20𝑎
𝑇𝐺4 = 0  because the 
contribution of DNA-20a in TG4 is negligible – cf. Figure 4.8a) to subtract the contribution of 
these two targets in TG3 and TG4: 
ΔFRET-ratiozero
3 = FRET-ratiozero
3 − 𝑧20𝑎
𝑇𝐺3𝑐(DNA-20a) − 𝑧21
𝑇𝐺3𝑐(DNA-21)      (4.6) 
ΔFRET-ratiozero
4 = FRET-ratiozero
4 − 𝑧21
𝑇𝐺4𝑐(DNA-21)             (4.7) 
These corrected FRET-ratiozero values can then be used to determine the missing concentrations 
c(DNA-20b) and c(DNA-191) in combination with the slopes 𝑧20𝑏
𝑇𝐺3, 𝑧191
𝑇𝐺3, 𝑧20𝑏
𝑇𝐺4, and 𝑧191
𝑇𝐺4: 
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[
∆FRET-ratiozero
3
∆FRET-ratiozero
4
] = [
c(DNA-20b)
c(DNA-191)
] × [
𝑧20𝑏
𝑇𝐺3 𝑧191
𝑇𝐺3
𝑧20𝑏
𝑇𝐺4 𝑧191
𝑇𝐺4
]             (4.8) 
Equation 4.5 and Equation 4.6 were used for the recovery of the concentrations of the four 
DNA targets in the 10 different samples in Figure 4.8b. 
4.4 Conclusion 
In conclusion, RCA-FRET is the first method that can combine spectral and temporal 
multiplexing into higher-order multiplexed and highly sensitive detection of nucleic acids. It 
can be performed by straightforward procedures on commercially available time-resolved 
fluorescence plate readers and is adaptable to other RCA approaches and probably to any other 
DNA-amplification strategy that uses hybridization of fluorescent probes. RCA-FRET 
provided LODs down to 40 zeptomoles (300 aM) of DNA, which presents an improvement of 
more than four orders of magnitude compared to non-amplified TG-FRET detection of the same 
targets. Spectral-temporally multiplexed detection (from the same sample) of four different 
DNA targets in the 40 to 500 fM concentration range was accomplished by using only two 
different FRET-pairs and one excitation wavelength. These target concentrations were three 
orders of magnitude lower compared to spectral multiplexing of three DNA targets with three 
different FRET pairs.[7] This first demonstration of spectrotemporal multiplexing quantified 
only four DNAs by combining two spectral and two temporal components, but the use of TG-
FRET with five different acceptors and three different time-gated windows would allow for 15-
fold multiplexing from a single liquid sample or 125-fold multiplexing for imaging (Figure 
4.9). Although such extensions are beyond the current scope, our future research will investigate 
the experimental limits of spectrotemporal multiplexing and the adaption of RCA-FRET to in-
situ imaging in cells. The versatility, specificity, and sensitivity of isothermal RCA-FRET for 
higher-order multiplexed quantification of nucleic acids at extremely low concentrations are 
ideally suited to advance many fundamental and applied biological studies. Because no other 
technology can combine such technological versatility with accuracy and simplicity of 
application, we believe that RCA-FRET will be of high value both in research and diagnostics, 
and provide new insights about the role of DNA or RNA in biological functions and diseases. 
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Figure 4.9. High-order spectrotemporal multiplexing capabilities using five different colors 
and three different time gates. Top: in solution. Bottom: With spatially distinct RCA products, 
e.g., for imaging in cells. 
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5. Temporal multiplexing Tb-QD 
FRET for QD-DNA conformation 
analysis 
5.1. Introduction 
The development and application of DNA-nanoparticle conjugates for advanced chemical and 
biological sensing is a continuously growing field of research[110],[164]–[166]. Understanding 
the conformation and function of nucleic acids attached to nanosurfaces under physiological 
conditions is of paramount importance for the design of useful and versatile analytical tools 
with specific and sensitive target recognition. QDs are among the most often applied 
nanoparticles for DNA-nanobiotechnology because their chemical and photophysical stability 
and outstanding fluorescence properties can be used for both investigating the DNA-
nanosurface interaction and developing robust and sensitive biosensors[112], [168]–[170]. In 
particular, the combination with FRET opens the possibility for scrutinizing distance-
dependence and orientation of DNA-nanoparticle systems and for developing and optimizing 
DNA-hybridization biosensors with exceptional analytical properties[171], [172].  
The most interesting aspect of DNA-nanotechnology is its simplicity of constructing 
single- or double-stranded structures out of only four types of bases, which allows for placing 
energy transfer donors and acceptors at defined distances with single nucleotide (nt) sensitivity. 
Such flexibility in adapting donor-acceptor distances is not only useful for optimizing the 
energy transfer for each specific donor-acceptor pair with the aim of highest possible sensitivity. 
It can also be exploited to tune the photoluminescence (PL) decays for temporal optical 
multiplexing[173]–[175], which presents a powerful extension to the commonly used color 
multiplexing. Although DNA distances can be extended nt per nt, there remain important 
limitations both for very short and very long FRET distances. Conjugating donor and acceptor 
to the respective 3’ and 5’ ends of complementary ssDNA strands usually leads to very close 
distances (0 nt) upon hybridization and a concomitant FRET efficiency close to 100 %, which 
cannot be used for quantitatively analyzing donor-acceptor distances. Longer distances are 
mainly affected by the FRET distance limit (close to 0 % FRET efficiency), which is 
approximately 10 nm for efficient FRET pairs. Molecular FRET rulers were shown to be 
functional between ca. 5 and 9 nm with dye-dye and QD-dye pairs (polyproline distance 
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adjustment)[3] and between ca. 4 and 10 nm with Tb-dye pairs (dsDNA distance 
adjustment)[173]. A detailed analysis of many distances and the resulting conformations over 
a long DNA strand conjugated to a QD under physiological conditions (in aqueous solution at 
low concentrations) would significantly improve the understanding of how DNA orients and 
behaves on nanoparticle surfaces, which, in turn, would provide important information for 
designing DNA-nanoparticle-based biosensors. 
In the study, we analyzed the conformation of a 31 nt long DNA, attached via a 5’ 
modified peptide-His6 sequence (peptide-DNA) to a QD, when different Tb-conjugated 
complementary DNA probes hybridized at distances between 0 and 26 nt from the 5’ end of 
QD-conjugated DNA by Tb-QD temporal  multiplexed FRET and biomolecular modeling 
(Figure 5.1). Our results show that Tb-to-QD distances of up to 14 nm (center-to-center) can 
be precisely quantified using FRET theory with a dynamically averaged orientation and fitting 
the FRET-sensitized QD PL decay curves. In ssDNA conformation, the distance increase was 
linear with ~0.15 nm/nt and the orientation of the DNA was between vertical (or perpendicular) 
and parallel (or tangential) attachment to the QD surface. In dsDNA conformation, the distance 
increase was also linear but with ~0.31 nm/nt and the orientation of the DNA was in almost 
perfect agreement with vertical attachment to the QD surface. All 11 conformations (0, 2, 4, 6, 
10, and 14 nt for “3’-FRET” on ssDNA and 10, 14, 18, 22, and 26 nt for “5’FRET” on dsDNA) 
showed distinct PL decay curves and DNA-concentration-dependent time-gated FRET ratios 
that demonstrated the feasibility of quantitative DNA biosensing at many different Tb-QD 
distances for temporal multiplexing. Our results show that, despite the relatively large 
nanoparticle dimensions, QD-DNA conjugates can be used as precise nanometric FRET rulers 
over long distances and that all of the applied distances between ca. 7 and 14 nm can be used 
for quantitative DNA analysis in a low nM concentration range. 
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Figure 5.1. Top: All QD-DNA systems consisted of the same 31 nt long ssDNA (dark blue) 
that was appended (via a crosslinker at the 5’ end) to a 10 amino acid peptide sequence and a 
His6 for self-assembly to the QD625 surface. Different DNA probes (cyan) conjugated with Tb 
on their 3’ or 5’ ends were used to investigate the conformation of 0 to 14 nt long ssDNA 
appended to 31 to 17 nt long dsDNA (3’FRET, left) and 10 to 26 nt long dsDNA appended to 
21 to 5 nt long ssDNA (5’-FRET, right) by Tb-to-QD FRET. Schematic presentation not to 
scale. Bottom: Biomolecular modeling was used to calculate Tb-to-QD distance ranges in 
parallel (orange) and vertical (gray) DNA-surface attachment configurations. Due to the short 
peptide sequence and crosslinker after the His6, the DNA is situated outside the DHLA-PEG 
coating (dark blue) on the QD (cyan). Flexible molecular linkers between Tb and DNA led to 
an additional distance variation as visualized by two extreme Tb positions for each DNA. The 
left image shows a 14 nt 3’-FRET configuration. The right image shows a 22 nt 5’-FRET 
configuration. 
5.2 Materials and methods  
5.2.1 Materials 
Lumi4-Tb-NHS was provided by Lumiphore Inc. (Berkeley, CA, USA). 625 nm emitting 
proprietary CdSe/ZnS QDs were provided by Invitrogen by Life Technologies (Carlsbad, CA) 
and functionalized with dihydrolipoic acid-appended poly(ethylene glycol) (PEG, MW∼750) 
ligands in house. Peptide-oligonucleotides was synthesized by Biosynthesis (Lewisville, Texas, 
USA). All other modified oligonucleotides were purified with HPLC from Eurogentec (Liège, 
Belgium). All sequences and modifications of nucleic acids used in this study are summarized 
in Table 5.1. Tris(hydroxymethyl)-aminomethane, bovine serum albumin, and HEPES were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). NaCl was purchased from Duchefa 
 
73 
 
(Netherlands). All chemicals were used as received. Water was purified by MAXIMA (USF 
Elga, UK). Zeba Spin Desalting Columns (7 kDa MWCO) were purchased from Thermo Fisher 
Scientific (Nîmes, France). Tb-DNA conjugation was performed as described above. 
Table 5.1. DNA oligonucleotides used in the study 
 
5.2.2 Spectroscopic characterization  
Absorption spectra (Lambda 35 UV/vis System, PerkinElmer) and emission spectra (for Tb: 
FluoTime 300, PicoQuant; for QD625: Xenius, SAFAS) were recorded in 100 mM HEPES 
buffer (pH 7.4) for Tb and in 100 mM Na-tetraborate + 0.1 M NaCl buffer (pH 8.5) for QD625. 
5.2.3 Tb-QD FRET assays 
All FRET assays were prepared in DNA hybridization buffer and contained 50 μL of Tb-DNA 
and 50 μL of 625 nm DHLA capped QD at constant concentrations to which 50 μL of peptide-
oligonucleotides at different concentrations were added. The single sensor assays contained 20 
nM of Tb, 0.5 nM of QD and increasing concentrations of peptide-oligonucleotides (from 0 nM 
to 10 nM), and all samples were prepared once. After sample preparation, they were incubated 
in black 96-well microtiter plates for 30 min at room temperature (22 °C) with an optimal 
working volume of 150 μL. PL decay curves were acquired on a fluorescence plate reader 
(Edinburgh Instruments) using 4000 detection bins of 2 μs integration time and nitrogen laser 
(MNL 100, LTB Lasertechnik Berlin) excitation (337.1 nm, 20 Hz). Optical transmission filter 
(Semrock) bandpass wavelengths were 494 ± 20 nm for the Tb detection channel and 640 ± 14 
nm for the QD625 detection channel. FRET ratio was used as the DNA hybridization assay 
detection signal, the FRET ratios are calculated by dividing the intensity of QD625 by the 
intensity of Tb in the time-gated window (0.1 to 2 ms). Calibration curves show the increasing 
time-gated PL FRET ratios with increasing peptide-DNA. 
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5.3. Results and discussion  
5.3.1 Photophysical properties of Tb and QD and R0 calculation 
 
Figure 5.2. Absorption (dotted) and PL emission (solid) spectra of Tb (green) and QD625 
(orange) and filter transmission spectra (gray) used for Tb donor and QD acceptor time-resolved 
PL detection. 
 
A Förster distance (the donor-acceptor distance for which FRET is 50 % efficient) of R0 = 
10.3 nm was calculated using the following equation: 
𝑅0 = 0.02108(𝜅
2𝛷𝐷𝑛
−4𝐽)1/6   nm                    (5.1) 
The orientation factor κ2 was taken as 2/3 because of the random orientation of donor and 
acceptor during the FRET time (dynamic averaging), which is well justified by the long PL 
lifetime of the Tb donors and the unpolarized emission (fast isotropic rotation). The refractive 
index was n = 1.35 (aqueous solution). The Tb-centered quantum yield was ΦD = 0.81 ± 0.05. 
The overlap integral J was calculated by the following equation: 
𝐽 = ∫ 𝐼𝐷(𝜆)𝜀𝐴
650 𝑛𝑚
450 𝑛𝑚
(𝜆)𝜆4𝑑𝜆              (5.2) 
where ID(λ) is the emission intensity from the area-normalized (to unity) emission spectrum of 
Tb donor and εA(λ) is the molar absorptivity of the acceptor. The spectra are shown in Figure 
5.2. 
5.3.2 FRET DNA-Conjugates 
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The FRET pair consisted of a Lumi4-Tb donor (Tb) and a DHLA-PEG (dihydrolipoic acid-
appended poly(ethylene glycol)-coated Qdot625 acceptor (QD625). As shown in Figure 5.2, 
pulsed UV light (337.1 nm) efficiently excites both Tb and QD625, leading to four main Tb PL 
bands between 450 and 650 nm and one QD PL band around 625 nm. Owing to the large 
difference of PL lifetimes (ms vs. ns), the initially excited QDs decay quickly to their ground 
states and become available as FRET acceptors for the long-lifetime Tb donors, which leads to 
FRET-quenched Tb PL and FRET-sensitized QD-PL with the same PL decay times (τDA = τAD). 
The well-overlapping Tb PL and QD absorption (Figure 5.2) resulted in a Förster distance 
(donor-acceptor distance for which FRET is 50 % efficient) of R0 = 10.3 nm (see Equations 
5.1 and 5.2 and Materials and Methods section for details). For minimal spectral crosstalk 
between the Tb and QD, PL decays were measured at 494±20 nm for Tb and 640±14 nm for 
QD625 (see Figure 5.2 for filter transmission spectra).  
The main 31 nt long DNA strand (see Table 5.1 for sequences of all DNA used in our 
study) was attached via metal-affinity mediated self-assembly to the Zn-rich surface of 
QD625[176], [177]. The His6 was appended to 10 additional amino acids (SLGAAAGSGC) 
and a crosslinker that extended the DNA slightly beyond the DHLA-PEG coating on the QD625 
surface (cf. Figure 5.1 bottom), such that the conformational freedom of the DNA was not 
restrained. The Tb donor was brought into FRET proximity of the QD by hybridization of 
different Tb-DNA probes to the main QD-DNA strand. The distance between the first nt on the 
5’ end of peptide-DNA and the Tb (on the 3’ or 5’ end depending on the configuration) was 
adjusted in 11 different configurations between 0 and 26 nt, which resulted in Tb distances of 
0 to 14 ssDNA bases and 10 to 26 dsDNA base pairs after the peptide extension from the QD 
(cf. Figure 5.1). 
5.3.3 PL decay curves and fit results of Tb and QD for Tb-QD-DNA 
configurations with 0, 2, 4, 6, 10 and 14 bases ssDNAs, and 10, 14, 18, 22, 26 
bases dsDNAs separation. 
All PL decay curves were fit using multi-exponential intensity decay functions with a starting 
time point for the fit of t0, which corresponds to a short delay between the start of the actual PL 
decay and the start of the fit (due to very strong background fluorescence in the short time range, 
the fits usually start after a few tens of µs as indicated above each fit result table). The PL 
intensity decay is defined by the following equation: 
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𝐼 = ∑ 𝐴𝑖−𝐹𝑖𝑡𝑖 exp (−
𝑡−𝑡0
𝜏𝑖
) = ∑ 𝐴𝑖 exp (−
𝑡
𝜏𝑖
)𝑖             (5.3) 
Fast software from Edinburgh instruments was used for fitting all decay curves. As the actual 
decay starts before t0, the amplitudes (Ai-Fit), which are used to calculate average PL lifetimes, 
need to be corrected using the following equation: 
𝐴𝑖−𝐹𝑖𝑡 exp (−
𝑡−𝑡0
𝜏𝑖
) = 𝐴𝑖  exp (−
𝑡
𝜏𝑖
)  ⟹  𝐴𝑖 = 𝐴𝑖−𝐹𝑖𝑡 exp (−
𝑡0
𝑡
)                   (5.4) 
Because all decay curves (in particular those from the Tb donor detection channel) contain a 
certain amount of unquenched Tb decay, this “pure Tb” decay time (𝜏𝐷) was used as a fixed 
decay time in the multiexponential fit functions. 𝜏𝐷was determined for each set of experiments 
(in the Tb-donor channel and the QD-acceptor channel) by fitting the decay for a sample in 
which only Tb-DNA was present. 𝜏𝐷 (in ms) was also used to determine the Tb-centered PL 
quantum yield ( ΦTb =  𝜏𝐷 /3.45  ms; 3.45 ms is the Tb lifetime for ΦTb= 1), which is the 
quantum yield that needs to be used for calculating the Förster distance individually for each 
DNA system. Tb donor decays were fit by a three-exponential function (with τi corresponding 
to τD, τDA1, and τDA2) from Figure 5.3 to 5.9 and by a two-exponential function (with τ i 
corresponding to 𝜏𝐷 and 𝜏𝐷𝐴1) from Figure 5.10 to 5.13, whereas QD acceptor decays were fit 
with a quadruple-exponential function (with τi corresponding to τD, τAD1, τAD2, and τAD3).  
For Tb donor decays, the amplitude averaged decay time 〈𝜏𝐷𝐴〉 was used as FRET decay time 
to calculate the Tb-QD distance r. 
〈𝜏𝐷𝐴〉 =
∑ 𝐴𝑖𝜏𝑖
∑ 𝐴𝑖
                  (5.5) 
with τi corresponding to the FRET-quenched PL decay times τDA1 and τDA2 (the pure Tb decay 
with τD is not taken into account). 
 𝑟 = 𝑅0 (
〈𝜏𝐷𝐴〉
𝜏𝐷−〈𝜏𝐷𝐴〉
)
1/6
              (5.6) 
The FRET efficiency was calculated by: 
𝐸𝐹𝑅𝐸𝑇 =
𝑅0
6
𝑅0
6+𝑟6
= 1 −
〈𝜏𝐷𝐴〉
𝜏𝐷
              (5.7) 
For the QD acceptor, the amplitude averaged decay time 〈𝜏𝐴𝐷〉 was used as FRET decay time 
to calculate the Tb-QD distance r. The amplitudes Ai must be corrected by the FRET rates 
(kFRET-i) to take into account the FRET-efficiency dependent excitation of the acceptors: 
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   𝑘𝐹𝑅𝐸𝑇−𝑖 =
1
𝜏𝐴𝐷𝑖
−
1
𝜏𝐷
             (5.8) 
and 
  〈𝜏𝐴𝐷〉 = ∑ (
(𝐴𝑖 𝑘𝐹𝑅𝐸𝑇−𝑖⁄ )
∑(𝐴𝑖 𝑘𝐹𝑅𝐸𝑇−𝑖⁄ )
𝜏𝑖)              (5.9) 
with τi corresponding to the FRET-sensitized PL decay times τAD2, and τAD3 (the pure Tb decay 
with τD and the very short QD-background decay with τAD1 are not taken into account). 
The Tb-QD distance r was then calculated by: 
        𝑟 = 𝑅0 (
〈𝜏𝐴𝐷〉
𝜏𝐷−〈𝜏𝐴𝐷〉
)
1/6
            (5.10) 
The FRET efficiency was calculated by: 
   𝐸𝐹𝑅𝐸𝑇 =
𝑅0
6
𝑅0
6+𝑟6
= 1 −
〈𝜏𝐴𝐷〉
𝜏𝐷
           (5.11) 
Due to the relatively low FRET efficiencies for the configurations with long Tb-QD donor-
acceptor distances (18, 22, and 26 dsDNAs separation) the QD acceptor decay fits from Figure 
5.11 to 5.13 required further adjustment of the fit parameters. Here, the amplitude of pure Tb 
decay (from spectral crosstalk in the acceptor channel) was fixed to the following value: 
𝐴𝐷 =
𝐴𝐴0𝐴𝐷𝐴0
𝐴𝐷0
                    (5.12) 
where 𝐴𝐴0is the amplitude of the pure Tb decay curve in the QD detection channel and 𝐴𝐷𝐴0 
and 𝐴𝐷0 are the amplitudes of the Tb decay curves in the Tb detection channel, in the presence 
and in the absence of peptide-DNA, respectively. 
Figures 5.3 to 5.13 show the PL decay curves (and fitted curves) in the Tb donor and QD 
acceptor channels for all DNA systems (0, 2, 4, 6, 10 and 14 ssDNAs, and 10, 14, 18, 22, 26 
dsDNAs). The corresponding fit results (all decay times given in μs) are given directly below 
the Figures. 
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Figure 5.3. The PL decay curves of QD acceptor (left) and Tb donor (right) situated at 0 base 
distances from each other. Black: pure Tb (some Tb luminescence is also visible in the acceptor 
detection channel due to spectral crosstalk); green: 6 nM peptide-DNA; purple: 8.0 nM peptide-
DNA; yellow: 10.0 nM peptide-DNA. Black lines represent the fit results from below. 
 
Fit results (all decay times in μs): 
Donor Channel          R0 = 10.3 nm           Fitted from t0 = 0.02 ms to t = 8 ms  
Sample 
Tb background FRET parameter 
averaged results 
fixed free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 DA2 ADA2 DA> EFRET 
1 Tb alone 2800 1669 D in the absence of A (mono-exponential) 
2 6.0 2800 1284 230 230 860 121 450 0.84 
3 8.0 2800 1170 110 229 630 225 370 0.87 
4 10.0 2800 1037 57 231 510 311 320 0.89 
average 2-4 2800    130   670   380 0.86 
distance r (nm)     6.2   8.5   7.6 7.6 
    Maximum errors:      <DA> = 70 µs (19 %)        r = 0.3 nm (4 %) 
Acceptor channel       R0 = 10.3 nm       Fitted from t0 = 0.05 to t = 6 ms 
Sample 
Tb background QD background FRET parameter 
averaged results 
fixed free free free free free free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 kFRET-1 DA2 ADA2 kFRET-2 DA3 ADA3 kFRET-3 AD> EFRET 
1 Tb alone 2700  111 D in the absence of A (mono-exponential) 
2 6.0 2700 116 27 4283 0.0367 190 2506 0.0049 420 1799 0.0020 336 0.88 
3 8.0 2700 110 43 1833 0.0229 190 2964 0.0049 440 2072 0.0019 350 0.87 
4 10.0 2700 99 29 4240 0.0341 200 3050 0.0046 440 1974 0.0019 347 0.88 
average 2-4 2700   33     193     433     344 0.88 
distance r (nm)     4.9     6.7     7.8     7.4 7.4 
    Maximum errors:      <DA> = 8 µs (3 %)        r = 0.1 nm (2 %) 
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Figure 5.4. The PL decay curves of QD acceptor (left) and Tb donor (right) situated at 2 bases 
ssDNA distances from each other. Black: pure Tb (some Tb luminescence is also visible in the 
acceptor detection channel due to spectral crosstalk); green: 6 nM peptide-DNA; purple: 8.0 
nM peptide-DNA; yellow: 10.0 nM peptide-DNA. Black lines represent the fit results from 
below. 
 
Fit results (all decay times in μs): 
Donor Channel          R0 = 10.3 nm           Fitted from t0 = 0.02 ms to t = 8 ms  
Sample 
Tb background FRET parameter 
averaged results 
fixed free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 DA2 ADA2 DA> EFRET 
1 Tb alone 2800 1960 D in the absence of A (mono-exponential) 
2 6.0 2800 1237 89 328 600 365 360 0.87 
3 8.0 2800 1169 81 367 580 507 370 0.87 
4 10.0 2800 979 130 478 680 458 400 0.86 
average 2-4 2800   100   620   380 0.87 
distance r (nm)     5.9   8.4   7.6 7.6 
    Maximum errors:      <DA> = 20 µs (5 %)        r = 0.1 nm (2 %) 
Acceptor channel       R0 = 10.3 nm       Fitted from t0 = 0.05 to t = 6 ms 
Sample 
Tb background QD background FRET parameter 
averaged results 
fixed free free free free free free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 kFRET-1 DA2 ADA2 kFRET-2 DA3 ADA3 kFRET-3 AD> EFRET 
1 Tb alone 2700  115 D in the absence of A (mono-exponential) 
2 6.0 2700 116 36 3902 0.0270 220 3378 0.0042 480 2121 0.0017 377 0.87 
3 8.0 2700 115 33 4632 0.0303 240 4676 0.0038 500 2708 0.0016 389 0.86 
4 10.0 2700 103 34 4426 0.0294 240 4709 0.0038 500 2891 0.0016 393 0.86 
average 2-4 2700   34     233     493     386 0.86 
distance r (nm)     5.0     6.9     8.0     7.6 7.6 
    Maximum errors:      <DA> = 9 µs (3 %)        r = 0.1 nm (2 %) 
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Figure 5.5. The PL decay curves of QD acceptor (left) and Tb donor (right) situated at 4 bases 
ssDNA distances from each other. Black: pure Tb (some Tb luminescence is also visible in the 
acceptor detection channel due to spectral crosstalk); green: 6 nM peptide-DNA; purple: 8.0 
nM peptide-DNA; yellow: 10.0 nM peptide-DNA. Black lines represent the fit results from 
below. 
 
Fit results (all decay times in μs): 
Donor Channel          R0 = 10.3 nm           Fitted from t0 = 0.02 ms to t = 8 ms  
Sample 
Tb background FRET parameter 
averaged results 
fixed free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 DA2 ADA2 DA> EFRET 
1 Tb alone 2800 1673 D in the absence of A (mono-exponential) 
2 6.0 2800 1203 220 264 960 244 580 0.79 
3 8.0 2800 1077 120 283 780 374 500 0.82 
4 10.0 2800 955 140 318 750 442 490 0.83 
average 2-4 2800   160   830   520 0.81 
distance r (nm)     6.5   8.9   8.1 8.1 
    Maximum errors:      <DA> = 60 µs (11 %)        r = 0.1 nm (2 %) 
Acceptor channel       R0 = 10.3 nm       Fitted from t0 = 0.05 to t = 6 ms 
Sample 
Tb background QD background FRET parameter 
averaged results 
fixed free free free free free free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 kFRET-1 DA2 ADA2 kFRET-2 DA3 ADA3 kFRET-3 AD> EFRET 
1 Tb alone 2700  114 D in the absence of A (mono-exponential) 
2 6.0 2700 117 30 4868 0.0326 250 1679 0.0036 580 1672 0.0014 490 0.83 
3 8.0 2700 107 26 7049 0.0379 280 2080 0.0032 610 1702 0.0013 502 0.82 
4 10.0 2700 102 32 4865 0.0312 280 2292 0.0032 610 2001 0.0013 507 0.82 
average 2-4 2700   29     270     600     499 0.82 
distance r (nm)     4.8     7.1     8.3     8.0 8.0 
    Maximum errors:      <DA> = 9 µs (2 %)        r = 0.1 nm (2 %) 
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Figure 5.6. The PL decay curves of QD acceptor (left) and Tb donor (right) situated at 6 bases 
ssDNA distances from each other. Black: pure Tb (some Tb luminescence is also visible in the 
acceptor detection channel due to spectral crosstalk); green: 6 nM peptide-DNA; purple: 8.0 
nM peptide-DNA; yellow: 10.0 nM peptide-DNA. Black lines represent the fit results from 
below. 
 
Fit results (all decay times in μs):  
Donor Channel          R0 = 10.3 nm           Fitted from t0 = 0.02 ms to t = 8 ms  
Sample 
Tb background FRET parameter 
averaged results 
fixed free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 DA2 ADA2 DA> EFRET 
1 Tb alone 2800 1824 D in the absence of A (mono-exponential) 
2 6.0 2800 1219 180 248 990 359 660 0.76 
3 8.0 2800 993 210 255 930 449 670 0.76 
4 10.0 2800 908 100 350 810 596 550 0.80 
average 2-4 2800   160   910   630 0.78 
distance r (nm)     6.5   9.1   8.4 8.4 
    Maximum errors:      <DA> = 60 µs (13 %)        r = 0.3 nm (4 %) 
Acceptor channel       R0 = 10.3 nm       Fitted from t0 = 0.05 to t = 6 ms 
Sample 
Tb background QD background FRET parameter 
averaged results 
fixed free free free free free free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 kFRET-1 DA2 ADA2 kFRET-2 DA3 ADA3 kFRET-3 AD> EFRET 
1 Tb alone 2700  114 D in the absence of A (mono-exponential) 
2 6.0 2700 125 25 6963 0.0396 260 1246 0.0035 670 1872 0.0011 597 0.79 
3 8.0 2700 109 34 3807 0.0292 310 1704 0.0029 710 2111 0.0011 619 0.78 
4 10.0 2700 106 25 7008 0.0398 270 1761 0.0033 690 2545 0.0011 613 0.78 
average 2-4 2700   28     280     690     609 0.78 
distance r (nm)     4.8     7.1     8.5     8.3 8.3 
    Maximum errors:      <DA> = 10 µs (2 %)        r = 0.1 nm (2 %) 
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Figure 5.7. The PL decay curves of QD acceptor (left) and Tb donor (right) situated at 10 bases 
ssDNA distances from each other. Black: pure Tb (some Tb luminescence is also visible in the 
acceptor detection channel due to spectral crosstalk); green: 6 nM peptide-DNA; purple: 8.0 
nM peptide-DNA; yellow: 10.0 nM peptide-DNA. Black lines represent the fit results from 
below. 
 
Fit results (all decay times in μs): 
Donor Channel          R0 = 10.3 nm           Fitted from t0 = 0.02 ms to t = 8 ms  
Sample 
Tb background FRET parameter 
averaged results 
fixed free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 DA2 ADA2 DA> EFRET 
1 Tb alone 2800 3366 D in the absence of A (mono-exponential) 
2 6.0 2800 2516 140 235 990 526 730 0.74 
3 8.0 2800 2482 110 361 1000 676 690 0.75 
4 10.0 2800 2446 99 388 940 809 670 0.76 
average 2-4 2800   120   980   700 0.75 
distance r (nm)     6.1   9.3   8.6 8.6 
    Maximum errors:      <DA> = 30 µs (5 %)        r = 0.1 nm (2 %) 
Acceptor channel       R0 = 10.3 nm       Fitted from t0 = 0.05 to t = 6 ms 
Sample 
Tb background QD background FRET parameter 
averaged results 
fixed free free free free free free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 kFRET-1 DA2 ADA2 kFRET-2 DA3 ADA3 kFRET-3 AD> EFRET 
1 Tb alone 2700  226 D in the absence of A (mono-exponential) 
2 6.0 2700 240 30 4728 0.0330 240 921 0.0038 790 2163 0.0009 739 0.74 
3 8.0 2700 250 30 5411 0.0330 290 1088 0.0031 800 2650 0.0009 746 0.73 
4 10.0 2700 240 29 5810 0.0341 340 1443 0.0026 850 2693 0.0008 776 0.72 
average 2-4 2700   30     290     813     754 0.73 
distance r (nm)     4.8     7.2     8.9     8.7 8.7 
    Maximum errors:      <DA> = 22 µs (3 %)        r = 0.1 nm (2 %) 
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Figure 5.8. The PL decay curves of QD acceptor (left) and Tb donor (right) situated at 14 bases 
ssDNA distances from each other. Black: pure Tb (some Tb luminescence is also visible in the 
acceptor detection channel due to spectral crosstalk); green: 6 nM peptide-DNA; purple: 8.0 
nM peptide-DNA; yellow: 10.0 nM peptide-DNA. Black lines represent the fit results from 
below. 
 
Fit results (all decay times in μs): 
Donor Channel          R0 = 10.3 nm           Fitted from t0 = 0.02 ms to t = 8 ms  
Sample 
Tb background FRET parameter 
averaged results 
fixed free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 DA2 ADA2 DA> EFRET 
1 Tb alone 2800 1730 D in the absence of A (mono-exponential) 
2 6.0 2800 1103 180 143 1300 427 1020 0.64 
3 8.0 2800 949 270 210 1300 478 990 0.65 
4 10.0 2800 869 180 229 1200 624 930 0.67 
average 2-4 2800   210   1270   980 0.65 
distance r (nm)     6.8   10.0   9.3 9.3 
    Maximum errors:      <DA> = 50 µs (6 %)        r = 0.1 nm (2 %) 
Acceptor channel       R0 = 10.3 nm       Fitted from t0 = 0.05 to t = 6 ms 
Sample 
Tb background QD background FRET parameter 
averaged results 
fixed free free free free free free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 kFRET-1 DA2 ADA2 kFRET-2 DA3 ADA3 kFRET-3 AD> EFRET 
1 Tb alone 2700  112 D in the absence of A (mono-exponential) 
2 6.0 2700 122 31 5003 0.0323 280 592 0.0032 1000 816 0.0006 909 0.68 
3 8.0 2700 125 31 4910 0.0324 250 662 0.0036 990 1052 0.0007 915 0.67 
4 10.0 2700 114 44 2954 0.0226 390 821 0.0022 1100 1261 0.0006 1001 0.64 
average 2-4 2700   35     307     1030     941 0.66 
distance r (nm)     5.0     7.3     9.4     9.2 9.2 
    Maximum errors:      <DA> = 60 µs (7 %)        r = 0.1 nm (2 %) 
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Figure 5.9. The PL decay curves of QD acceptor (left) and Tb donor (right) situated at 10 bps 
dsDNA distances from each other. Black: pure Tb (some Tb luminescence is also visible in the 
acceptor detection channel due to spectral crosstalk); green: 6 nM peptide-DNA; purple: 8.0 
nM peptide-DNA; yellow: 10.0 nM peptide-DNA. Black lines represent the fit results from 
below. 
 
Fit results (all decay times in μs):  
Donor Channel          R0 = 10.3 nm           Fitted from t0 = 0.02 ms to t = 8 ms  
Sample 
Tb background FRET parameter 
averaged results 
fixed free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 DA2 ADA2 DA> EFRET 
1 Tb alone 2800 3373 D in the absence of A (mono-exponential) 
2 6.0 2800 2893 26 294 1300 627 890 0.68 
3 8.0 2800 2978 380 162 1500 807 1310 0.53 
4 10.0 2800 2919 85 145 1300 1009 1150 0.59 
average 2-4 2800   160   1370   1120 0.60 
distance r (nm)     6.5   10.2   9.6 9.6 
    Maximum errors:      <DA> = 190 µs (17 %)       r = 0.5 nm (6 %) 
Acceptor channel       R0 = 10.3 nm       Fitted from t0 = 0.05 to t = 6 ms 
Sample 
Tb background QD background FRET parameter 
averaged results 
fixed free free free free free free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 kFRET-1 DA2 ADA2 kFRET-2 DA3 ADA3 kFRET-3 AD> EFRET 
1 Tb alone 2700  230 D in the absence of A (mono-exponential) 
2 6.0 2700 320 26 7911 0.0384 280 551 0.0032 1100 1150 0.0006 1038 0.63 
3 8.0 2700 366 24 9950 0.0420 230 631 0.0040 1100 1570 0.0006 1054 0.62 
4 10.0 2700 352 31 5761 0.0316 350 611 0.0025 1200 1746 0.0005 1147 0.59 
average 2-4 2700   27     287     1133     1080 0.61 
distance r (nm)     4.8     7.2     9.7     9.5 9.5 
    Maximum errors:      <DA> = 67 µs (7 %)        r = 0.2 nm (3 %) 
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Figure 5.10. The PL decay curves of QD acceptor (left) and Tb donor (right) situated at 14 bps 
dsDNA distances from each other. Black: pure Tb (some Tb luminescence is also visible in the 
acceptor detection channel due to spectral crosstalk); green: 6 nM peptide-DNA; purple: 8.0 
nM peptide-DNA; yellow: 10.0 nM peptide-DNA. Black lines represent the fit results from 
below. 
 
Fit results (all decay times in μs): 
Donor Channel          R0 = 10.3 nm           Fitted from t0 = 0.02 ms to t = 8 ms  
Sample 
Tb background FRET parameter 
averaged results 
fixed free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 DA> EFRET 
1 Tb alone 2800 3391 D in the absence of A (mono-exponential) 
2 6.0 2800 2982 1800 570 1800 0.36 
3 8.0 2800 2875 1900 738 1900 0.32 
4 10.0 2800 3032 1800 895 1800 0.36 
average 2-4 2800   1830   1830 0.35 
distance r (nm)     11.4   11.4 11.5 
    Maximum errors:      <DA> = 70 µs (4 %)        r = 0.3 nm (3 %) 
Acceptor channel       R0 = 10.3 nm       Fitted from t0 = 0.05 to t = 6 ms 
Sample 
Tb background QD background FRET parameter 
averaged results 
fixed free free free free free free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 kFRET-1 DA2 ADA2 kFRET-2 DA3 ADA3 kFRET-3 AD> EFRET 
1 Tb alone 2700  237  D in the absence of A (mono-exponential) 
2 6.0 2700 236 37 3832 0.0267 400 377 0.0021 1900 493 0.0002 1814 0.35 
3 8.0 2700 228 36 4227 0.0274 460 411 0.0018 2000 580 0.0001 1919 0.31 
4 10.0 2700 240 33 4860 0.0299 410 490 0.0021 1900 764 0.0002 1826 0.35 
average 2-4 2700   35     423     1933     1853 0.34 
distance r (nm)     5.0     7.7     11.8     11.5 11.5 
    Maximum errors:      <DA> = 66 µs (4 %)        r = 0.2 nm (2 %) 
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Figure 5.11. The PL decay curves of QD acceptor (left) and Tb donor (right) situated at 18 bps 
dsDNA distances from each other. Black: pure Tb (some Tb luminescence is also visible in the 
acceptor detection channel due to spectral crosstalk); green: 6 nM peptide-DNA; purple: 8.0 
nM peptide-DNA; yellow: 10.0 nM peptide-DNA. Black lines represent the fit results from 
below. 
 
Fit results (all decay times in μs): 
Donor Channel          R0 = 10.3 nm           Fitted from t0 = 0.02 ms to t = 8 ms  
Sample 
Tb background FRET parameter 
averaged results 
fixed free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 DA> EFRET 
1 Tb alone 2800 1748 D in the absence of A (mono-exponential) 
2 6.0 2800 1526 1900 305 1900 0.32 
3 8.0 2800 1414 1900 355 1900 0.32 
4 10.0 2800 1431 1800 369 1800 0.36 
average 2-4 2800   1870   1870 0.33 
distance r (nm)     11.6   11.6 11.6 
    Maximum errors:      <DA> = 70 µs (4 %)        r = 0.2 nm (2 %) 
Acceptor channel       R0 = 10.3 nm       Fitted from t0 = 0.05 to t = 6 ms 
Sample 
Tb background QD background FRET parameter 
averaged results 
fixed fixed free free free free free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 kFRET-1 DA2 ADA2 kFRET-2 DA3 ADA3 kFRET-3 AD> EFRET 
1 Tb alone 2700 112 D in the absence of A (mono-exponential) 
2 6.0 2700 100 30 872 0.0330 290 200 0.0031 2100 208 0.0001 2035 0.27 
3 8.0 2700 93 29 925 0.0345 290 211 0.0031 2100 237 0.0001 2040 0.27 
4 10.0 2700 94 32 874 0.0309 330 209 0.0027 2100 260 0.0001 2039 0.27 
average 2-4 2700   30     303     2100     2038 0.27 
distance r (nm)     4.9     7.2     12.4     12.1 12.1 
    Maximum errors:      <DA> = 3 µs (1 %)        r = 0.1 nm (1 %) 
 
87 
 
 
Figure 5.12. The PL decay curves of QD acceptor (left) and Tb donor (right) situated at 22 bps 
dsDNA distances from each other. Black: pure Tb (some Tb luminescence is also visible in the 
acceptor detection channel due to spectral crosstalk); green: 6 nM peptide-DNA; purple: 8.0 
nM peptide-DNA; yellow: 10.0 nM peptide-DNA.  
 
Fit results (all decay times in μs): 
Donor Channel          R0 = 10.3 nm           Fitted from t0 = 0.02 ms to t = 8 ms  
Sample 
Tb background FRET parameter 
averaged results 
fixed free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 DA> EFRET 
1 Tb alone 2800 1690 D in the absence of A (mono-exponential) 
2 6.0 2800 1349 2100 366 2100 0.25 
3 8.0 2800 1320 1900 362 1900 0.32 
4 10.0 2800 1312 1900 393 1900 0.32 
average 2-4 2800   1970   1970 0.30 
distance r (nm)     11.9   11.9 11.9 
    Maximum errors:      <DA> = 130 µs (7 %)        r = 0.5 nm (5 %) 
Acceptor channel       R0 = 10.3 nm       Fitted from t0 = 0.05 to t = 6 ms 
Sample 
Tb background QD background FRET parameter 
averaged results 
fixed fixed free free free free free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 kFRET-1 DA2 ADA2 kFRET-2 DA3 ADA3 kFRET-3 AD> EFRET 
1 Tb alone 2700 112 D in the absence of A (mono-exponential) 
2 6.0 2700 89 27 6773 0.0367 250 280 0.0036 2400 164 0.0001 2342 0.16 
3 8.0 2700 88 31 4902 0.0319 290 248 0.0031 2400 187 0.0001 2347 0.16 
4 10.0 2700 87 30 5326 0.0330 290 264 0.0031 2400 194 0.0001 2346 0.16 
average 2-4 2700   29     277     2400     2345 0.16 
distance r (nm)     4.8     7.1     13.9     13.5 13.5 
    Maximum errors:      <DA> = 3 µs (1 %)        r = 0.1 nm (1 %) 
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Figure 5.13. The PL decay curves of QD acceptor (left) and Tb donor (right) situated at 26 bps 
dsDNA distances from each other. Black: pure Tb (some Tb luminescence is also visible in the 
acceptor detection channel due to spectral crosstalk); green: 6 nM peptide-DNA; purple: 8.0 
nM peptide-DNA; yellow: 10.0 nM peptide-DNA.  
 
Fit results (all decay times in μs): 
Donor Channel          R0 = 10.3 nm           Fitted from t0 = 0.02 ms to t = 8 ms  
Sample 
Tb background FRET parameter 
averaged results 
fixed free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 DA> EFRET 
1 Tb alone 2800 1708 D in the absence of A (mono-exponential) 
2 6.0 2800 1368 1900 286 1900 0.32 
3 8.0 2800 1348 1900 304 1900 0.32 
4 10.0 2800 1353 1700 334 1700 0.39 
average 2-4 2800   1830   1830 0.35 
distance r (nm)     11.4   11.4 11.5 
    Maximum errors:      <DA> = 130 µs (7 %)        r = 0.3 nm (3 %) 
Acceptor channel       R0 = 10.3 nm       Fitted from t0 = 0.05 to t = 6 ms 
Sample 
Tb background QD background FRET parameter 
averaged results 
fixed fixed free free free free free free free free free 
# 
Peptide 
conc./nM 
D AD DA1 ADA1 kFRET-1 DA2 ADA2 kFRET-2 DA3 ADA3 kFRET-3 AD> EFRET 
1 Tb alone 2700 113 D in the absence of A (mono-exponential) 
2 6.0 2700 92 30 4548 0.0330 280 202 0.0032 2500 103 0.00004 2507 0.10 
3 8.0 2700 90 29 5518 0.0341 280 209 0.0032 2500 107 0.00004 2444 0.13 
4 10.0 2700 89 29 4581 0.0341 290 221 0.0031 2400 138 0.00006 2409 0.14 
average 2-4 2700   29     283     2467     2453 0.12 
distance r (nm)     4.8     7.2     14.4     14.3 14.3 
    Maximum errors:      <DA> = 54 µs (3 %)        r = 0.4 nm (3 %) 
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Table 5.2. Tb-to-QD center-to-center distances (r) and FRET-efficiencies (EFRET) as calculated 
by the lifetime fits (Figure 5.3 to Figure 5.13) and the equations in 5.3.3. 
 
5.3.4 Time-Resolved Tb-to-QD FRET DNA-Nanoruler and Distance 
Modeling. 
For all 11 configurations, PL decays of both the Tb donor and the QD625 acceptor were 
measured in a time range between 0 and 8 ms (Figures 5.3 to 5.13). To distinguish between 
FRET and non-FRET contributions (from non-quenched Tb and directly excited QDs) and to 
be able to analyze various independent PL decay curves, the concentrations of Tb-DNA and 
QD625 were kept constant (20 nM Tb-DNA and 0.5 nM QD625) whereas the concentration of 
the peptide-appended main DNA was varied (0, 2, 4, 6, 8, 10, and 20 nM). This strategy 
provided one background and six independent FRET measurements per configuration and a 
proof-of-concept system for a quantitative (signal over concentration) DNA hybridization assay. 
Figure 5.14 shows representative QD625 PL decays for all configurations at constant 
concentrations of 20 nM peptide-DNA (PL decays for both Tb and DQ625 at different peptide-
DNA concentrations are shown in Figures 5.3 to 5.13). As expected from FRET theory, the 
increasing Tb-to-QD distances led to increasing FRET-sensitized lifetimes of the PL decays, 
all of which can be readily distinguished without lifetime fitting of the curves. Such fine-tuning 
of PL decay curves via displacement of the Tb donor by only a few nt demonstrates the high 
distance sensitivity of FRET and the possibility to extend nanoparticle-based temporal 
multiplexing beyond two distinct PL decays[173].  
r  (nm) r  (nm) E FRET E FRET r  (nm) r  (nm) E FRET E FRET
0 nt 3'FRET 7.4 0.1 0.88 0.01 7.6 0.3 0.86 0.03
2 nt 3'FRET 7.6 0.1 0.86 0.02 7.6 0.1 0.86 0.02
4 nt 3'FRET 8 0.1 0.82 0.02 8.1 0.1 0.81 0.02
6 nt 3'FRET 8.3 0.1 0.79 0.02 8.4 0.3 0.77 0.08
10 nt 3'FRET 8.7 0.1 0.73 0.03 8.6 0.1 0.75 0.03
14 nt 3'FRET 9.2 0.1 0.66 0.03 9.3 0.1 0.65 0.03
10 nt 5'FRET 9.5 0.2 0.62 0.06 9.6 0.5 0.60 0.15
14 nt 5'FRET 11.5 0.2 0.34 0.05 11.4 0.3 0.35 0.07
18 nt 5'FRET 12.1 0.1 0.28 0.02 11.6 0.2 0.33 0.05
22 nt 5'FRET 13.5 0.1 0.16 0.01 11.9 0.5 0.30 0.11
26 nt 5'FRET 14.3 0.4 0.12 0.04 11.4 0.3 0.35 0.07
QD ACCEPTOR CHANNEL Tb DONOR CHANNEL
Construct
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Figure 5.14. QD625 PL decay curves of the different FRET configurations (A: ssDNA or 3’-
FRET, B: dsDNA or 5’-FRET) shown in Figure 5.1. Concentrations of peptide-DNA were 20 
nM for all curves. PL decay curves of different concentrations for both Tb and QD625 are 
shown in Figures 5.3 to 5.13. Black curves present spectral crosstalk of Tb (only Tb-DNA 
without peptide-DNA and QD625) inside the QD625 detection channel. 
 
In order to understand the orientation of the ssDNA and dsDNA on the nanoparticle 
surface and the distance tunability or sensitivity (distance per nt) in these two open and 
hybridized configurations, we fitted the decay curves for three peptide-DNA concentrations (6, 
8, and 10 nM) for both FRET-sensitized QD625 PL and FRET-quenched Tb PL. All PL curves 
showed multiexponential decays (Equations 5.3 and 5.4), which consist of a monoexponential 
contribution from unquenched Tb (τD = 2.75±0.05 ms, from Tb that do not participate in FRET) 
and a multiexponential contribution from FRET owing to a Tb-to-QD distance distribution 
caused by the flexibility of the DNA and the linker between Tb and DNA (cf. Figure 5.1 
bottom). Although the single FRET-sensitized PL lifetimes (τ AD) of QD625 and FRET-
quenched PL lifetime (τDA) of Tb are the same, the average FRET-sensitized acceptor lifetime 
must be corrected by the FRET rates of each single component (Equations 5.8 and 5.9). The 
average FRET lifetimes (<τAD> and <τDA>) can then be used to calculate the average Tb-to-
QD distance (Equations 5.6 and 5.10) and FRET efficiencies (Equations 5.7 and 5.11).  Due 
to the much weaker PL background of unquenched Tb in the QD acceptor detection channel 
(cf. Figures 5.3 to 5.13), this channel usually provides better fitting results[173][178]. Tb-to-
QD distances were also calculated by biomolecular modeling. Closest and furthest distances for 
both parallel and vertical orientation of the peptide-DNA on the QD625 surface were calculated 
(Table 5.3).  
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Table 5.3A: Minimum (near) and maximum (far) Tb-to-QD distances for DNA attached 
vertically or parallel to the QD surface as calculated from biomolecular modeling  
 
Table 5.3B: Average Tb-to-QD center-to-center distances as calculated from the minimum and 
maximum values of Table 5.3A. 
 
The average theoretical distances and the FRET distances (calculated from QD625 
acceptor PL decays – the Tb donor PL results, which are very similar to the QD acceptor results 
for shorter distances but deviate for longer distances, are shown in Figure 5.16) of all 
configurations are shown in Figure 5.15. For both configurations (single and double-stranded) 
the FRET results show a linearly increasing Tb-to-QD distance with the number of bases. With 
0.31 nm per base pair, the dsDNA distance increase is approximately twice as large as the one 
of ssDNA (0.15 nm per base). While the dsDNA distance is in very good agreement with the 
near far near far near far near far
0 nt 3'FRET 4.65 6.02 0.9 3.9 0.5 5.3 5.5 8.6 5.1 9.9
2 nt 3'FRET 4.65 6.02 0.9 5.1 0.8 5.1 5.5 9.7 5.4 9.8
4 nt 3'FRET 4.65 6.02 1.5 6.2 0.8 3.9 6.2 10.8 5.4 8.6
6 nt 3'FRET 4.65 6.02 2.8 7 1.2 5.3 7.4 11.7 5.9 10
10 nt 3'FRET 4.65 6.02 3.6 7.8 0.8 5.6 8.2 12.4 5.4 10.3
14 nt 3'FRET 4.65 6.02 4.8 9.2 0.7 4.2 9.4 13.9 5.4 8.8
10 nt 5'FRET 4.65 6.02 2.9 7.1 0.2 4 7.6 11.8 4.8 8.7
14 nt 5'FRET 4.65 6.02 4.9 9 0.2 5.6 9.5 13.7 4.8 10.2
18 nt 5'FRET 4.65 6.02 5.4 9.6 0.9 5 10.1 14.3 5.5 9.7
22 nt 5'FRET 4.65 6.02 6.6 11.7 1.6 6.5 11.2 16.4 6.3 11.2
26 nt 5'FRET 0 0 0 0 0 0 0 0 0 0
QD-DHLA-
PEG radius 
(nm)
QD radius 
(nm)
Construct
distance from 
surface
distance from 
surface
distance from 
center
distance from 
center
vertical parallel vertical parallel
0 nt 3'FRET 7.1 1.6 7.5 2.4
2 nt 3'FRET 7.6 2.1 7.6 2.2
4 nt 3'FRET 8.5 2.3 7.0 1.6
6 nt 3'FRET 9.6 2.2 8.0 2.1
10 nt 3'FRET 10.3 2.1 7.9 2.5
14 nt 3'FRET 11.7 2.3 7.1 1.7
10 nt 5'FRET 9.7 2.1 6.8 2.0
14 nt 5'FRET 11.6 2.1 7.5 2.7
18 nt 5'FRET 12.2 2.1 7.6 2.1
22 nt 5'FRET 13.8 2.6 8.8 2.5
26 nt 5'FRET 0.0 0.0 0.0 0.0
Construct
vertical parallel
average 
distance from 
center (nm)
ERROR (nm)
average 
distance from 
center (nm)
ERROR (nm)
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literature (~0.33 nm length per base pair)[179] and confirms the excellent long-range precision 
of our FRET nanoruler, the one for ssDNA is relatively short compared to previous studies. In 
a single-molecule FRET approach, Murphy et al. investigated a similar ssDNA-dsDNA system, 
which contained a Cy3 donor on the 3’ end of ssDNA and a Cy5 acceptor on the 5’ end of a 18 
nt long ssDNA probe that was hybridized to the ssDNA and attached via a 3’-biotin 
functionalization to a streptavidin-coated microscope slide[180]. At similar buffer conditions 
(12 ~ 20 mM Tris, pH 8.0, 400 mM NaCl) they found ssDNA lengths of 4.4, 5.0, 5.3, 5.6, 6.0, 
and 7.1 nm for 10, 15, 17, 23, 27, and 40 nt lengths of poly dT ssDNA, respectively. These 
values correspond to 0.44, 0.33, 0.31, 0.24, 022, and 0.18 nm per base and taking into account 
that our ssDNA lengths varied between 0 and 14 nt, a distance above 0.33 nm per base would 
have been expected from the single-molecule FRET study. On the other hand, our ssDNA had 
a variable sequence whereas the single-molecule study investigated poly dT ssDNA. Moreover, 
the conditions of a DNA attached to a nanoparticle (on the ssDNA end) in solution could be 
quite different from a DNA attached to a microscopy slide (on the dsDNA end). Taking into 
account the almost perfect linearity determined by 5 different lengths over 14 nt and the 
relatively good agreement with the model data (Figure 5.15A), it can be assumed that the value 
of 0.15 nm per base is realistic for our QD-DNA system. This unexpectedly short distance also 
shows the necessity of measuring the actual DNA conformation on a nanoparticle surface 
instead of assuming a value from a study with similar but still significantly different conditions. 
Another very interesting FRET information concerns the orientation of the DNA on the 
QD surface. The ssDNA extension can be well approximated by an average of the theoretical 
parallel and vertical orientations, which presents a flexible ssDNA that can take any orientation 
on the QD surface. The same behavior should be found for dsDNA if the peptide linker between 
DNA and QD625 would be responsible for the flexibility (functioning as a hinge). However, 
the dsDNA extension is almost a perfect reproduction of the theoretical vertical orientation, 
which presents a stiff dsDNA that does not bend on the QD surface. Although this different 
behavior between ssDNA and dsDNA is not surprising, it cannot be simply taken for granted 
for DNA attached to the surface of a nanoparticle. The experimental determination by FRET at 
low concentrations and physiological conditions provides highly important information 
concerning the natural structure of DNA-nanoparticle conjugates. As many DNA-based 
nanosensors depend on distances and conformations that change from single ssDNA (probe 
alone) to dsDNA (probe-target hybridization), knowledge about the conformational behavior 
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within such a sensor will be extremely valuable to design and optimize the biological 
recognition and signal generation. 
 
Figure 5.15. Tb-donor-to-QD-acceptor distances measured by FRET-sensitized PL of QD625 
(black dots) and modeled in vertical (red diamonds) and parallel (blue diamonds) configuration 
(see Figure 5.1) for 3’FRET (A) and 5’-FRET (B). Error bars for models present the closest 
and furthest distance of Tb from the QD in the two different configurations. Error bars for FRET 
present maximum PL lifetime errors from three measurements with different concentrations. 
See Figures 5.3 to 5.13 and Tables 5.2 and 5.3 for details.  
 
Figure 5.16. Tb-donor-to-QD-acceptor distances measured by FRET-quenched PL of Tb 
(black dots) and modeled in vertical (red diamonds) and parallel (blue diamonds) configuration 
(see Figure 5.1) for 3’FRET (A) and 5’-FRET (B). Error bars for models present the closest 
and furthest distance of Tb from the QD in the two different configurations. Error bars for FRET 
present maximum PL lifetime errors from three measurements with different concentrations. 
See Figures 5.3 to 5.13 and Tables 5.2 and 5.3 for details.  
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5.3.5 Prototypical DNA Hybridization Assays 
In addition to the structural and conformational information, the precise distance tuning also 
allows for the generation of many distinct decay curves of FRET-sensitized QD625 PL (cf. 
Figure 5.14). Such PL decays can be used for higher order multiplexed quantification of 
biomarkers or optical barcoding of cells, as recently demonstrated by time-gated PL detection 
of other Tb-QD[173], Tb-dye[181], or Tb/Eu-QD[133] FRET pairs. To demonstrate target 
quantification by concentration-dependent FRET ratios (ratio of time-gated intensities of 
QD625 and Tb PL) we used peptide-DNA concentrations between 0 and 10 nM while keeping 
all other assay components constant. As shown in Figure 5.17, all 11 configurations provided 
a FRET-ratio increase (linear up to at least 6 nM) over peptide-DNA concentration. Despite the 
relatively low assay sensitivities (slopes of the calibration curves) for the very long distance 
configurations (i.e., 18, 22, and 26 nt), all FRET constructs could be used for quantifying DNA 
at low nanomolar concentrations. Although such systems need to be adapted to real targets (in 
our case both QD-peptide-DNA and Tb-DNA were DNA probes), the proof-of-concept 
hybridization assays demonstrated the possible application of DNA-based Tb-to-QD distance 
tuning for higher order temporal multiplexing that can also be combined with several different 
QD colors[182].  
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Figure 5.17. Calibration curves of prototypical DNA hybridization assays showing increasing 
time-gated (0.1 to 2 ms) PL FRET ratios with increasing peptide-DNA concentrations for all 
3’-FRET (A) and 5’-FRET (B) configurations.  
5.4 Conclusion 
In summary, we have extensively investigated the orientation of a 31 nt long DNA attached via 
a peptide-His6 linker to a QD by Tb-to-QD FRET and biomolecular modeling. Our results show 
that time-resolved analysis of FRET-sensitized QD PL can be used to precisely measure the 
distances along the QD-DNA conjugate by hybridization of different Tb-DNA probes at 
different positions of the QD-DNA. Long-range QD-to-Tb distances between ca. 7 and 14 nm 
(from center to center) significantly extended beyond previous FRET systems. The detailed 
investigation of 11 different DNA configurations on the nanoparticle surface and the 
comparison of the FRET results with biomolecular modeling allowed us to extract important 
conformational information from the FRET data. In single-stranded conformation, the DNA 
extended from the QD with ~0.15 nm per base and the flexible ssDNA could take any 
orientation between parallel and vertical in regard to the QD surface. In double-stranded 
conformation, the DNA extended with ~0.31 nm per base pair and the orientation was purely 
vertical, reflecting the stiffness of dsDNA. Determination of different lengths and orientations 
of ssDNA and dsDNA on nanoparticle surfaces under physiological conditions and at low 
nanomolar concentrations is highly important for efficient development and optimization of 
hybridization-based DNA nanosensors and our Tb-to-QD FRET ruler provided very useful 
information that should in principle be transferable to any other DNA-nanoparticle conjugate. 
In addition to the precise conformational FRET analysis, we showed that the DNA distance 
tuning can be used to generate many distinct PL decay curves (with different average PL 
lifetimes), whose intensities were dependent on the peptide-DNA concentration, even for 
configurations with very long donor-acceptor distances (~14 nm). Prototypical DNA-
hybridization assays for all 11 configurations suggest that these Tb-to-QD FRET DNA 
constructs have a strong potential to significantly extend the multiplexing range of the recently 
developed time-gated temporal optical multiplexing concept. Our results demonstrate that QDs, 
despite their relatively large sizes, can be used for precise conformational analysis and extended 
temporal multiplexed detection of nucleic acid biomarkers and that the Tb-QD donor-acceptor 
FRET pair presents a useful optical tool for both diagnostic and biophysical applications. 
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6. Summary and Outlook 
This thesis presents three successful applications of FRET in two distinct research fields. The 
first two are multiplexed LTC-to-Dye FRET biosensors for cancer related nucleic acid 
biomarker detection based on amplification methods and time-gated measurements. We used 
two strategies to achieve multiplexed detection, temporal-multiplexed detection based on 
distinguishable decay times of a single LTC-to-dye FRET pair and spectral-temporal 
multiplexed detection based on different emission spectra of different color dyes and different 
decay times of the same LTC-to-dye pair. Hybridization chain reaction and rolling circle 
amplification methods were combined for high sensitivity and for placing Tb donors and dye 
acceptors at controlled distances within the amplified DNA production. Time-gated 
measurements were used to collect the PL intensities and calculate the contributions of different 
analytes in different time-gated windows by a simple matrix calculation. The last one is single 
and double strand QD conjugated DNA conformation study by LTC-to-QD FRET lifetime. The 
results demonstrate that QDs can be used for temporal multiplexed detection and Tb-to-QD 
FRET DNA construct have a strong potential to significantly extend the multiplexing range of 
the time-gated temporal multiplexing concept. All of these assays are homogeneous, no 
washing and separation needed even with the amplified assay. All of them are specific, can 
distinguish very similar sequences. All these detecting techniques are easily transferable to 
other nucleic acid targets. 
In the first work, the multiplexing capacity is not limited to two, we can also try to use this 
technique for triplex assays and the capacity in real samples also should be figured out in future 
investigations. In the second work, we have detected four different DNAs, which are the DNA-
equivalents of the miRNAs. We did not detect miRNA directly because the calibration curves 
were not linear. It is difficult to do the matrix calculation with exponential functions, so more 
optimization should be done for miRNA assays. This first demonstration of spectral-temporal 
multiplexing quantified only four DNAs by combining two spectral and two temporal 
components, but when more different acceptor and more time-gated windows are added, the 
number of detectable targets in a single sample will be greatly increased. Tb-to-QD FRET DNA 
construct not only presents a valuable alternative to DNA conformation analysis techniques but 
also have a strong potential to be used for developing biosensors to quantify DNA at low 
nanomolar concentrations. The proof-of-concept hybridization assays demonstrated the 
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possible application of DNA-based Tb-to-QD distance tuning for higher order temporal 
multiplexing that can also be combined with several different QD colors.  
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7. Appendix 
7.1 Abbreviations 
BSA 
 
bovine serum albumin 
ChA 
 
acceptor channel 
ChD 
 
donor channel 
DHLA 
 
dihydrolipoic acid 
DNA 
 
deoxyribonucleic acid 
dsDNA 
 
double strands DNA 
FDA 
 
Food and Drug Administration 
FLIM 
 
fluorescence lifetime imaging 
FRET 
 
Förster resonance energy transfer 
FWHM 
 
full-width-at-half-maximum 
His6 
 
hexahistidine 
HPLC 
 
high performance liquid chromatography 
IR 
 
infrared 
Ln 
 
lanthanides 
LOD 
 
limit of detection 
LTC 
 
luminescent terbium complex 
miRNA 
 
microRNA 
NGS 
 
next generation sequencing 
NHS 
 
N-hydroxysuccinimide 
NIR 
 
near infrared 
NMR 
 
nuclear magnetic resonance 
NP 
 
nanoparticle 
PEG 
 
poly(ethylene glycol) 
PL 
 
photoluminescence 
PMT 
 
photomultiplier tube 
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POCT 
 
point-of-care testing 
QD 
 
quantum dot 
qRT-PCR quantitative reverse transcription-polymerase chain reaction 
RCA 
 
rolling circle amplification 
ref. 
 
reference 
RNA 
 
ribonucleic acid 
sAv 
 
streptavidin 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
ssDNA 
 
single strand DNA 
TCSPC 
 
time-correlated single-photon counting 
TEM 
 
transmission electron microscopy 
TG 
 
time-gated 
Tm 
 
melting temperature 
TR 
 
time-resolved 
UC 
 
upconversion 
UCNP 
 
upconversion nanoparticle 
UV 
 
ultraviolet 
Vis 
 
visible 
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7.2 LTC-ssDNA conjugation protocol (a typical protocol, 
suitable for all ssDNAs used in this work)  
Conjugation:  
7.9 μL Carbonate buffer (pH 9.0) + 10 μL ssDNA (100 μM) + 2.1 μL L4Tb-NHS (in DMF, 8 
mM) in 0.5 mL Eppendorf-tube.  
Concentration of ssDNA in conjugation solution is 50 μM, reaction ratio LTC/ ssDNA= 16/1.  
- Shortly vortex  
- Intelli Mixer: prewetting tube-walls by rotating the tube  
                        sample in alu foil  
                        program F1 - 30 rpm  
- Incubation time: overnight  
Purification:  
Purification buffer: 100 mM HEPES, pH 7.4  
A. Desalting Spin Column Preparation  
1. Remove column’s bottom closure and loosen cap (do not remove cap).  
2. Place column in a 2.0 mL collection tube. Centrifuge at 1500 × g for 1 minute to remove 
storage solution.  
3. Place a mark on the side of the column where the compacted resin is slanted upward. Place 
column in the microcentrifuge with the mark facing outward in all subsequent centrifugation 
steps.  
4. Add 300 μL of purification buffer on top of the resin bed. Centrifuge at 1500 × g for 1 minute 
to remove buffer.  
5. Repeat Step 4 two to three additional times, discarding buffer from the collection tube.  
B. Sample Loading  
1. Place column in a new collection tube, remove the cap and apply 100 μL of sample (20 μL 
sample plus 80 μL purification buffer) to the top of the compact resin bed.  
2. Centrifuge at 1500 × g for 2 minutes to collect the sample. Discard desalting column after 
use.  
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Repeat A and B two more times to fully separate free LTC from reporter 20a-LTC sample 
(checked with UV table)  
Characterization:  
Absorbance measurement by PerkinElmer reader  
PL emission and lifetime measurement by FT300 
7.3 Cy 3.5-ssDNA conjugation protocol (a typical protocol, 
suitable for all ssDNAs used in this work)  
Conjugation:  
7.9 μL Carbonate buffer (pH 9.0) + 10 μL ssDNA (100 μM) + 2.1 μL Cy 3.5-NHS (in DMF, 
6.6 mM) in 0.5 mL Eppendorf-tube  
concentration of ssDNA in conjugation solution is 50 μM, reaction ratio Cy 3.5/ssDNA= 14/1  
- shortly vortex  
- Intelli Mixer: prewetting tube-walls by rotating the tube  
                        sample in alu foil  
                        program F1 - 30 rpm  
- incubation time: overnight  
Purification:  
Purification buffer: 100 mM HEPES, pH 7.4  
A. Desalting Spin Column Preparation  
1. Remove column’s bottom closure and loosen cap (do not remove cap).  
2. Place column in a 2.0 mL collection tube. Centrifuge at 1500 × g for 1 minute to remove 
storage solution.  
3. Place a mark on the side of the column where the compacted resin is slanted upward. Place 
column in the microcentrifuge with the mark facing outward in all subsequent centrifugation 
steps.  
4. Add 300 μL of purification buffer on top of the resin bed. Centrifuge at 1500 × g for 1 minute 
to remove buffer.  
5. Repeat Step 4 two to three additional times, discarding buffer from the collection tube.  
B. Sample Loading  
1. Place column in a new collection tube, remove the cap and apply 100 μL of sample (20 μL 
sample plus 80 μL purification buffer) to the top of the compact resin bed.  
2. Centrifuge at 1500 × g for 2 minutes to collect the sample. Discard desalting column after 
use.  
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Repeat A and B two more times to fully separate free LTC from reporter 20a-LTC sample 
(checked with UV table)  
Characterization:  
Absorbance measurement by PerkinElmer reader  
PL emission and lifetime measurement by FT300 
7.4 Cy 5.5-ssDNA conjugation protocol (a typical protocol, 
suitable for all ssDNAs used in this work)  
Conjugation:  
9.0 μL Carbonate buffer (pH 9.0) + 10 μL ssDNA (100 μM) + 1.0 μL Cy 5.5-NHS (in DMF, 
16.6 mM) in 0.5 mL Eppendorf-tube  
concentration of ssDNA in conjugation solution is 50 μM, reaction ratio Cy 5.5/ ssDNA= 16/1  
- shortly vortex  
- Intelli Mixer: prewetting tube-walls by rotating the tube  
                        sample in alu foil  
                        program F1 - 30 rpm  
- incubation time: overnight  
Purification:  
Purification buffer: 100 mM HEPES, pH 7.4  
A. Desalting Spin Column Preparation  
1. Remove column’s bottom closure and loosen cap (do not remove cap).  
2. Place column in a 2.0 mL collection tube. Centrifuge at 1500 × g for 1 minute to remove 
storage solution.  
3. Place a mark on the side of the column where the compacted resin is slanted upward. Place 
column in the microcentrifuge with the mark facing outward in all subsequent centrifugation 
steps.  
4. Add 300 μL of purification buffer on top of the resin bed. Centrifuge at 1500 × g for 1 minute 
to remove buffer.  
5. Repeat Step 4 two to three additional times, discarding buffer from the collection tube.  
B. Sample Loading  
1. Place column in a new collection tube, remove the cap and apply 100 μL of sample (20 μL 
sample plus 80 μL purification buffer) to the top of the compact resin bed.  
2. Centrifuge at 1500 × g for 2 minutes to collect the sample. Discard desalting column after 
use.  
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Repeat A and B two more times to fully separate free LTC from reporter 20a-LTC sample 
(checked with UV table)  
Characterization:  
Absorbance measurement by PerkinElmer reader  
PL emission and lifetime measurement by FT300 
7.5 Instrument 
All FRET measurements were performed by two fluorescence plate readers. The first plate 
reader was a modified KRYPTOR compact PLUS (Cezanne/Thermo Fisher Scientific, France) 
using 500 detection bins of 2 µs integration time. The system has an integrated pulsed nitrogen 
laser with an excitation wavelength of 337 nm and a repetition rate of 20 Hz. The second 
fluorescence plate reader is a prototype from Edinburgh Instruments (UK) developed during a 
joined project and referred in this work as EI plate reader. The system allows time-resolved 
FRET assay measurements using 4000 detection bins of 2 µs integration time. The excitation 
source was a pulsed nitrogen laser (MNL 100, LTB Berlin) with an excitation wavelength of 
337 nm and a repetition rate of 20 Hz. 
 
Dichroic mirrors and bandpass filter 
The instrumental construction for all used plate readers is shown in Figure 7.1. After sample 
excitation, a dichroic mirror is used to separate the emission signals from the sample into two 
individual detection channels. This separation allows the simultaneous measurement of the 
FRET acceptor signals (ChA) and the FRET donor signals (ChD) using two photomultiplier 
tubes (PMTs). A further selection of the emission wavelengths inside the channels is obtained 
by the use of bandpass filters, which are optimized for the emission detection of the LTC and 
for the Cyanine dyes or QD.  
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Figure 7.1. Simplified schematic instrumental setup of the used fluorescence plate readers.  
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9. Synthèse en français 
Le cancer tue des millions de personnes chaque année, c'est l'un des plus grands problèmes de 
santé des êtres humains. Le prix Nobel de physiologie ou médecine 2018 a été décerné à James 
P. Allison et Tasuku Honjo pour leur découverte du traitement du cancer par inhibition de la 
régulation immunitaire négative. Si le cancer peut être diagnostiqué à un stade précoce, les 
chances de succès des traitements seront considérablement augmentées. Reconnaître les signes 
avant-coureurs possibles du cancer et agir rapidement mène à un diagnostic précoce.  
L'une des meilleures façons de diagnostiquer précocement un cancer est d’identifier des 
biomarqueurs sériques ou tissulaires. Les biomarqueurs du cancer peuvent être de l'ADN, de 
l'ARN, des protéines, des métabolites ou des processus comme l'apoptose, l'angiogenèse ou la 
prolifération [1]. Ces biomarqueurs sont produits par la tumeur elle-même ou par d'autres tissus 
et peuvent se trouver dans divers fluides, tissus et lignées cellulaires, en réponse à la présence 
du cancer ou d’affections connexes. Les microARNs (miARNs), qui sont de petits (~22bp) 
ARNs non codants hautement conservés et exprimés de façon endogène dans chaque type 
cellulaire, ont émergé en tant que nouveau type de biomarqueur spécifique du cancer [2]. Ils 
fonctionnent comme des régulateurs de l'expression génétique en réduisant au silence des 
transcrits cibles par complémentation des paires de bases. Les miARNs peuvent être sécrétés 
par les cellules et se trouvent dans une variété de fluides corporels comme le sang, la salive et 
l'urine, où ils sont quantifiables et extrêmement stables [1]. Pour ces raisons, les miARNs sont 
considérés aujourd’hui comme des candidats idéaux en tant biomarqueurs non-invasifs pour le 
cancer. 
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La détection des acides nucléiques par transfert d'énergie de résonance de type Förster (FRET) 
est l'une des techniques les plus prometteuses qui peut répondre à presque toutes les exigences 
d'un diagnostic rapide, simple et multiplexé [3]. Le FRET est un transfert d'énergie non radiatif 
d'une molécule donneuse excitée (FRET-donneur) vers une molécule acceptrice à l’état 
fondamental (FRET-accepteur) par des interactions dipôle-dipôle [4]. Les principales 
conditions pour que le FRET apparaisse sont que le donneur et l’accepteur doivent être proches 
l'un de l'autre et qu’il doit exister un recouvrement spectral entre l’émission du donneur et 
l’excitation de l'accepteur. En raison de la forte dépendance à la distance entre le donneur et 
l’accepteur, les biocapteurs basés sur le principe du FRET sont très performants pour l'analyse 
des interactions biologiques et des changements structuraux à l'échelle nanométrique (environ 
1 à 20 nm). Pour la plupart des tests de détection des acides nucléiques basés sur le FRET, le 
donneur et l'accepteur sont conjugués à l'ADN, le miARN ciblant cet ADN peut s’hybrider pour 
modifier la distance entre le donneur et l'accepteur, modifiant ainsi l'efficacité et la durée de vie 
du signal FRET. Les miARNs peuvent être détectés qualitativement et quantitativement par le 
changement de l'efficacité de FRET et de l'intensité de la photoluminescence (PL) du donneur 
ou de l’accepteur [5-9]. 
Avec le nombre croissant de systèmes de détection basés sur le FRET développés, de nombreux 
types de fluorophores ont été utilisés comme donneurs de FRET. Comparé aux fluorophores 
traditionnels, le complexe de lanthanide terbium (LTC) en tant que donneur de FRET présente 
des avantages uniques pour la détection par multiplexage avec différents accepteurs de FRET, 
comme les colorants organiques et les points quantiques ("quantum dots", QDs) [10-11]. En 
raison des transitions interdites f-f dans les ions terbium, le LTC possède des propriétés photo-
physiques particulières, comme un grand décalage de Stokes, de multiples et étroites bandes 
d'émission et des durées de vie extrêmement longues (jusqu'à quelques millisecondes) qui 
permettent des mesures avec une sélection temporelle ("time-gated measurements", TG) [12]. 
Ces mesures en sélection temporelle (TG) permettent la distinction entre le signal FRET 
(longue durée de vie) et le bruit de fond dû à l’auto-fluorescence (de courte durée de vie) avec 
une très haute sensibilité de détection. Les bandes d'émission du Terbium (Tb) sont bien 
séparées et donc très bénéfiques pour le multiplexage spectral ; les temps de décroissance long 
et distinguables (en raison des différentes efficacités de FRET) des accepteurs sensibilisés 
offrent un grand potentiel pour le multiplexage temporel. 
Les colorants ou sondes fluorescentes, aussi appelés fluorophores, sont des molécules non 
protéiques qui absorbent la lumière et la réémettent à une plus grande longueur d'onde. Ils sont 
utilisés dans les expériences biologiques depuis des décennies parce qu'ils sont faciles à 
manipuler et non toxiques. Les sondes fluorescentes offrent une plus grande photo-stabilité et 
luminosité que les protéines fluorescentes et ne nécessitent pas de temps de maturation. Les 
sondes fluorescentes sont également populaires en raison de leur rendement quantique élevé, 
de leur solubilité et de leur facilité de bio-conjugaison. Leur grande variété et leur grande 
disponibilité commerciale en ont fait la classe de fluorophores la plus fréquemment utilisée 
pour le FRET [13-14]. La combinaison de donneur LTC avec des sondes fluorescentes 
acceptrices a été utilisée dans des expériences de bio-détection multiplexée en FRET [15-16]. 
Bien qu'il soit possible de multiplexer les LTC et les sondes fluorescentes et d’obtenir une 
sensibilité élevée, la mauvaise séparation des spectres d'absorption et d'émission induit des 
interférences spectrales entre différents accepteurs durant le multiplexage spectral, et une 
correction appropriée est nécessaire. 
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Pour des bandes d'émission beaucoup plus étroites et des maximums de longueur d’onde 
d'émission réglables en fonction de leurs tailles, les QDs sont d'excellents candidats en tant 
qu’accepteurs de FRET pour le multiplexage. Les QDs ont plusieurs propriétés photo-
physiques intrinsèques uniques : des rendements quantiques relativement élevés ; les QDs 
adaptables en taille et en type de matériau peuvent être utilisés pour donner un meilleur 
recouvrement spectral avec leur partenaire de FRET ; des coefficients d'extinction 10 à 100 fois 
supérieurs aux sondes fluorescentes, coefficients qui sont extrêmement importants pour le 
recouvrement spectral avec l'émission du LTC [17-18]. Des distances de Förster R0 supérieures 
à 10 nm peuvent être obtenues avec des paires de FRET LTC-QD, ce qui est nettement supérieur 
aux valeurs de R0 des paires donneur-accepteur conventionnelles [19-20]. La combinaison des 
LTC et des QDs pour des mesures de FRET a donc un potentiel très élevé (en termes de haute 
sensibilité et de grand R0). 
Cette thèse est divisée en six chapitres et est complétée par une annexe et la bibliographie. 
Après une introduction présentant le contexte de ce travail, trois projets individuels sont 
présentés. Chaque chapitre est organisé en une introduction, une section de matériel et méthode, 
les résultats, une discussion et une conclusion.  
Le premier projet (Figure 1.1) présente des expériences de duplexage temporel pour la 
détection de miARNs en utilisant une seule paire de FRET Tb-sonde fluorescente et la 
technique de réaction d'hybridation en chaîne (HCR). J’ai fait la démonstration de la mise en 
œuvre du FRET en sélection temporelle (TG, "time-gated") entre les donneurs (Tb) et les 
accepteurs (sondes fluorescentes) en utilisant la technique de HCR pour la quantification 
multiplexée des miARNs (miR-20a et miR-21) et de leurs analogues d’ADN. Le HCR-TG-
FRET a permis une quantification des acides nucléiques sans lavage avec des limites de 
détection (LOD) très basses, jusqu'à 240 attomoles (1,7 pM) de miARNs et 123 attomoles (0,88 
pM) d'ADN. Une distinction efficace entre des miARNs très homologues a démontré une 
spécificité très élevée. Le multiplexage en une seule mesure, une seule longueur d'onde 
d'excitation et une seule paire de FRET a permis de quantifier simultanément miR-20a et miR-
21 à des concentrations comprises entre 30 pM et 300 pM dans le même échantillon. Le HCR-
TG-FRET a montré une performance similaire pour les échantillons avec ou sans sérum sans 
l'utilisation d'inhibiteurs de RNase. Nos résultats présentent une amélioration significative des 
approches actuelles par HCR en matière de simplicité, de sensibilité et de multiplexage. La 
performance diagnostique polyvalente du HCR-TG-FRET, même dans des environnements 
biologiques complexes, présente un avantage important pour la biodétection des acides 
nucléiques. 
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Figure 1.1. Représentation schématique pour la détection duplexée des miRNAs (miR-20a et 
miR-21) en utilisant le HCR-TG-FRET.  
 
Dans le deuxième projet (Figure 1.2), j'ai combiné le multiplexage temporel et le multiplexage 
spectral, mis au point un test FRET Tb-sondes fluorescentes quadruplexé et un test RCA 
(amplification circulaire de l’ADN) pour la détection de l'ADN simple brin (ssDNA). Nous 
avons démontré la possibilité de faire une mesure de FRET en sélection temporelle d'un 
complexe Tb à longue durée de vie avec des sondes fluorescentes Cy3.5 et Cy5.5 pour le 
multiplexage spectro-temporel de quatre cibles d'ADN différentes dans le même échantillon 
(avec deux fenêtres temporelles et deux couleurs différentes). Nous avons utilisé l'amplification 
circulaire de l’ADN (RCA) pour obtenir une détection à haute sensibilité et pour placer les 
fragments d’ADN contenant les donneurs de FRET (Tb) et les fragments d’ADN contenant les 
sondes acceptrices à des distances contrôlées dans les concatémères d'ADN. Nous avons 
sélectionné quatre courts ADNs simple brins différents (ADN-20a, ADN-20b, ADN-21 et 
ADN-191), qui sont les équivalents ADN des miARNs hsa-mir-20a/20b/21/191, tous étant liés 
au cancer du sein. Le principe du RCA-FRET est que chaque cible d'ADN est reconnue par les 
séquences terminales d'une sonde à cadenas ("padlock probe") spécifique. Après cette étape 
d'hybridation, une ligase ferme le cadenas, qui transforme la cible en une amorce pour la 
synthèse ultérieure d'ADN. L'amplification de l'ADN par RCA est effectuée à 37 °C pendant 2 
h et le produit d’amplification obtenu est marqué (hybridation spécifique) par des séquences 
d'ADN conjuguées à un donneur de FRET (Tb) ou des colorants accepteurs de FRET. Le choix 
précis de la distance entre les sondes d’ADN conduit à des déclins de PL spécifiques des paires 
donneur/accepteur de FRET utilisées et à une quantification simple, sans séparation (sans 
purification préalable de l’échantillon) et multiplexée de l'ADN. Le test de RCA-FRET a permis 
de distinguer des séquences d’ADN très homologues et a permis d’obtenir des limites de 
détection entre 40 et 570 zeptomoles (0,3 à 4,1 fM) pour quatre ADNs cibles différents. Nous 
avons démontré la possibilité de combiner les dimensions spectrale et temporelle de la PL pour 
un multiplexage d'ordre supérieur avec la dimension d'intensité du PL pour la quantification 
des quatre différents ADN à de faibles concentrations (fM) dans un même échantillon, en 
utilisant une seule source d'excitation et seulement deux couleurs de fluorescence. 
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Figure 1.2. Le principe du test spectro-temporel quadruplexé de RCA-FRET et le multiplexage 
de la PL en trois dimensions. Axes x : durée de vie ; y : couleur ; z : Intensité PL. 
 
Dans le troisième projet (Figure 1.3), j'ai étudié la FRET à multiplexage temporel Tb-QD en 
ajustant la longueur de l'ADN séparant les deux marqueurs Tb et QD. J'ai analysé par 
modélisation moléculaire et mesure de FRET résolue en temps 11 configurations d'un ADN de 
31 nt de long, lié à un QD par une séquence peptide-His6 (peptide-ADN), hybridé avec 
différentes sondes d'ADN complémentaires auxquelles est conjugué le Tb, l’hybridation des 
sondes à l’ADN séparant le Tb du QD par des distances de 0 à 26 nt. Nos résultats montrent 
que l'augmentation des distances Tb-QD a conduit à une augmentation de la durée de vie de la 
sensibilisation des QDs, les 11 configurations pouvant être identifiées sans "fitting" des courbes 
de décroissance de durée de vie de PL.  Les déclins de PL temporellement distincts des 
différentes configurations d’ADN peuvent être utilisés pour des essais d'hybridation 
prototypiques. Un tel réglage fin des mesures de PL par déplacement du donneur de Tb de 
quelques nucléotides démontre la grande sensibilité du FRET à la distance donneur/accepteur 
et la possibilité d'étendre le multiplexage temporel à l’utilisation de nanoparticules tels que les 
QDs. 
 
Figure 1.3. En haut : Représentation schématique du FRET Tb-QD à multiplexage temporel. 
En bas : La modélisation moléculaire a été utilisée pour calculer les distances Tb-QD dans les 
configurations de liaison de l’ADN parallèlement et verticalement à la surface. 
 
Cette thèse présente trois applications réussites de l'FRET dans deux domaines de recherche 
distincts. Les deux premiers sont des biocapteurs LTC-Colorant FRET multiplexés pour la 
détection de biomarqueurs d'acides nucléiques liés au cancer, basés sur des méthodes 
d'amplification et des mesures à des lapse de temps déterminé. Nous avons utilisé deux 
stratégies pour réaliser la détection multiplexée, la détection temporelle multiplexée basée sur 
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les temps de décroissance remarquable d'une paire FRET LTC-Colorant et la détection spectral- 
temporelle multiplexé basée sur des spectres d'émission différents de différents colorants et des 
temps de décroissance différents de la même paire LTC-Colorant. Les méthodes de réaction en 
chaîne d'hybridation et d'amplification par cercle de roulant ont été combinées pour obtenir une 
sensibilité élevée et pour placer les Tb donneurs et les colorants accepteurs à des distances 
contrôlées sur l’ADN amplifié. Des mesures à des laps de temps déterminés ont été utilisées 
pour recueillir les intensités PL et calculer les contributions de différentes analytes dans 
différentes fenêtres temporelles à l'aide d'une simple matrice de calcul. La dernière est l'étude 
de conformation de l'ADN conjugué QD à simple et double brin par la durée de vie des FRET 
LTC-QD. Les résultats démontrent que les QD peuvent être utilisés pour la détection temporelle 
multiplexée et que la construction d'ADN Tb-QD FRET a un fort potentiel d'extension 
significative de la plage de multiplexage du concept de multiplexage temporel. Tous ces tests 
sont homogènes, aucun lavage ni séparation n'est nécessaire même avec le test amplifié. Ils sont 
tous spécifiques, peuvent distinguer des séquences très similaires. Toutes ces techniques de 
détection sont facilement transférables à d'autres cibles d'acides nucléiques. 
Dans le premier travail, la capacité de multiplexage n'est pas limitée à deux, nous pouvons 
également essayer d'utiliser cette technique pour des essais triplex et la capacité en échantillons 
réels devrait également être déterminée dans les recherches futures. Dans le second travail, nous 
avons détecté quatre ADN différents, qui sont les équivalents ADN des miARNs. Nous n'avons 
pas détecté directement les miARN parce que les courbes d'étalonnage n'étaient pas linéaires. 
Il est difficile d'effectuer le calcul de la matrice avec des fonctions exponentielles, pour cela il 
faudrait faire plus d'optimisation pour les tests miRNA. Cette première démonstration de 
multiplexage spectral-temporel n'a quantifié que quatre ADN en combinant deux composantes 
spectrales et deux composantes temporelles, mais lorsque plus d'accepteurs différents et plus 
de fenêtres temporelles sont ajoutés, le nombre de cibles détectables dans un seul échantillon 
sera considérablement augmenté. La construction du complexe Tb-QD FRET ADN représente 
non seulement une alternative valable aux techniques d'analyse de conformation de l'ADN, mais 
elle a également un fort potentiel pour être utilisée pour développer des biocapteurs permettant 
de quantifier l'ADN à de faibles concentrations nano molaires. Les essais d'hybridation de 
preuve de concept ont démontré l'application possible de l'accord de distance Tb-QD basé sur 
l'ADN pour le multiplexage temporel d'ordre supérieur qui peut également être combiné avec 
plusieurs couleurs QD différentes. 
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